US20050103625A1 - Sensor head for use with implantable devices - Google Patents
Sensor head for use with implantable devices Download PDFInfo
- Publication number
- US20050103625A1 US20050103625A1 US11/021,162 US2116204A US2005103625A1 US 20050103625 A1 US20050103625 A1 US 20050103625A1 US 2116204 A US2116204 A US 2116204A US 2005103625 A1 US2005103625 A1 US 2005103625A1
- Authority
- US
- United States
- Prior art keywords
- sensor
- domain
- region
- electrode
- electrochemically reactive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
- G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
- G01N27/3272—Test elements therefor, i.e. disposable laminated substrates with electrodes, reagent and channels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1486—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using enzyme electrodes, e.g. with immobilised oxidase
- A61B5/14865—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using enzyme electrodes, e.g. with immobilised oxidase invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/001—Enzyme electrodes
- C12Q1/002—Electrode membranes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/001—Enzyme electrodes
- C12Q1/005—Enzyme electrodes involving specific analytes or enzymes
- C12Q1/006—Enzyme electrodes involving specific analytes or enzymes for glucose
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/48707—Physical analysis of biological material of liquid biological material by electrical means
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/48785—Electrical and electronic details of measuring devices for physical analysis of liquid biological material not specific to a particular test method, e.g. user interface or power supply
Definitions
- the present invention relates generally to novel sensor heads utilized with implantable devices, devices including these sensor heads and methods for determining analyte levels using these implantable devices. More particularly, the invention relates to sensor heads, implantable devices including these sensor heads and methods for monitoring glucose levels in a biological fluid using these devices.
- Amperometric electrochemical sensors require a counter electrode to balance the current generated by the species being measured at the working electrode.
- the species being measured at the working electrode is H 2 O 2 .
- Glucose oxidase catalyzes the conversion of oxygen and glucose to hydrogen peroxide and gluconate according to the following reaction: Glucose+O 2 ⁇ Gluconate+H 2 O 2
- H 2 O 2 Because for each glucose molecule metabolized, there is a proportional change in the product H 2 O 2 , one can monitor the change in H 2 O 2 to determine glucose concentration. Oxidation of H 2 O 2 by the working electrode is balanced by reduction of ambient oxygen, enzyme generated H 2 O 2 , or other reducible species at the counter electrode. In vivo glucose concentration may vary from about one hundred times or more that of the oxygen concentration. Consequently, oxygen becomes a limiting reactant in the electrochemical reaction and when insufficient oxygen is provided to the sensor, the sensor will be unable to accurately measure glucose concentration. Those skilled in the art have come to interpret oxygen limitations resulting in depressed function as being a problem of availability of oxygen to the enzyme.
- the sensor head 10 includes a working electrode 21 (anode), counter electrode 22 (cathode), and reference electrode 20 which are affixed to the head by both brazing 26 the electrode metal to the ceramic and potting with epoxy 28 .
- the working electrode 21 (anode) and counter-electrode 22 (cathode) of a glucose oxidase-based glucose sensor head 10 require oxygen in different capacities.
- Prior art teaches an enzyme-containing membrane that resides above an amperometric electrochemical sensor.
- region 32 includes an immobilized enzyme, i.e. glucose oxidase. Within the enzyme layer above the working electrode 21 , oxygen is required for the production of H 2 O 2 from glucose.
- the H 2 O 2 produced from the glucose oxidase reaction further reacts at surface 21 a of working electrode 21 and produces two electrons.
- the products of this reaction are two protons (2H + ), two electrons (2 e ⁇ ), and one oxygen molecule (O 2 ) (Fraser, D. M. “An Introduction to In Vivo Biosensing: Progress and problems.” In “Biosensors and the Body,” D. M. Fraser, ed., 1997, pp. 1-56 John Wiley and Sons, New York).
- the oxygen concentration near the working electrode 21 which is consumed during the glucose oxidase reaction, is replenished by the second reaction at the working electrode. Therefore, the net consumption of oxygen is zero.
- neither all of the H 2 O 2 produced by the enzyme diffuses to the working electrode surface nor does all of the oxygen produced at the electrode diffuse to the enzyme domain.
- the counter electrode 22 utilizes oxygen as an electron acceptor.
- the most likely reducible species for this system are oxygen or enzyme generated peroxide (Fraser, D. M. supra).
- the two-electron pathway is shown in FIG. 1 .
- Oxygen is further consumed above the counter electrode by the glucose oxidase in region 32 . Due to the oxygen consumption by both the enzyme and the counter electrode, there is a net consumption of oxygen at the surface 22 a of the counter electrode.
- loss of glucose oxidase sensor function may not be due to a limitation of oxygen in the enzyme layer near the working electrode, but may instead be due to a limitation of oxygen at the counter electrode.
- a higher peroxide concentration results, thereby increasing the current at the working electrode.
- the counter electrode limitation begins to manifest itself as this electrode moves to increasingly negative voltages in the search for reducible species.
- the counter electrode voltage reaches a circuitry limit of ⁇ 0.6V resulting in compromised sensor function (see FIG. 3 ).
- FIG. 3 shows simultaneous measurement of counter-electrode voltage and sensor output to glucose levels from a glucose sensor implanted subcutaneously in a canine host. It can be observed that as glucose levels increase, the counter electrode voltage decreases. When the counter electrode voltage reaches ⁇ 0.6V, the signal to noise ratio increases significantly. This reduces the accuracy of the device.
- FIG. 4 shows a further example of another glucose sensor in which the counter-electrode reaches the circuitry limit. Again, once the counter electrode reaches ⁇ 0.6V, the sensitivity and/or signal to noise ratio of the device is compromised. In both of these examples, glucose levels reached nearly 300 mg/dl. However, in FIG. 3 the sensor showed a greater than three-fold higher current output than the sensor in FIG. 4 .
- FIG. 5 shows a glucose sensor in which the counter electrode voltage did not reach ⁇ 0.6V.
- the sensor was able to maintain a current balance between the working and counter electrodes, thereby enabling accurate measurements throughout the course of the experiment.
- the results shown in FIGS. 3, 4 and 5 led the present inventors to postulate that by keeping the counter electrode from reaching the circuitry limit, one could maintain sensitivity and accuracy of the device.
- the first approach involves the widening of the potential range over which the counter electrode can move in the negative direction to avoid reaching circuitry limitations. Unfortunately, this approach increases undesirable products that are produced at lower potentials. One such product, hydrogen, may form at the counter electrode,which may then diffuse back to the working electrode. This may contribute to additional current resulting in erroneously high glucose concentration readings. Additionally, at these increasingly negative potentials, the probability of passivating or poisoning the counter electrode greatly increases. This effectively reduces the counter electrode surface area requiring a higher current density at the remaining area to maintain current balance. Furthermore, increased current load increases the negative potentials eventually resulting in electrode failure.
- the second approach is utilizing the metal case of the device as a counter electrode (see U.S. Pat. No. 4,671,288, Gough or U.S. Pat. No. 5,914,026, Blubaugh).
- This provides an initial excess in surface area which is expected to serve the current balancing needs of the device over its lifetime.
- the counter electrode reaction is a reduction reaction, as in Blubaugh, the normally present metal oxide layer will be reduced to bare metal over time leaving the surface subject to corrosion, poisoning, and eventual cascade failure. This problem is magnified when considering the various constituents of the body fluid that the metal casing is exposed to during in vivo use. To date, there has been no demonstration of long-term performance of such a device with this counter electrode geometry.
- a sensor head for use in an implantable analyte measuring device which includes the same sensor head components as those described above.
- the sensor heads of the present invention include a multi-region membrane that controls the number of species that are able to reach the surface of the electrodes.
- a membrane allows the passage of desired substrate molecules (e.g. oxygen and glucose) and rejects other larger molecules that may interfere with accurate detection of an analyte.
- desired substrate molecules e.g. oxygen and glucose
- the sensor heads of the present invention also provide a larger counter electrode reactive surface that balances the current between the working and counter electrodes, thereby minimizing negative potential extremes that may interfere with accurate analyte detection.
- an implantable device for measuring an analyte in a biological fluid including at least one of the sensor heads described above.
- a method of monitoring glucose levels is disclosed which includes the steps of providing a host, and an implantable device as provided above and implanting the device in the host.
- a method of measuring glucose in a biological fluid including the steps of providing a host and a implantable device described above, which includes a sensor head capable of accurate continuous glucose sensing; and implanting the device in the host.
- the sensor head, membrane architectures, devices and methods of the present invention allow for the collection of continuous information regarding desired analyte levels (e.g. glucose). Such continuous information enables the determination of trends in glucose levels, which can be extremely important in the management of diabetic patients.
- desired analyte levels e.g. glucose
- the term “sensor head” refers to the region of a monitoring device responsible for the detection of a particular analyte.
- the sensor head generally comprises a non-conductive body, a working electrode (anode), a reference electrode and a counter electrode (cathode) passing through and secured within the body forming an electrochemically reactive surface at one location on the body and an electronic connective means at another location on the body, and a multi-region membrane affixed to the body and covering the electrochemically reactive surface.
- the counter electrode has a greater electrochemically reactive surface area than the working electrode.
- a biological sample e.g., blood or interstitial fluid
- an enzyme e.g., glucose oxidase
- the reaction of the biological sample (or portion thereof) results in the formation of reaction products that allow a determination of the analyte (e.g. glucose) level in the biological sample.
- the multi-region membrane further comprises an enzyme domain, and an electrolyte phase (i.e., a free-flowing liquid phase comprising an electrolyte-containing fluid described further below).
- analyte refers to a substance or chemical constituent in a biological fluid (e.g., blood, interstitial fluid, cerebral spinal fluid, lymph fluid or urine) that can be analyzed.
- a preferred analyte for measurement by the sensor heads, devices and methods of the present invention is glucose.
- electrochemically reactive surface refers to the surface of an electrode where an electrochemical reaction takes place.
- the hydrogen peroxide produced by the enzyme catalyzed reaction of the analyte being detected reacts creating a measurable electronic current (e.g. detection of glucose analyte utilizing glucose oxidase produces H 2 O 2 peroxide as a by product, H 2 O 2 reacts with the surface of the working electrode producing two protons ( 2 H + ), two electrons ( 2 e ⁇ ) and one molecule of oxygen (O 2 ) which produces the electronic current being detected).
- a reducible species e.g. O 2 is reduced at the electrode surface in order to balance the current being generated by the working electrode.
- electronic connection refers to any electronic connection known to those in the art that may be utilized to interface the sensor head electrodes with the electronic circuitry of a device such as mechanical (e.g., pin and socket) or soldered.
- domain refers to regions of the membrane of the present invention that may be layers, uniform or non-uniform gradients (e.g. anisotropic) or provided as portions of the membrane.
- multi-region membrane refers to a permeable membrane that may be comprised of two or more domains and constructed of biomaterials of a few microns thickness or more which are permeable to oxygen and may or may not be permeable to glucose.
- One of the the membranes may be placed over the sensor body to keep host cells (e.g., macrophages) from gaining proximity to, and thereby damaging, the enzyme membrane or forming a barrier cell layer and interfering with the transport of analyte across the tissue-device interface.
- a biological fluid measuring device comprises a multi-region membrane that may be comprised of a number of domains. If the electrodes of the sensor head are deemed to be the point of reference, and one of the multi-region membrane domains is positioned farther from the electrodes, than that domain is distant from the electrodes.
- oxygen antenna domain refers to a domain composed of a material that has higher oxygen solubility than aqueous media so that it concentrates oxygen from the biological fluid surrounding the biointerface membrane.
- the domain can then act as an oxygen reservoir during times of minimal oxygen need and has the capacity to provide on demand a higher oxygen gradient to facilitate oxygen transport across the membrane. This enhances function in the enzyme reaction domain and at the counter electrode surface when glucose conversion to hydrogen peroxide in the enzyme domain consumes oxygen from the surrounding domains.
- this ability of the oxygen antenna domain to apply a higher flux of oxygen to critical domains when needed improves overall sensor function.
- solid portions refer to a material having a structure that may or may not have an open-cell configuration but in either case prohibits whole cells from traveling through or residing within the material.
- substantially number refers to the number of cavities or solid portions having a particular size within a domain in which greater than 50 percent of all cavities or solid portions are of the specified size, preferably greater than 75 percent and most preferably greater than 90 percent of the cavities or solid portions have the specified size.
- co-continuous and the like refers to a solid portion wherein an unbroken curved line in three dimensions exists between any two points of the solid portion.
- the term “host” refers to both humans and animals.
- glucose means, for example, 90% of measured glucose values are within the “A” and “B” region of a standard Clarke error grid when the sensor measurements are compared to a standard reference measurement. It is understood that like any analytical device, calibration, calibration validation and recalibration are required for the most accurate operation of the device.
- continuous glucose sensing refers to the period in which monitoring of plasma glucose concentration is continuously performed, for example, about every 10 minutes.
- FIG. 1 Illustration of thermodynamically favored reactions at the working electrode and counter electrode at the desired voltage potentials.
- FIG. 2A depicts a cross-sectional exploded view of a sensor head of the present invention wherein the multi-region membrane comprises three regions.
- FIG. 2B depicts a cross-sectional exploded view of a sensor head of the present invention wherein a portion of the second membrane region does not cover the working electrode.
- FIG. 2C depicts a cross-sectional exploded view of a sensor head of the present invention which includes two distinct regions, wherein the region adjacent the electrochemically reactive surfaces includes a portion positioned over the counter electrode which corresponds to a silicone domain.
- FIG. 2D depicts a cross-sectional exploded view of a sensor head of the present invention wherein an active enzyme of the immobilized enzyme domain is positioned only over the working electrode.
- FIG. 2E depicts a cross-sectional exploded view of a sensor head of the present invention wherein the enzyme positioned over the counter electrode has been inactivated.
- FIG. 2F depicts a cross-sectional exploded view of a sensor head of the present invention wherein the membrane region containing immobilized enzyme is positioned only over the working electrode.
- FIG. 3 Illustration of an implantable glucose sensor's ability to measure glucose concentration during an infusion study in a canine when the counter electrode voltage drops to the electronic circuitry limit at approximately 0.75 hours wherein the sensor current output reaches 2.50 nA.
- FIG. 4 Illustration of an implantable glucose sensor's ability to measure glucose concentration during an infusion study in a canine when the counter electrode voltage drops to the electronic circuitry limit after 0.5 hours wherein the sensor current output reaches 0.50 nA.
- FIG. 5 Illustration of an implantable glucose sensor's ability to measure glucose concentration during an infusion study in a canine when the counter electrode voltage is maintained above the electronic circuitry limit.
- FIG. 6A shows a schematic representation of a cylindrical analyte measuring device including a sensor head according to the present invention.
- FIG. 6B is an exploded view of the sensor head of the device shown in FIG. 6A .
- FIG. 7 Graphical representation of the function of a device of the present invention utilizing the multi-region membrane architecture of FIG. 2B in vitro at 400 mg/dL glucose.
- FIG. 8 depicts a cross-sectional exploded view of the electrode and membrane regions of a prior sensor device where the electrochemical reactive surface of the counter electrode is substantially equal to the surface area of the working electrode.
- FIG. 9 Graphical representation of the counter electrode voltage as a function of oxygen concentration at 400 mg/dL glucose for sensor devices including the membrane shown in FIG. 8 .
- the sensor heads, devices and methods of the present invention may be used to determine the level of glucose or other analytes in a host.
- the level of glucose is a particularly important measurement for individuals having diabetes in that effective treatment depends on the accuracy of this measurement.
- the present invention increases the effectiveness of counter electrode function by a method that does not depend on increasing the local concentration of oxygen.
- the counter electrode has an electrochemical reactive surface area greater than twice the surface area of the working electrode thereby substantially increasing the electrodes ability to utilize oxygen as a substrate. Further enhancement of the counter electrode's activity may be achieved if the electrode were made of gold.
- the counter electrode has a textured surface, with surface topography that increases the surface area of the electrode while the diameter of the electrode remains constant.
- the proximity of the glucose oxidase enzyme to the counter electrode may be decreased. Since the enzyme depletes oxygen locally, the counter electrode would best be situated at a location distant from the enzyme.
- the membrane could be covered with an additional domain where glucose is selectively blocked from the area over the counter electrode.
- the present invention reduces the potential for electrode poisoning by positioning all electrodes underneath a multi-region membrane so that there is control of the species reaching the electrode surfaces.
- These membranes allow passage of dissolved oxygen to support the counter electrode reactions at reasonable negative potentials while rejecting larger molecules which when reduced would coat the surface of the counter electrode eventually leading to cascade failure.
- the positioning of the counter electrode underneath the membrane assures that all currents are passing through the same conductive media, thereby reducing voltage losses due to membrane or solution resistance.
- the counter electrode will be able to collect enough species for the balancing current while minimizing the need to move towards negative potential extremes.
- the description that follows is primarily directed at glucose monitoring sensor heads, devices and methods for their use, the sensor heads, devices and methods of the present invention are not limited to glucose measurement. Rather, the devices and methods may be applied to detect and quantitate other analytes present in biological fluids (including, but not limited to, amino acids and lactate), especially those analytes that are substrates for oxidase enzymes [see, e.g., U.S. Pat. No. 4,703,756 to Gough et al., hereby incorporated by reference].
- FBC foreign body capsule
- the teachings of the present invention recognize that FBC formation is the dominant event surrounding long-term implantation of any sensor and must be managed to support, rather than hinder or block, sensor performance. It has been observed that during the early periods following implantation of an analyte sensing device, particularly a glucose sensing device, that glucose sensors function well. However, after a few days to two or more weeks of implantation, these device lose their function.
- the present invention contemplates the use of particular biointerface membrane architectures that interfere with barrier cell layer formation on the membrane's surface.
- the present invention also contemplates the use of these membranes with a variety of implantable devices (e.g. analyte measuring devices particularly glucose measuring devices).
- the body is made of a non-conductive material such as ceramic, glass, or polymer.
- the sensor head interface region may include several different layers and/or membranes that cover and protect the electrodes of an implantable analyte-measuring device.
- the characteristics of these layers and/or membranes are now discussed in more detail.
- the layers and/or membranes prevent direct contact of the biological fluid sample with the electrodes, while permitting selected substances (e.g., analytes) of the fluid to pass therethrough for reaction in an enzyme rich domain with subsequent electrochemical reaction of formed products at the electrodes.
- the active electrochemical surfaces of the sensor electrodes are preserved, retaining activity for extended periods of time in vivo.
- a small number of molecular species such as, for example, molecules having a molecular weight of about 34 Daltons (the molecular weight of peroxide) or less, only a small subset of the many molecular species present in biological fluids are permitted to contact the sensor.
- Use of such membranes has enabled sustained function of devices for over one year in vivo.
- the multi-region membrane is constructed of two or more regions.
- the multi-region membrane may be provided in a number of different architectures.
- the multi-region membrane includes a first region distant from the electrochemically reactive surfaces, a second region less distant from the electrochemically reactive surfaces and a third region adjacent to the electrochemically reactive surfaces.
- the first region includes a cell disruptive domain distant from the electrochemically reactive surfaces and a cell impermeable domain less distant from the electrochemically reactive surfaces.
- the second region is a glucose exclusion domain and the third region includes a resistance domain distant from the electrochemically reactive surfaces, an immobilized enzyme domain less distant from the electrochemically reactive surfaces, an interference domain less distant from the electrochemically reactive surfaces than the immobilized enzyme domain and a hydrogel domain adjacent to the electrochemically reactive surfaces.
- the multi-region membrane includes a first region distant from the electrochemically reactive surfaces and a further region less distant from the electrochemically reactive surfaces.
- the first region includes a cell disruptive domain and a cell impermeable domain as described above.
- the “further region” includes a resistance domain, immobilized enzyme domain, interference domain, and hydrogel domain and serves as the equivalent of the “third region” described above.
- the multi-region membrane further includes an oxygen antenna domain. Each of these domains will now be described in further detail.
- the domain of the multi-region membrane positioned most distal to the electrochemically reactive surfaces corresponds to the cell disruptive domain.
- This domain includes a material that supports tissue in-growth and may be vascularized.
- the cell disruptive domain prevents formation of the barrier cell layer on the surface of the membrane, which as described above, blocks the transport of glucose into the sensor device.
- a useful cell disruptive domain is described in a U.S. application entitled “Membrane for use with Implantable Devices” which was filed on the same day as the present application.
- the cell disruptive domain may be composed of an open-cell configuration having cavities and solid portions. Cells may enter into the cavities, however, they can not travel through or wholly exist within the solid portions. The cavities allow most substances to pass through, including, e.g., macrophages.
- the open-cell configuration yields a co-continuous solid domain that contains greater than one cavity in three dimensions substantially throughout the entirety of the membrane.
- the cavities and cavity interconnections may be formed in layers having different cavity dimensions.
- a linear line can be used to define a dimension across a cavity or solid portion the length of which is the distance between two points lying at the interface of the cavity and solid portion.
- a substantial number of the cavities are not less than 20 microns in the shortest dimension and not more than 1000 microns in the longest dimension.
- a substantial number of the cavities are not less than 25 microns in the shortest dimension and not more than 500 microns in the longest dimension.
- the solid portion has not less than 5 microns in a substantial number of the shortest dimensions and not more than 2000 microns in a substantial number of the longest dimensions.
- the solid portion is not less than 10 microns in a substantial number of the shortest dimensions and not more than 1000 microns in a substantial number of the longest dimensions and most preferably, not less than 10 microns in a substantial number of the shortest dimensions and not more than 400 microns in a substantial number of the longest dimensions.
- the solid portion may be made of polytetrafluoroethylene or polyethylene-co-tetrafluoroethylene, for example.
- the solid portion includes polyurethanes or block copolymers and, most preferably, includes silicone.
- the non-woven fibers may be greater than 5 microns in the shortest dimension.
- the non-woven fibers are about 10 microns in the shortest dimension and most preferably, the non-woven fibers are greater than or equal to 10 microns in the shortest dimension.
- the non-woven fibers may be constructed of polypropylene (PP), polyvinylchloride (PVC), polyvinylidene fluoride (PVDF), polybutylene terephthalate (PBT), polymethylmethacrylate (PMMA), polyether ether ketone (PEEK), polyurethanes, cellulosic polymers, polysulfones, and block copolymers thereof including, for example, di-block, tri-block, alternating, random and graft copolymers (block copolymers are discussed in U.S. Pat. Nos. 4,803,243 and 4,686,044, hereby incorporated by reference).
- the non-woven fibers are comprised of polyolefins or polyester or polycarbonates or polytetrafluoroethylene.
- a subset of the cell disruptive domain is the oxygen antenna domain.
- This domain can act as an oxygen reservoir during times of minimal oxygen need and has the capacity to provide on demand a higher oxygen gradient to facilitate oxygen transport across the membrane.
- This domain may be composed of a material such as silicone, that has higher oxygen solubility than aqueous media so that it concentrates oxygen from the biological fluid surrounding the biointerface membrane. This enhances function in the enzyme reaction domain and at the counter electrode surface when glucose conversion to hydrogen peroxide in the enzyme domain consumes oxygen from the surrounding domains.
- this ability of the oxygen antenna domain to apply a higher flux of oxygen to critical domains when needed improves overall sensor function.
- this domain is composed of silicone and has a thickness of about 100 microns.
- the thickness of the cell disruptive domain is usually not less than about 20 microns and not more than about 2000 microns.
- the cell impermeable of the first region is positioned less distal to the electrochemically reactive surfaces than the cell disruptive domain of the same region.
- This domain is impermeable to host cells, such as macrophages.
- Cell impermeable domains are described in U.S. Pat. No. 6,001,067, herein incorporated by reference, and in copending, commonly owned U.S. application entitled “Membrane for use with Implantable Devices”, Serial No. ______, filed on even date herewith.
- the inflammatory response that initiates and sustains a FBC is associated with disadvantages in the practice of sensing analytes. Inflammation is associated with invasion of inflammatory response cells (e.g.
- tissue macrophages which have the ability to overgrow at the interface and form barrier cell layers, which may block transport of glucose across the biointerface membrane. These inflammatory cells may also biodegrade many artificial biomaterials (some of which were, until recently, considered nonbiodegradable).
- tissue macrophages When activated by a foreign body, tissue macrophages degranulate, releasing from their cytoplasmic myeloperoxidase system hypochlorite (bleach) and other oxidative species. Hypochlorite and other oxidative species are known to break down a variety of polymers, including ether based polyurethanes, by a phenomenon referred to as environmental stress cracking.
- polycarbonate based polyurethanes are believed to be resistant to environmental stress cracking and have been termed biodurable.
- biodurable because hypochlorite and other oxidizing species are short-lived chemical species in vivo, biodegradation will not occur if macrophages are kept a sufficient distance from the enzyme active membrane.
- the present invention contemplates the use of cell impermeable biomaterials of a few microns thickness or more (i.e., a cell impermeable domain) in most of its membrane architectures.
- This domain of the biointerface membrane is permeable to oxygen and may or may not be permeable to glucose and is constructed of biodurable materials (e.g. for period of several years in vivo) that are impermeable by host cells (e.g. macrophages) such as for example polymer blends of polycarbonate based polyurethane and PVP.
- the thickness of the cell impermeable domain is not less than about 10 microns and not more than about 100 microns.
- the glucose exclusion domain includes a thin, hydrophobic membrane that is non-swellable and blocks diffusion of glucose while being permeable to oxygen.
- the glucose exclusion domain serves to allow analytes and other substances that are to be measured or utilized by the sensor to pass through, while preventing passage of other substances.
- the glucose exclusion domain is constructed of a material such as, for example, silicone.
- the glucose exclusion domain has a preferred thickness not less than about 130 microns, more preferably not less than about 5 and not more than about 75 microns and most preferably not less than 15 microns and not more than about 50 microns.
- the “third region” or “further region” of the multi-region membrane includes a resistance domain.
- the resistance domain is located more distal to the electrochemically reactive surfaces relative to other domains in this region.
- the resistance domain controls the flux of oxygen and glucose to the underlying enzyme domain.
- glucose There is a molar excess of glucose relative to the amount of oxygen in samples of blood. Indeed, for every free oxygen molecule in extracellular fluid, there are typically more than 100 glucose molecules present [Updike et al., Diabetes Care 5:207-21(1982)].
- an immobilized enzyme-based sensor using oxygen (O 2 ) as cofactor must be supplied with oxygen in non-rate-limiting excess in order to respond linearly to changes in glucose concentration, while not responding to changes in oxygen tension. More specifically, when a glucose-monitoring reaction is oxygen-limited, linearity is not achieved above minimal concentrations of glucose. Without a semipermeable membrane over the enzyme domain, linear response to glucose levels can be obtained only up to about 40 mg/dL; however, in a clinical setting, linear response to glucose levels are desirable up to at least about 500 mg/dL.
- the resistance domain includes a semipermeable membrane that controls the flux of oxygen and glucose to the underlying enzyme domain (i.e., limits the flux of glucose), rendering the necessary supply of oxygen in non-rate-limiting excess.
- the devices of the present invention contemplate resistance domains including polymer membranes with oxygen-to-glucose permeability ratios of approximately 200:1; as a result, one-dimensional reactant diffusion is adequate to provide excess oxygen at all reasonable glucose and oxygen concentrations found in the subcutaneous matrix [Rhodes et al., Anal. Chem., 66:1520-1529 (1994)].
- the resistance domain is constructed of a polyurethane urea/polyurethane-block-polyethylene glycol blend and has a thickness of not more than about 45 microns, more preferably not less than about 15 microns, and not more than about 40 microns and, most preferably, not less than about 20 microns, and not more than about 35 microns.
- the resistance domain When the resistance domain is combined with the cell-impermeable domain, it is the immobilized enzyme domain which corresponds to the outermost domain of the “third region” or “further region”, i.e. it is located more distal to the electrochemically reactive surfaces as compared to the other domains in this region.
- the enzyme domain includes glucose oxidase.
- the present invention contemplates the use of a domain impregnated with other oxidases, e.g., galactose oxidase or uricase, For an enzyme-based electrochemical glucose sensor to perform well, the sensor's response must neither be limited by enzyme activity nor cofactor concentration. Because enzymes, including glucose oxidase, are subject to deactivation as a function of ambient conditions, this behavior needs to be accounted for in constructing sensors for long-term use.
- the domain is constructed of aqueous dispersions of colloidal polyurethane polymers including the enzyme.
- the coating has a thickness of not less than about 2.5 microns and not more than about 12.5 microns, preferably about 6.0 microns.
- the interference domain in the “third region” or “further region” is located less distant from the electrochemically reactive surfaces than the immobilized enzyme domain in this same region. It includes a thin membrane that can limit diffusion of molecular weight species greater than 34 kD.
- the interference domain serves to allow analytes and other substances that are to be measured by the electrodes to pass through, while preventing passage of other substances, including potentially interfering substances.
- the interference domain is preferably constructed of a polyurethane.
- the interference domain has a preferred thickness of not more than about 5 microns, more preferably not less than about 0.1 microns, and not more than about 5 microns and, most preferably, not less than about 0.5 microns, and not more than about 3 microns.
- the hydrogel domain is located adjacent to the electrochemically reactive surfaces.
- the hydrogel domain includes a semipermeable coating that maintains hydrophilicity at the electrode region of the sensor interface.
- the hydrogel domain enhances the stability of the interference domain of the present invention by protecting and supporting the membrane that makes up the interference domain. Furthermore, the hydrogel domain assists in stabilizing operation of the device by overcoming electrode start-up problems and drifting problems caused by inadequate electrolyte.
- the buffered electrolyte solution contained in the hydrogel domain also protects against pH-mediated damage that may result from the formation of a large pH gradient between the hydrophobic interference domain and the electrode (or electrodes) due to the electrochemical activity of the electrode(s).
- the hydrogel domain includes a flexible, water-swellable, substantially solid gel-like film having a “dry film” thickness of not less than about 2.5 microns and not more than about 12.5 microns; preferably, the thickness is about 6.0 microns.
- “Dry film” thickness refers to the thickness of a cured film cast from a coating formulation onto the surface of the membrane by standard coating techniques
- Suitable hydrogel domains are formed of a curable copolymer of a urethane polymer and a hydrophilic film-forming polymer.
- Particularly preferred coatings are formed of a polyurethane polymer having anionic carboxylate functional groups and non-ionic hydrophilic polyether segments, which is crosslinked in the present of polyvinylpyrrolidone and cured at a moderate temperature of about 50° C.
- the electrolyte phase is a free-fluid phase including a solution containing at least one compound, usually a soluble chloride salt, that conducts electric current.
- the electrolyte phase flows over the electrodes and is in contact with the hydrogel domain.
- the devices of the present invention contemplate the use of any suitable electrolyte solution, including standard, commercially available solutions.
- the electrolyte phase should have the same or less osmotic pressure than the sample being analyzed.
- the electrolyte phase includes normal saline.
- an enzyme containing membrane that resides above an amperometric electrochemical sensor can possess the same architecture throughout the electrode surfaces.
- the function of converting glucose into hydrogen peroxide by glucose oxidase may only by necessary above the working electrode.
- first region 33 is permeable to oxygen and glucose and includes a cell disruptive domain distant from the electrodes and a cell impermeable domain less distant from the electrodes.
- the second region 31 is permeable to oxygen and includes a glucose exclusion domain and region three 32 includes a resistance domain, distant from the electrochemically reactive surfaces, an immobilized enzyme domain less distant from the electrochemically reactive surfaces, an interference domain less distant from the electrochemically reactive surfaces than the immobilized enzyme and a hydrogel domain adjacent to the electrochemically reactive surfaces.
- the multi-region membrane is positioned over the sensor interface 30 of the non-conductive body 10 , covering the working electrode 21 , the reference electrode 20 and the counter electrode 22 .
- the electrodes are brazed to the sensor head and back filled with epoxy 28 .
- the glucose exclusion domain has been positioned over the electrochemically reactive surfaces such that it does not cover the working electrode 21 .
- a hole 35 has been created in the second region 31 and positioned directly above the working electrode 21 .
- the glucose-blocking domain is made of a material that allows sufficient O 2 to pass to the counter electrode.
- the glucose-blocking domain may be made of a variety of materials such as silicone or silicone containing copolymers.
- the glucose-blocking domain is made of silicone.
- the multi-region membrane is shown as being constructed of two regions: a first region 33 which includes a cell disruptive domain and a cell impermeable domain; and a further region 32 .
- Region 32 is defined herein as including an enzyme immobilized domain, interference domain, and hydrogel domain and may also include a resistance domain.
- Region 32 is referred to as the “third region” in embodiments where the multi-region membrane includes three regions.
- a silicone domain plug 36 positioned over the counter electrode 22 in order to eliminate the consumption of O 2 above the counter electrode by the oxidation of glucose with glucose oxidase.
- the enzyme immobilized domain can be fabricated as previously described, then a hole punched into the domain.
- the silicone domain plug 36 may be cut to fit the hole, and then adhered into place, for example, with silicone adhesive (e.g., MED-1511, NuSil, Carpinteria, Calif.).
- the immobilized enzyme domain of the multi-region membrane can be fabricated such that active enzyme 37 is positioned only above the working electrode 21 .
- the immobilized enzyme domain may be prepared so that the glucose oxidase only exists above the working electrode 21 .
- the immobilized enzyme domain coating solution can be applied as a circular region similar to the diameter of the working electrode. This fabrication can be accomplished in a variety of ways such as screen printing or pad printing.
- the enzyme domain is pad printed during the enzyme membrane fabrication with equipment as available from Pad Print Machinery of Vermont (Manchester, Vt.).
- the immobilized enzyme of the multi-region membrane in region 32 may be deactivated 38 except for the area covering the working electrode 21 .
- the glucose oxidase is distributed homogeneously throughout the immobilized enzyme domain.
- the active enzyme need only reside above the working electrode. Therefore, the enzyme may be deactivated 38 above the counter 22 and reference 20 electrodes by irradiation.
- a mask that covers the working electrode 21 such as those used for photolithography can be placed above the membrane. In this way, exposure of the masked membrane to ultraviolet light deactivates the glucose oxidase in all regions except that covered by the mask.
- FIG. 2F shows an architecture in which the third region 32 which includes immobilized enzyme only resides over the working electrode 21 .
- this architecture consumption of O 2 above the counter electrode 22 by the oxidation of glucose with glucose oxidase is eliminated.
- the electrode assembly of this invention comprises a non-conductive body and three electrodes affixed within the body having electrochemically reactive surfaces at one location on the body and an electronic connection means at another location on the body and may be used in the manner commonly employed in the making of amperometric measurements.
- a sample of the fluid being analyzed is placed in contact with a reference electrode, e.g., silver/silver-chloride, a working electrode which is preferably formed of platinum, and a counter electrode which is preferably formed of gold or platinum.
- the electrodes are connected to a galvanometer or polarographic instrument and the current is read or recorded upon application of the desired D.C. bias voltage between the electrodes.
- the ability of the present device electrode assembly to accurately measure the concentration of substances such as glucose over a broad range of concentrations in fluids including undiluted whole blood samples enables the rapid and accurate determination of the concentration of those substances. That information can be employed in the study and control of metabolic disorders including diabetes.
- the present invention contemplates several structural architectures that effectively increase the electrochemically reactive surface of the counter electrode.
- the diameter of wire used to create the counter electrode is at least twice the diameter of the working electrode.
- the electrochemically reactive surface of the counter electrode be not less than about 2 and not more than about 100 times the surface area of the working electrode. More preferably, the electrochemically reactive surface of the counter electrode is not less than about 2 and not more than about 50, not less than about 2 and not more than about 25 or not less than about 2 and not more than about 10 times the surface area of the working electrode. In another embodiment, the electrochemically reactive surface is larger that the wire connecting this surface to the sensor head.
- the electrode could have a cross-sectional view that resembles a “T”.
- the present invention contemplates a variety of configurations of the electrode head that would provide a large reactive surface, while maintaining a relatively narrow connecting wire.
- Such configurations could be prepared by micromachining with techniques such as reactive ion etching, wet chemical etching and focused ion beam machining as available from Norsam Technologies (Santa Fe, N.Mex.).
- the diameter of the counter electrode is substantially similar to the working electrode; however, the surface of the counter electrode has been modified to increase the surface area such that it has at least twice the surface area of the working electrode. More specifically the counter electrodes surface may be textured, effectively increasing its surface area without significantly increasing its diameter. This may be accomplished by a variety of methods known to those skilled in the art including, such as acid etching.
- the electrochemically reactive surface may be provided in a variety of shapes and sizes (e.g. round, triangular, square or free form) provided that it is at least twice the surface area of the working electrode.
- the electrodes are prepared from a 0.020′′ diameter wire having the desired modified reactive surface.
- the electrodes are secured inside the non-conductive body by brazing.
- the counter electrode is preferably made of gold or platinum.
- FIG. 6A A preferred embodiment of an analyte measuring device including a sensor head according to the present invention is shown in FIG. 6A .
- a ceramic body 1 and ceramic head 10 houses the sensor electronics that include a circuit board 2 , a microprocessor 3 , a battery 4 , and an antenna 5 . Furthermore, the ceramic body 1 and head 10 possess a matching taper joint 6 that is sealed with epoxy. The electrodes are subsequently connected to the circuit board via a socket 8 .
- three electrodes protrude through the ceramic head 10 , a platinum working electrode 21 , a platinum counter electrode 22 and a silver/silver chloride reference electrode 20 .
- Each of these is hermetically brazed 26 to the ceramic head 10 and further secured with epoxy 28 .
- the sensing region 24 is covered with a multi-region membrane described above and the ceramic head 10 contains a groove 29 so that the membrane may be affixed into place with an o-ring.
- Eq and Eqs (equivalents); mEq (milliequivalents); M (molar); mM (millimolar) ⁇ M (micromolar); N (Normal); mol (moles); mmol (millimoles); ⁇ mol (micromoles); nmol (nanomoles); g (grams); mg (milligrams); ⁇ g (micrograms); Kg (kilograms); L (liters); mL (milliliters); dL (deciliters); ⁇ L (microliters); cm (centimeters); mm (millimeters); ⁇ m (micrometers); nm (nanometers); h and hr (hours); min.
- the cell disruptive domain may be an ePTFE filtration membrane and the cell impermeable domain may then be coated on this domain layer.
- the cell impermeable domain was prepared by placing approximately 706 gm of dimethylacetamide (DMAC) into a 3 L stainless steel bowl to which a polycarbonateurethane solution (1325 g, Chronoflex AR 25% solids in DMAC and 5100 cp) and polyvinylpyrrolidone (125 g, Plasdone K-90 D) are added. The bowl was then fitted to a planetary mixer with a paddle type blade and the contents were stirred for 1 hour at room temperature. This solution was then coated on the cell disruptive domain by knife edge drawn at a gap of 0.006′′ and dried at 60° C. for 24 hours.
- DMAC dimethylacetamide
- the polyurethane polyvinylpyrrolidone solution prepared above can be coated onto a PET release liner using a knife over roll coating machine. This material is then dried at 305° F. for approximately 2 minutes.
- the ePTFE membrane is immersed in 50:50 (w/v) mixture of THF/DMAC and then placed atop the coated polyurethane polyvinylpyrrolidone material. Light pressure atop the assembly intimately embeds the ePTFE into the polyurethane polyvinylpyrrolidone. The membrane is then dried at 60° C. for 24 hours.
- An oxime cured silicone dispersion (NuSil Technologies, MED-6607) was cast onto a polypropylene sheet and cured at 40° C. for three days.
- the “third region” or “further region” includes a resistance domain, an immobilized enzyme domain, an interference domain and an hydrogel domain.
- the resistance domain was prepared by placing approximately 281 gm of dimethylacetamide into a 3 L stainless steel bowl to which a solution of polyetherurethaneurea (344 gm of Chronothane H, 29,750 cp at 25% solids in DMAC). To this mixture was added another polyetherurethaneurea (312 gm, Chronothane 1020, 6275 cp at 25% solids in DMAC.) The bowl was fitted to a planetary mixer with a paddle type blade and the contents were stirred for 30 minutes at room temperature.
- the resistance domain coating solutions produced is coated onto a PET release liner (Douglas Hansen Co., Inc. Minneapolis, Minn.) using a knife over roll set at a 0.012′′ gap. This film is then dried at 305° F. The final film is approximately 0.0015′′ thick.
- the immobilized enzyme domain was prepared by placing 304 gm polyurethane latex (Bayhydrol 140 AQ, Bayer, Pittsburgh, Pa.) into a 3 L stainless steel bowl to which 51 gm of pyrogen free water and 5.85 gm of glucose oxidase (Sigma type VII from Aspergillus niger) is added. The bowl was then fitted to a planetary mixer with a whisk type blade and the mixture was stirred for 15 minutes. Approximately 24 hr prior to coating a solution of glutaraldehyde (15.4 mL of a 2.5% solution in pyrogen free water) and 14 mL of pyrogen free water was added to the mixture. The solution was mixed by inverting a capped glass bottle by hand for about 3 minutes at room temperature. This mixture was then coated over the resistance domain with a #10 Mayer rod and dried above room temperature preferably at about 50° C.
- the interference domain was prepared by placing 187 gm of tetrahydrofuran into a 500 mL glass bottle to which an 18.7 gm aliphatic polyetherurethane (Tecoflex SG-85A, Thermedics Inc., Woburn, Mass.) was added. The bottle was placed onto a roller at approximately 3 rpm within an oven set at 37° C. The mixture was allowed to roll for 24 hr. This mixture was coated over the dried enzyme domain using a flexible knife and dried above room temperature preferably at about 50° C.
- the hydrogel domain was prepared by placing 388 gm of polyurethane latex (Bayhydrol 123, Bayer, Pittsburgh, Pa. in a 3 L stainless steel bowl to which 125 gm of pyrogen free water and 12.5 gm polyvinylpyrrolidone (Plasdone K-90D) was added. The bowl was then fitted to a planetary mixer with a paddle type blade and stirred for 1 hr at room temperature. Within 30 minutes of coating approximately 13.1 mL of carbodiimide (UCARLNK) was added and the solution was mixed by inverting a capped polyethylene jar by hand for about 3 min at room temperature. This mixture was coated over the dried interference domain with a #10 Mayer rod and dried above room temperature preferably at about 50° C.
- UARLNK carbodiimide
- this multi-region membrane In order to affix this multi-region membrane to a sensor head, it is first placed into buffer for about 2 minutes. It is then stretched over the nonconductive body of sensor head and affixed into place with an o-ring.
- This example describes experiments directed at sensor function of several sensor devices contemplated by the present invention.
- a glucose solution (9.4 ml of 100 mg/ml glucose in buffer) was added in order to raise the glucose concentration to 400 mg/dl within the container.
- the sensors were allowed to equilibrate for at least 30 minutes and their output value recorded. In this way, the sensitivity of the sensor to glucose is given as the slope of sensor output versus glucose concentration.
- the container was then fitted with an O 2 meter (WTW, model Oxi-340) and a gas purge. A mixture of compressed air and nitrogen was used to decrease the O 2 concentration.
- Sensor output was recorded at an ambient O 2 level, then sensor output was recorded for the following O 2 concentrations; 1 mg/L, 0.85 to 0.75 mg/L, 0.65 to 0.55 mg/L and 0.40 to 0.30 mg/L. In this way, the function of the sensor could be compared to its function at ambient O 2 .
- FIGS. 6A and 6B which included inventive sensor heads having a multi-region membrane with the architecture shown in FIG. 2B , were tested in vitro. Eight of these devices were fitted with membranes that possessed a 0.020′′ diameter hole, four with a 0.0015′′ thick polyurethane (Chronoflex AR, CardioTech International Inc.) and four with a 0.032′′ thick silicone (MED-1511, NuSil Technologies Inc.). The hole was positioned above the working electrode and both membranes were secured to the device with an o-ring. Four control devices were also tested which were fitted with a multi-region membrane which lacked region 31 shown in FIB. 2 B.
- a multi-region membrane which lacked region 31 shown in FIB. 2 B.
- region 31 shown in FIG. 2B which includes a glucose blocking domain, above all areas other than above the working electrode 21 , oxygen consumption in areas other than working electrode areas is limited. In contrast, by eliminating region 31 in the control devices, less overall oxygen becomes available to electrode surfaces due to the increased availability of glucose.
- the devices were activated, placed into a 500 ml-polyethylene container with sodium phosphate buffered solution (300 ml, pH 7.3) and allowed to equilibrate. Each device's baseline value was recorded. Then 12 ml of glucose solution (100 mg/ml in sodium phosphate buffer) was added to the container so that the total glucose concentration became 400 mg/dL. After this, the container was covered and fitted with an oxygen sensor and a source of nitrogen and compressed air. In this way, the oxygen concentration was controlled with a gas sparge. A glucose value was recorded for each device at decreasing oxygen concentrations from ambient to approximately 0.1 mg/L.
- FIG. 7 graphically represents the formation of a device of the present invention utilizing the multi-region membrane architecture in FIG. 2B in vitro.
- the data is expressed in percent Device Function at 400 mg/dL glucose vs. oxygen concentration.
- the percent function of the device is simply the device output at any given oxygen concentration divided by that device's output at ambient oxygen.
- inventive sensor devices containing the silicone membrane have better function at lower oxygen concentrations relative to both the control devices and the devices containing the polyurethane membrane. For example, at an oxygen concentration of about 0.5 mg/L, devices containing the silicone membrane are providing 100% output as compared to 80% output for the control devices.
- Example 2 An in vitro testing procedure used in this example was similar to that described in Example 2.
- Six devices similar to the one shown in FIG. 6A and 6B were fitted with the multi-region membrane described herein. Two of these tested devices were comparative devices that possessed Pt counter electrodes having a 0.020′′ diameter; this diameter provided for an electrochemically reactive surface of the counter electrode which was substantially equal to the surface area of the working electrode, as schematically shown in FIG. 8 .
- the electrode-membrane region includes two distinct regions, the compositions and functions of which have already been described.
- Region 32 includes an immobilized enzyme.
- Region 33 includes a cell disruptive domain and a cell impermeable domain.
- Electrodes 21 (working), 20 (reference) and 22 (counter) are in contact with an electrolyte phase 30 , a free-flowing phase.
- Two other tested devices possessed Pt counter electrodes having a 0.060′′ diameter.
- two additional devices possessed Au counter electrodes having a 0.060′′ diameter.
- the 0.006′′ diameter devices provided for an electrochemically reactive surface of the counter electrode which was approximately six times the surface area of the working electrode.
- Each of the devices including counter electrodes of 0.060′′ diameter include a multi-region membrane above the electrode region which is similar to that shown in FIG. 8 .
- the devices were activated, placed into a 500 ml-polyethylene container with sodium phosphate buffered solution (300 ml, pH 7.3) and allowed to equilibrate. Each device's baseline value was recorded. Then 12 ml of glucose solution (100 mg/ml in sodium phosphate buffer) was added to the container so that the total glucose concentration became 400 mg/dL. After this, the container was covered and fitted with an oxygen sensor and a source of nitrogen and compressed air. In this way, the oxygen concentration was controlled with a gas sparge. A counter electrode voltage was recorded for each device at decreasing oxygen concentrations from ambient to approximately 0.1 mg/L.
- FIG. 9 graphically presents the counter electrode voltage as a function of oxygen concentration and 400 mg/dL glucose. This figure demonstrates that both the large Pt and Au counter electrode devices do not begin to reach the circuitry limits at low oxygen concentrations. Therefore, increased performance and accuracy can be obtained from a counter electrode that has an electrochemical reactive surface greater than the surface area of the working electrode.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- General Physics & Mathematics (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Optics & Photonics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Emergency Medicine (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Human Computer Interaction (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Description
- The present invention relates generally to novel sensor heads utilized with implantable devices, devices including these sensor heads and methods for determining analyte levels using these implantable devices. More particularly, the invention relates to sensor heads, implantable devices including these sensor heads and methods for monitoring glucose levels in a biological fluid using these devices.
- Amperometric electrochemical sensors require a counter electrode to balance the current generated by the species being measured at the working electrode. In the case of a glucose oxidase based glucose sensor, the species being measured at the working electrode is H2O2. Glucose oxidase catalyzes the conversion of oxygen and glucose to hydrogen peroxide and gluconate according to the following reaction:
Glucose+O2 →Gluconate+H2O2 - Because for each glucose molecule metabolized, there is a proportional change in the product H2O2, one can monitor the change in H2O2 to determine glucose concentration. Oxidation of H2O2 by the working electrode is balanced by reduction of ambient oxygen, enzyme generated H2O2, or other reducible species at the counter electrode. In vivo glucose concentration may vary from about one hundred times or more that of the oxygen concentration. Consequently, oxygen becomes a limiting reactant in the electrochemical reaction and when insufficient oxygen is provided to the sensor, the sensor will be unable to accurately measure glucose concentration. Those skilled in the art have come to interpret oxygen limitations resulting in depressed function as being a problem of availability of oxygen to the enzyme.
- As shown in
FIG. 1 , thesensor head 10 includes a working electrode 21 (anode), counter electrode 22 (cathode), andreference electrode 20 which are affixed to the head by both brazing 26 the electrode metal to the ceramic and potting withepoxy 28. The working electrode 21 (anode) and counter-electrode 22 (cathode) of a glucose oxidase-basedglucose sensor head 10 require oxygen in different capacities. Prior art teaches an enzyme-containing membrane that resides above an amperometric electrochemical sensor. InFIG. 1 ,region 32 includes an immobilized enzyme, i.e. glucose oxidase. Within the enzyme layer above the workingelectrode 21, oxygen is required for the production of H2O2 from glucose. The H2O2 produced from the glucose oxidase reaction further reacts atsurface 21 a of workingelectrode 21 and produces two electrons. The products of this reaction are two protons (2H+), two electrons (2e −), and one oxygen molecule (O2) (Fraser, D. M. “An Introduction to In Vivo Biosensing: Progress and problems.” In “Biosensors and the Body,” D. M. Fraser, ed., 1997, pp. 1-56 John Wiley and Sons, New York). In theory, the oxygen concentration near the workingelectrode 21, which is consumed during the glucose oxidase reaction, is replenished by the second reaction at the working electrode. Therefore, the net consumption of oxygen is zero. In practice, neither all of the H2O2 produced by the enzyme diffuses to the working electrode surface nor does all of the oxygen produced at the electrode diffuse to the enzyme domain. - With further reference to
FIG. 1 , thecounter electrode 22 utilizes oxygen as an electron acceptor. The most likely reducible species for this system are oxygen or enzyme generated peroxide (Fraser, D. M. supra). There are two main pathways by which oxygen may be consumed at thecounter electrode 22. These are a four-electron pathway to produce hydroxide and a two-electron pathway to produce hydrogen peroxide. The two-electron pathway is shown inFIG. 1 . Oxygen is further consumed above the counter electrode by the glucose oxidase inregion 32. Due to the oxygen consumption by both the enzyme and the counter electrode, there is a net consumption of oxygen at thesurface 22 a of the counter electrode. Theoretically, in the domain of the working electrode there is significantly less net loss of oxygen than in the region of the counter electrode. In addition, there is a close correlation between the ability of the counter electrode to maintain current balance and sensor function. Taken together, it appears that counter electrode function becomes limited before the enzyme reaction becomes limited when oxygen concentration is lowered. - Those practicing in the field of implantable glucose oxidase sensors have focused on improving sensor function by increasing the local concentration of oxygen in the region of the working electrode. (Fraser, D. M. supra).
- We have observed that in some cases, loss of glucose oxidase sensor function may not be due to a limitation of oxygen in the enzyme layer near the working electrode, but may instead be due to a limitation of oxygen at the counter electrode. In the presence of increasing glucose concentrations, a higher peroxide concentration results, thereby increasing the current at the working electrode. When this occurs, the counter electrode limitation begins to manifest itself as this electrode moves to increasingly negative voltages in the search for reducible species. When a sufficient supply of reducible species, such as oxygen, are not available, the counter electrode voltage reaches a circuitry limit of −0.6V resulting in compromised sensor function (see
FIG. 3 ). -
FIG. 3 shows simultaneous measurement of counter-electrode voltage and sensor output to glucose levels from a glucose sensor implanted subcutaneously in a canine host. It can be observed that as glucose levels increase, the counter electrode voltage decreases. When the counter electrode voltage reaches −0.6V, the signal to noise ratio increases significantly. This reduces the accuracy of the device.FIG. 4 shows a further example of another glucose sensor in which the counter-electrode reaches the circuitry limit. Again, once the counter electrode reaches −0.6V, the sensitivity and/or signal to noise ratio of the device is compromised. In both of these examples, glucose levels reached nearly 300 mg/dl. However, inFIG. 3 the sensor showed a greater than three-fold higher current output than the sensor inFIG. 4 . These data suggest that there may be a limitation of reducible species at the counter electrode, which may limit the sensitivity of the device as the glucose levels increase. In contrast,FIG. 5 shows a glucose sensor in which the counter electrode voltage did not reach −0.6V. InFIG. 5 it can be observed that the sensor was able to maintain a current balance between the working and counter electrodes, thereby enabling accurate measurements throughout the course of the experiment. The results shown inFIGS. 3, 4 and 5 led the present inventors to postulate that by keeping the counter electrode from reaching the circuitry limit, one could maintain sensitivity and accuracy of the device. - Two approaches have been utilized by others to relieve the counter electrode limitation described above. The first approach involves the widening of the potential range over which the counter electrode can move in the negative direction to avoid reaching circuitry limitations. Unfortunately, this approach increases undesirable products that are produced at lower potentials. One such product, hydrogen, may form at the counter electrode,which may then diffuse back to the working electrode. This may contribute to additional current resulting in erroneously high glucose concentration readings. Additionally, at these increasingly negative potentials, the probability of passivating or poisoning the counter electrode greatly increases. This effectively reduces the counter electrode surface area requiring a higher current density at the remaining area to maintain current balance. Furthermore, increased current load increases the negative potentials eventually resulting in electrode failure.
- The second approach is utilizing the metal case of the device as a counter electrode (see U.S. Pat. No. 4,671,288, Gough or U.S. Pat. No. 5,914,026, Blubaugh). This provides an initial excess in surface area which is expected to serve the current balancing needs of the device over its lifetime. However, when the counter electrode reaction is a reduction reaction, as in Blubaugh, the normally present metal oxide layer will be reduced to bare metal over time leaving the surface subject to corrosion, poisoning, and eventual cascade failure. This problem is magnified when considering the various constituents of the body fluid that the metal casing is exposed to during in vivo use. To date, there has been no demonstration of long-term performance of such a device with this counter electrode geometry.
- Consequently, there is a need for a sensor that will provide accurate analyte measurements, that reduces the potential for cascade failure due to increasing negative potentials, corrosion and poisoning, and that will function effectively and efficiently in low oxygen concentration environments.
- In one aspect of the present invention, a sensor head for use in a device that measures the concentration of an analyte in a biological fluid is provided that includes a non-conductive body; a working electrode, a reference electrode and a counter electrode, wherein the electrodes pass through the non-conductive body forming an electrochemically reactive surface at one location on the body and forming an electronic connection at another location on the body, and further wherein the electrochemically reactive surface of the counter electrode is greater than the surface area of the working electrode; and a multi-region membrane affixed to the nonconductive body and covering the working electrode, reference electrode and counter electrode.
- In another aspect of the present invention, a sensor head for use in an implantable analyte measuring device is provided which includes the same sensor head components as those described above.
- The sensor heads of the present invention include a multi-region membrane that controls the number of species that are able to reach the surface of the electrodes. In particular, such a membrane allows the passage of desired substrate molecules (e.g. oxygen and glucose) and rejects other larger molecules that may interfere with accurate detection of an analyte. The sensor heads of the present invention also provide a larger counter electrode reactive surface that balances the current between the working and counter electrodes, thereby minimizing negative potential extremes that may interfere with accurate analyte detection.
- In another aspect of the present invention, an implantable device for measuring an analyte in a biological fluid is provided including at least one of the sensor heads described above. In still another aspect of the present invention, a method of monitoring glucose levels is disclosed which includes the steps of providing a host, and an implantable device as provided above and implanting the device in the host.
- Further encompassed by the invention is a method of measuring glucose in a biological fluid including the steps of providing a host and a implantable device described above, which includes a sensor head capable of accurate continuous glucose sensing; and implanting the device in the host.
- The sensor head, membrane architectures, devices and methods of the present invention allow for the collection of continuous information regarding desired analyte levels (e.g. glucose). Such continuous information enables the determination of trends in glucose levels, which can be extremely important in the management of diabetic patients.
- Definitions
- In order to facilitate an understanding of the present invention, a number of terms are defined below.
- The term “sensor head” refers to the region of a monitoring device responsible for the detection of a particular analyte. The sensor head generally comprises a non-conductive body, a working electrode (anode), a reference electrode and a counter electrode (cathode) passing through and secured within the body forming an electrochemically reactive surface at one location on the body and an electronic connective means at another location on the body, and a multi-region membrane affixed to the body and covering the electrochemically reactive surface. The counter electrode has a greater electrochemically reactive surface area than the working electrode. During general operation of the sensor a biological sample (e.g., blood or interstitial fluid) or a portion thereof contacts (directly or after passage through one or more membranes or domains) an enzyme (e.g., glucose oxidase); the reaction of the biological sample (or portion thereof) results in the formation of reaction products that allow a determination of the analyte (e.g. glucose) level in the biological sample. In preferred embodiments of the present invention, the multi-region membrane further comprises an enzyme domain, and an electrolyte phase (i.e., a free-flowing liquid phase comprising an electrolyte-containing fluid described further below).
- The term “analyte” refers to a substance or chemical constituent in a biological fluid (e.g., blood, interstitial fluid, cerebral spinal fluid, lymph fluid or urine) that can be analyzed. A preferred analyte for measurement by the sensor heads, devices and methods of the present invention is glucose.
- The term “electrochemically reactive surface” refers to the surface of an electrode where an electrochemical reaction takes place. In the case of the working electrode, the hydrogen peroxide produced by the enzyme catalyzed reaction of the analyte being detected reacts creating a measurable electronic current (e.g. detection of glucose analyte utilizing glucose oxidase produces H2O2 peroxide as a by product, H2O2 reacts with the surface of the working electrode producing two protons (2H+), two electrons (2 e −) and one molecule of oxygen (O2) which produces the electronic current being detected). In the case of the counter electrode, a reducible species, e.g. O2 is reduced at the electrode surface in order to balance the current being generated by the working electrode.
- The term “electronic connection” refers to any electronic connection known to those in the art that may be utilized to interface the sensor head electrodes with the electronic circuitry of a device such as mechanical (e.g., pin and socket) or soldered.
- The term “domain” refers to regions of the membrane of the present invention that may be layers, uniform or non-uniform gradients (e.g. anisotropic) or provided as portions of the membrane.
- The term “multi-region membrane” refers to a permeable membrane that may be comprised of two or more domains and constructed of biomaterials of a few microns thickness or more which are permeable to oxygen and may or may not be permeable to glucose. One of the the membranes may be placed over the sensor body to keep host cells (e.g., macrophages) from gaining proximity to, and thereby damaging, the enzyme membrane or forming a barrier cell layer and interfering with the transport of analyte across the tissue-device interface.
- The phrase “distant from” refers to the spatial relationship between various elements in comparison to a particular point of reference. For example, some embodiments of a biological fluid measuring device comprise a multi-region membrane that may be comprised of a number of domains. If the electrodes of the sensor head are deemed to be the point of reference, and one of the multi-region membrane domains is positioned farther from the electrodes, than that domain is distant from the electrodes.
- The term “oxygen antenna domain” and the like refers to a domain composed of a material that has higher oxygen solubility than aqueous media so that it concentrates oxygen from the biological fluid surrounding the biointerface membrane. The domain can then act as an oxygen reservoir during times of minimal oxygen need and has the capacity to provide on demand a higher oxygen gradient to facilitate oxygen transport across the membrane. This enhances function in the enzyme reaction domain and at the counter electrode surface when glucose conversion to hydrogen peroxide in the enzyme domain consumes oxygen from the surrounding domains. Thus, this ability of the oxygen antenna domain to apply a higher flux of oxygen to critical domains when needed improves overall sensor function.
- The term “solid portions” and the like refer to a material having a structure that may or may not have an open-cell configuration but in either case prohibits whole cells from traveling through or residing within the material.
- The term “substantial number” refers to the number of cavities or solid portions having a particular size within a domain in which greater than 50 percent of all cavities or solid portions are of the specified size, preferably greater than 75 percent and most preferably greater than 90 percent of the cavities or solid portions have the specified size.
- The term “co-continuous” and the like refers to a solid portion wherein an unbroken curved line in three dimensions exists between any two points of the solid portion.
- The term “host” refers to both humans and animals.
- The term “accurately” means, for example, 90% of measured glucose values are within the “A” and “B” region of a standard Clarke error grid when the sensor measurements are compared to a standard reference measurement. It is understood that like any analytical device, calibration, calibration validation and recalibration are required for the most accurate operation of the device.
- The phrase “continuous glucose sensing” refers to the period in which monitoring of plasma glucose concentration is continuously performed, for example, about every 10 minutes.
-
FIG. 1 Illustration of thermodynamically favored reactions at the working electrode and counter electrode at the desired voltage potentials. -
FIG. 2A depicts a cross-sectional exploded view of a sensor head of the present invention wherein the multi-region membrane comprises three regions. -
FIG. 2B depicts a cross-sectional exploded view of a sensor head of the present invention wherein a portion of the second membrane region does not cover the working electrode. -
FIG. 2C depicts a cross-sectional exploded view of a sensor head of the present invention which includes two distinct regions, wherein the region adjacent the electrochemically reactive surfaces includes a portion positioned over the counter electrode which corresponds to a silicone domain. -
FIG. 2D depicts a cross-sectional exploded view of a sensor head of the present invention wherein an active enzyme of the immobilized enzyme domain is positioned only over the working electrode. -
FIG. 2E depicts a cross-sectional exploded view of a sensor head of the present invention wherein the enzyme positioned over the counter electrode has been inactivated. -
FIG. 2F depicts a cross-sectional exploded view of a sensor head of the present invention wherein the membrane region containing immobilized enzyme is positioned only over the working electrode. -
FIG. 3 Illustration of an implantable glucose sensor's ability to measure glucose concentration during an infusion study in a canine when the counter electrode voltage drops to the electronic circuitry limit at approximately 0.75 hours wherein the sensor current output reaches 2.50 nA. -
FIG. 4 Illustration of an implantable glucose sensor's ability to measure glucose concentration during an infusion study in a canine when the counter electrode voltage drops to the electronic circuitry limit after 0.5 hours wherein the sensor current output reaches 0.50 nA. -
FIG. 5 Illustration of an implantable glucose sensor's ability to measure glucose concentration during an infusion study in a canine when the counter electrode voltage is maintained above the electronic circuitry limit. -
FIG. 6A shows a schematic representation of a cylindrical analyte measuring device including a sensor head according to the present invention. -
FIG. 6B is an exploded view of the sensor head of the device shown inFIG. 6A . -
FIG. 7 Graphical representation of the function of a device of the present invention utilizing the multi-region membrane architecture ofFIG. 2B in vitro at 400 mg/dL glucose. -
FIG. 8 depicts a cross-sectional exploded view of the electrode and membrane regions of a prior sensor device where the electrochemical reactive surface of the counter electrode is substantially equal to the surface area of the working electrode. -
FIG. 9 Graphical representation of the counter electrode voltage as a function of oxygen concentration at 400 mg/dL glucose for sensor devices including the membrane shown inFIG. 8 . - In a preferred embodiment, the sensor heads, devices and methods of the present invention may be used to determine the level of glucose or other analytes in a host. The level of glucose is a particularly important measurement for individuals having diabetes in that effective treatment depends on the accuracy of this measurement.
- The present invention increases the effectiveness of counter electrode function by a method that does not depend on increasing the local concentration of oxygen. In a preferred embodiment, the counter electrode has an electrochemical reactive surface area greater than twice the surface area of the working electrode thereby substantially increasing the electrodes ability to utilize oxygen as a substrate. Further enhancement of the counter electrode's activity may be achieved if the electrode were made of gold. In a second preferred embodiment, the counter electrode has a textured surface, with surface topography that increases the surface area of the electrode while the diameter of the electrode remains constant. In a third preferred embodiment, the proximity of the glucose oxidase enzyme to the counter electrode may be decreased. Since the enzyme depletes oxygen locally, the counter electrode would best be situated at a location distant from the enzyme. This could be achieved by depleting the enzyme from or inactivating the enzyme located in the region near and over the counter electrode by methods known to those skilled in the art such as laser ablation, or chemical ablation. Alternatively, the membrane could be covered with an additional domain where glucose is selectively blocked from the area over the counter electrode.
- In particular, the present invention reduces the potential for electrode poisoning by positioning all electrodes underneath a multi-region membrane so that there is control of the species reaching the electrode surfaces. These membranes allow passage of dissolved oxygen to support the counter electrode reactions at reasonable negative potentials while rejecting larger molecules which when reduced would coat the surface of the counter electrode eventually leading to cascade failure. The positioning of the counter electrode underneath the membrane assures that all currents are passing through the same conductive media, thereby reducing voltage losses due to membrane or solution resistance. In addition, the counter electrode will be able to collect enough species for the balancing current while minimizing the need to move towards negative potential extremes.
- Although the description that follows is primarily directed at glucose monitoring sensor heads, devices and methods for their use, the sensor heads, devices and methods of the present invention are not limited to glucose measurement. Rather, the devices and methods may be applied to detect and quantitate other analytes present in biological fluids (including, but not limited to, amino acids and lactate), especially those analytes that are substrates for oxidase enzymes [see, e.g., U.S. Pat. No. 4,703,756 to Gough et al., hereby incorporated by reference].
- I. Nature of the Foreign Body Capsule
- Devices and probes that are implanted into subcutaneous tissue will almost always elicit a foreign body capsule (FBC) as part of the body's response to the introduction of a foreign material. Therefore, implantation of a glucose sensor results in an acute inflammatory reaction followed by building of fibrotic tissue. Ultimately, a mature FBC comprising primarily a vascular fibrous tissue forms around the device (Shanker and Greisler, Inflammation and Biomaterials in Greco R S, ed. Implantation Biology: The Host Response and Biomedical Devices, pp68-80, CRC Press (1994)).
- In general, the formation of a FBC has precluded the collection of reliable, continuous information, reportedly because of poor vascularization (Updike, S. J. et al., “Principles of Long-term Fully Implanted Sensors with Emphasis on Radiotelemetric Monitoring of Blood Glucose from inside a Subcutaneous Foreign Body Capsule (FBC)” in “Biosensors and the Body,” D. M. Fraser, ed., 1997, pp. 117-38, John Wiley and Sons, New York). Thus, those skilled in the art have previously attempted to minimize FBC formation by, for example, using a short-lived needle geometry or sensor coatings to minimize the foreign body.
- In contrast to the prior art, the teachings of the present invention recognize that FBC formation is the dominant event surrounding long-term implantation of any sensor and must be managed to support, rather than hinder or block, sensor performance. It has been observed that during the early periods following implantation of an analyte sensing device, particularly a glucose sensing device, that glucose sensors function well. However, after a few days to two or more weeks of implantation, these device lose their function.
- We have observed that this lack of sensor function is most likely due to cells (barrier cells) that associate with the outer surface of the device and physically block the transport of glucose into the device (i.e. form a a barrier cell layer). Increased vascularization would not be expected to overcome this blockage. The present invention contemplates the use of particular biointerface membrane architectures that interfere with barrier cell layer formation on the membrane's surface. The present invention also contemplates the use of these membranes with a variety of implantable devices (e.g. analyte measuring devices particularly glucose measuring devices).
- II. The Sensor Head
- In one embodiment of the sensor head of the invention, the body is made of a non-conductive material such as ceramic, glass, or polymer.
- In a preferred embodiment, the sensor head interface region may include several different layers and/or membranes that cover and protect the electrodes of an implantable analyte-measuring device. The characteristics of these layers and/or membranes are now discussed in more detail. The layers and/or membranes prevent direct contact of the biological fluid sample with the electrodes, while permitting selected substances (e.g., analytes) of the fluid to pass therethrough for reaction in an enzyme rich domain with subsequent electrochemical reaction of formed products at the electrodes.
- It is well known in the art that electrode surfaces exposed to a wide range of biological molecules may suffer poisoning of catalytic activity and possible corrosion that could result in failure. However, utilizing the unique multi-region membrane architectures of the present invention, the active electrochemical surfaces of the sensor electrodes are preserved, retaining activity for extended periods of time in vivo. By limiting access to the electrochemically reactive surface of the electrodes to a small number of molecular species such as, for example, molecules having a molecular weight of about 34 Daltons (the molecular weight of peroxide) or less, only a small subset of the many molecular species present in biological fluids are permitted to contact the sensor. Use of such membranes has enabled sustained function of devices for over one year in vivo.
- A. Multi-Region Membrane
- The multi-region membrane is constructed of two or more regions. The multi-region membrane may be provided in a number of different architectures. In one architecture, the multi-region membrane includes a first region distant from the electrochemically reactive surfaces, a second region less distant from the electrochemically reactive surfaces and a third region adjacent to the electrochemically reactive surfaces. The first region includes a cell disruptive domain distant from the electrochemically reactive surfaces and a cell impermeable domain less distant from the electrochemically reactive surfaces. The second region is a glucose exclusion domain and the third region includes a resistance domain distant from the electrochemically reactive surfaces, an immobilized enzyme domain less distant from the electrochemically reactive surfaces, an interference domain less distant from the electrochemically reactive surfaces than the immobilized enzyme domain and a hydrogel domain adjacent to the electrochemically reactive surfaces.
- In another architecture, the multi-region membrane includes a first region distant from the electrochemically reactive surfaces and a further region less distant from the electrochemically reactive surfaces. The first region includes a cell disruptive domain and a cell impermeable domain as described above. The “further region” includes a resistance domain, immobilized enzyme domain, interference domain, and hydrogel domain and serves as the equivalent of the “third region” described above. In certain embodiments of the sensor head, the multi-region membrane further includes an oxygen antenna domain. Each of these domains will now be described in further detail.
- i. Cell Disruptive Domain
- The domain of the multi-region membrane positioned most distal to the electrochemically reactive surfaces corresponds to the cell disruptive domain. This domain includes a material that supports tissue in-growth and may be vascularized. The cell disruptive domain prevents formation of the barrier cell layer on the surface of the membrane, which as described above, blocks the transport of glucose into the sensor device. A useful cell disruptive domain is described in a U.S. application entitled “Membrane for use with Implantable Devices” which was filed on the same day as the present application. The cell disruptive domain may be composed of an open-cell configuration having cavities and solid portions. Cells may enter into the cavities, however, they can not travel through or wholly exist within the solid portions. The cavities allow most substances to pass through, including, e.g., macrophages.
- The open-cell configuration yields a co-continuous solid domain that contains greater than one cavity in three dimensions substantially throughout the entirety of the membrane. In addition, the cavities and cavity interconnections may be formed in layers having different cavity dimensions.
- A linear line can be used to define a dimension across a cavity or solid portion the length of which is the distance between two points lying at the interface of the cavity and solid portion. In this way, a substantial number of the cavities are not less than 20 microns in the shortest dimension and not more than 1000 microns in the longest dimension. Preferably, a substantial number of the cavities are not less than 25 microns in the shortest dimension and not more than 500 microns in the longest dimension.
- Furthermore, the solid portion has not less than 5 microns in a substantial number of the shortest dimensions and not more than 2000 microns in a substantial number of the longest dimensions. Preferably, the solid portion is not less than 10 microns in a substantial number of the shortest dimensions and not more than 1000 microns in a substantial number of the longest dimensions and most preferably, not less than 10 microns in a substantial number of the shortest dimensions and not more than 400 microns in a substantial number of the longest dimensions.
- The solid portion may be made of polytetrafluoroethylene or polyethylene-co-tetrafluoroethylene, for example. Preferably, the solid portion includes polyurethanes or block copolymers and, most preferably, includes silicone.
- When non-woven fibers are utilized as the solid portion of the present invention, the non-woven fibers may be greater than 5 microns in the shortest dimension. Preferably, the non-woven fibers are about 10 microns in the shortest dimension and most preferably, the non-woven fibers are greater than or equal to 10 microns in the shortest dimension.
- The non-woven fibers may be constructed of polypropylene (PP), polyvinylchloride (PVC), polyvinylidene fluoride (PVDF), polybutylene terephthalate (PBT), polymethylmethacrylate (PMMA), polyether ether ketone (PEEK), polyurethanes, cellulosic polymers, polysulfones, and block copolymers thereof including, for example, di-block, tri-block, alternating, random and graft copolymers (block copolymers are discussed in U.S. Pat. Nos. 4,803,243 and 4,686,044, hereby incorporated by reference). Preferably, the non-woven fibers are comprised of polyolefins or polyester or polycarbonates or polytetrafluoroethylene.
- A subset of the cell disruptive domain is the oxygen antenna domain. This domain can act as an oxygen reservoir during times of minimal oxygen need and has the capacity to provide on demand a higher oxygen gradient to facilitate oxygen transport across the membrane. This domain may be composed of a material such as silicone, that has higher oxygen solubility than aqueous media so that it concentrates oxygen from the biological fluid surrounding the biointerface membrane. This enhances function in the enzyme reaction domain and at the counter electrode surface when glucose conversion to hydrogen peroxide in the enzyme domain consumes oxygen from the surrounding domains. Thus, this ability of the oxygen antenna domain to apply a higher flux of oxygen to critical domains when needed improves overall sensor function. Preferably, this domain is composed of silicone and has a thickness of about 100 microns.
- The thickness of the cell disruptive domain is usually not less than about 20 microns and not more than about 2000 microns.
- ii. Cell Impermeable Domain
- The cell impermeable of the first region is positioned less distal to the electrochemically reactive surfaces than the cell disruptive domain of the same region. This domain is impermeable to host cells, such as macrophages. Cell impermeable domains are described in U.S. Pat. No. 6,001,067, herein incorporated by reference, and in copending, commonly owned U.S. application entitled “Membrane for use with Implantable Devices”, Serial No. ______, filed on even date herewith. The inflammatory response that initiates and sustains a FBC is associated with disadvantages in the practice of sensing analytes. Inflammation is associated with invasion of inflammatory response cells (e.g. macrophages) which have the ability to overgrow at the interface and form barrier cell layers, which may block transport of glucose across the biointerface membrane. These inflammatory cells may also biodegrade many artificial biomaterials (some of which were, until recently, considered nonbiodegradable). When activated by a foreign body, tissue macrophages degranulate, releasing from their cytoplasmic myeloperoxidase system hypochlorite (bleach) and other oxidative species. Hypochlorite and other oxidative species are known to break down a variety of polymers, including ether based polyurethanes, by a phenomenon referred to as environmental stress cracking. Alternatively, polycarbonate based polyurethanes are believed to be resistant to environmental stress cracking and have been termed biodurable. In addition, because hypochlorite and other oxidizing species are short-lived chemical species in vivo, biodegradation will not occur if macrophages are kept a sufficient distance from the enzyme active membrane.
- The present invention contemplates the use of cell impermeable biomaterials of a few microns thickness or more (i.e., a cell impermeable domain) in most of its membrane architectures. This domain of the biointerface membrane is permeable to oxygen and may or may not be permeable to glucose and is constructed of biodurable materials (e.g. for period of several years in vivo) that are impermeable by host cells (e.g. macrophages) such as for example polymer blends of polycarbonate based polyurethane and PVP.
- The thickness of the cell impermeable domain is not less than about 10 microns and not more than about 100 microns.
- iii. Glucose Exclusion Domain
- The glucose exclusion domain includes a thin, hydrophobic membrane that is non-swellable and blocks diffusion of glucose while being permeable to oxygen. The glucose exclusion domain serves to allow analytes and other substances that are to be measured or utilized by the sensor to pass through, while preventing passage of other substances. Preferably, the glucose exclusion domain is constructed of a material such as, for example, silicone.
- The glucose exclusion domain has a preferred thickness not less than about 130 microns, more preferably not less than about 5 and not more than about 75 microns and most preferably not less than 15 microns and not more than about 50 microns.
- iv. Resistance Domain
- In one embodiment of the sensor head the “third region” or “further region” of the multi-region membrane includes a resistance domain. When present, the resistance domain is located more distal to the electrochemically reactive surfaces relative to other domains in this region. As described in further detail below, the resistance domain controls the flux of oxygen and glucose to the underlying enzyme domain. There is a molar excess of glucose relative to the amount of oxygen in samples of blood. Indeed, for every free oxygen molecule in extracellular fluid, there are typically more than 100 glucose molecules present [Updike et al., Diabetes Care 5:207-21(1982)]. However, an immobilized enzyme-based sensor using oxygen (O2) as cofactor must be supplied with oxygen in non-rate-limiting excess in order to respond linearly to changes in glucose concentration, while not responding to changes in oxygen tension. More specifically, when a glucose-monitoring reaction is oxygen-limited, linearity is not achieved above minimal concentrations of glucose. Without a semipermeable membrane over the enzyme domain, linear response to glucose levels can be obtained only up to about 40 mg/dL; however, in a clinical setting, linear response to glucose levels are desirable up to at least about 500 mg/dL.
- The resistance domain includes a semipermeable membrane that controls the flux of oxygen and glucose to the underlying enzyme domain (i.e., limits the flux of glucose), rendering the necessary supply of oxygen in non-rate-limiting excess. As a result, the upper limit of linearity of glucose measurement is extended to a much higher value than that which could be achieved without the resistance domain. The devices of the present invention contemplate resistance domains including polymer membranes with oxygen-to-glucose permeability ratios of approximately 200:1; as a result, one-dimensional reactant diffusion is adequate to provide excess oxygen at all reasonable glucose and oxygen concentrations found in the subcutaneous matrix [Rhodes et al., Anal. Chem., 66:1520-1529 (1994)].
- In preferred embodiments, the resistance domain is constructed of a polyurethane urea/polyurethane-block-polyethylene glycol blend and has a thickness of not more than about 45 microns, more preferably not less than about 15 microns, and not more than about 40 microns and, most preferably, not less than about 20 microns, and not more than about 35 microns.
- v. Immobilized Enzyme Domain
- When the resistance domain is combined with the cell-impermeable domain, it is the immobilized enzyme domain which corresponds to the outermost domain of the “third region” or “further region”, i.e. it is located more distal to the electrochemically reactive surfaces as compared to the other domains in this region. In one embodiment, the enzyme domain includes glucose oxidase. In addition to glucose oxidase, the present invention contemplates the use of a domain impregnated with other oxidases, e.g., galactose oxidase or uricase, For an enzyme-based electrochemical glucose sensor to perform well, the sensor's response must neither be limited by enzyme activity nor cofactor concentration. Because enzymes, including glucose oxidase, are subject to deactivation as a function of ambient conditions, this behavior needs to be accounted for in constructing sensors for long-term use.
- Preferably, the domain is constructed of aqueous dispersions of colloidal polyurethane polymers including the enzyme. Preferably, the coating has a thickness of not less than about 2.5 microns and not more than about 12.5 microns, preferably about 6.0 microns.
- vi. Interference Domain
- The interference domain in the “third region” or “further region” is located less distant from the electrochemically reactive surfaces than the immobilized enzyme domain in this same region. It includes a thin membrane that can limit diffusion of molecular weight species greater than 34 kD. The interference domain serves to allow analytes and other substances that are to be measured by the electrodes to pass through, while preventing passage of other substances, including potentially interfering substances. The interference domain is preferably constructed of a polyurethane.
- The interference domain has a preferred thickness of not more than about 5 microns, more preferably not less than about 0.1 microns, and not more than about 5 microns and, most preferably, not less than about 0.5 microns, and not more than about 3 microns.
- vii. Hydrogel Domain
- The hydrogel domain is located adjacent to the electrochemically reactive surfaces. To ensure electrochemical reaction, the hydrogel domain includes a semipermeable coating that maintains hydrophilicity at the electrode region of the sensor interface. The hydrogel domain enhances the stability of the interference domain of the present invention by protecting and supporting the membrane that makes up the interference domain. Furthermore, the hydrogel domain assists in stabilizing operation of the device by overcoming electrode start-up problems and drifting problems caused by inadequate electrolyte. The buffered electrolyte solution contained in the hydrogel domain also protects against pH-mediated damage that may result from the formation of a large pH gradient between the hydrophobic interference domain and the electrode (or electrodes) due to the electrochemical activity of the electrode(s).
- Preferably, the hydrogel domain includes a flexible, water-swellable, substantially solid gel-like film having a “dry film” thickness of not less than about 2.5 microns and not more than about 12.5 microns; preferably, the thickness is about 6.0 microns. “Dry film” thickness refers to the thickness of a cured film cast from a coating formulation onto the surface of the membrane by standard coating techniques
- Suitable hydrogel domains are formed of a curable copolymer of a urethane polymer and a hydrophilic film-forming polymer. Particularly preferred coatings are formed of a polyurethane polymer having anionic carboxylate functional groups and non-ionic hydrophilic polyether segments, which is crosslinked in the present of polyvinylpyrrolidone and cured at a moderate temperature of about 50° C.
- B. Electrolyte Phase
- The electrolyte phase is a free-fluid phase including a solution containing at least one compound, usually a soluble chloride salt, that conducts electric current. The electrolyte phase flows over the electrodes and is in contact with the hydrogel domain. The devices of the present invention contemplate the use of any suitable electrolyte solution, including standard, commercially available solutions.
- Generally speaking, the electrolyte phase should have the same or less osmotic pressure than the sample being analyzed. In preferred embodiments of the present invention, the electrolyte phase includes normal saline.
- C. Membrane Architectures
- Prior art teaches that an enzyme containing membrane that resides above an amperometric electrochemical sensor can possess the same architecture throughout the electrode surfaces. However, the function of converting glucose into hydrogen peroxide by glucose oxidase may only by necessary above the working electrode. In fact, it may be beneficial to limit the conversion of glucose into hydrogen peroxide above the counter electrode. Therefore, the present invention contemplates a number of membrane architectures that include a multi-region membrane wherein the regions include at least one domain.
- Referring now to
FIG. 2A , which shows one desired embodiment of the general architecture of a three region membrane,first region 33 is permeable to oxygen and glucose and includes a cell disruptive domain distant from the electrodes and a cell impermeable domain less distant from the electrodes. Thesecond region 31 is permeable to oxygen and includes a glucose exclusion domain and region three 32 includes a resistance domain, distant from the electrochemically reactive surfaces, an immobilized enzyme domain less distant from the electrochemically reactive surfaces, an interference domain less distant from the electrochemically reactive surfaces than the immobilized enzyme and a hydrogel domain adjacent to the electrochemically reactive surfaces. The multi-region membrane is positioned over thesensor interface 30 of thenon-conductive body 10, covering the workingelectrode 21, thereference electrode 20 and thecounter electrode 22. The electrodes are brazed to the sensor head and back filled withepoxy 28. - In
FIG. 2B , the glucose exclusion domain has been positioned over the electrochemically reactive surfaces such that it does not cover the workingelectrode 21. To illustrate this, ahole 35 has been created in thesecond region 31 and positioned directly above the workingelectrode 21. In this way, glucose is blocked from entering the underlying enzyme membrane above thecounter electrode 22 and O2 is conserved above the counter electrode because it is not being consumed by the glucose oxidation reaction. The glucose-blocking domain is made of a material that allows sufficient O2 to pass to the counter electrode. The glucose-blocking domain may be made of a variety of materials such as silicone or silicone containing copolymers. Preferably, the glucose-blocking domain is made of silicone. - In
FIG. 2C , the multi-region membrane is shown as being constructed of two regions: afirst region 33 which includes a cell disruptive domain and a cell impermeable domain; and afurther region 32.Region 32 is defined herein as including an enzyme immobilized domain, interference domain, and hydrogel domain and may also include a resistance domain.Region 32 is referred to as the “third region” in embodiments where the multi-region membrane includes three regions. In the embodiment shown, a silicone domain plug 36 positioned over thecounter electrode 22 in order to eliminate the consumption of O2 above the counter electrode by the oxidation of glucose with glucose oxidase. The enzyme immobilized domain can be fabricated as previously described, then a hole punched into the domain. The silicone domain plug 36 may be cut to fit the hole, and then adhered into place, for example, with silicone adhesive (e.g., MED-1511, NuSil, Carpinteria, Calif.). - In
FIG. 2D , the immobilized enzyme domain of the multi-region membrane can be fabricated such thatactive enzyme 37 is positioned only above the workingelectrode 21. In this architecture, the immobilized enzyme domain may be prepared so that the glucose oxidase only exists above the workingelectrode 21. During the preparation of the multi-region membrane, the immobilized enzyme domain coating solution can be applied as a circular region similar to the diameter of the working electrode. This fabrication can be accomplished in a variety of ways such as screen printing or pad printing. Preferably, the enzyme domain is pad printed during the enzyme membrane fabrication with equipment as available from Pad Print Machinery of Vermont (Manchester, Vt.). These architectures eliminate the consumption of O2 above thecounter electrode 22 by the oxidation of glucose with glucose oxidase. - In
FIG. 2E , the immobilized enzyme of the multi-region membrane inregion 32 may be deactivated 38 except for the area covering the workingelectrode 21. In some of the previous membrane architectures, the glucose oxidase is distributed homogeneously throughout the immobilized enzyme domain. However, the active enzyme need only reside above the working electrode. Therefore, the enzyme may be deactivated 38 above thecounter 22 andreference 20 electrodes by irradiation. A mask that covers the workingelectrode 21, such as those used for photolithography can be placed above the membrane. In this way, exposure of the masked membrane to ultraviolet light deactivates the glucose oxidase in all regions except that covered by the mask. -
FIG. 2F shows an architecture in which thethird region 32 which includes immobilized enzyme only resides over the workingelectrode 21. In this architecture, consumption of O2 above thecounter electrode 22 by the oxidation of glucose with glucose oxidase is eliminated. - D. The Electrode Assembly
- The electrode assembly of this invention comprises a non-conductive body and three electrodes affixed within the body having electrochemically reactive surfaces at one location on the body and an electronic connection means at another location on the body and may be used in the manner commonly employed in the making of amperometric measurements. A sample of the fluid being analyzed is placed in contact with a reference electrode, e.g., silver/silver-chloride, a working electrode which is preferably formed of platinum, and a counter electrode which is preferably formed of gold or platinum. The electrodes are connected to a galvanometer or polarographic instrument and the current is read or recorded upon application of the desired D.C. bias voltage between the electrodes.
- The ability of the present device electrode assembly to accurately measure the concentration of substances such as glucose over a broad range of concentrations in fluids including undiluted whole blood samples enables the rapid and accurate determination of the concentration of those substances. That information can be employed in the study and control of metabolic disorders including diabetes.
- The present invention contemplates several structural architectures that effectively increase the electrochemically reactive surface of the counter electrode. In one embodiment, the diameter of wire used to create the counter electrode is at least twice the diameter of the working electrode. In this architecture, it is preferable that the electrochemically reactive surface of the counter electrode be not less than about 2 and not more than about 100 times the surface area of the working electrode. More preferably, the electrochemically reactive surface of the counter electrode is not less than about 2 and not more than about 50, not less than about 2 and not more than about 25 or not less than about 2 and not more than about 10 times the surface area of the working electrode. In another embodiment, the electrochemically reactive surface is larger that the wire connecting this surface to the sensor head. In this architecture, the electrode could have a cross-sectional view that resembles a “T”. The present invention contemplates a variety of configurations of the electrode head that would provide a large reactive surface, while maintaining a relatively narrow connecting wire. Such configurations could be prepared by micromachining with techniques such as reactive ion etching, wet chemical etching and focused ion beam machining as available from Norsam Technologies (Santa Fe, N.Mex.).
- In another embodiment, the diameter of the counter electrode is substantially similar to the working electrode; however, the surface of the counter electrode has been modified to increase the surface area such that it has at least twice the surface area of the working electrode. More specifically the counter electrodes surface may be textured, effectively increasing its surface area without significantly increasing its diameter. This may be accomplished by a variety of methods known to those skilled in the art including, such as acid etching. The electrochemically reactive surface may be provided in a variety of shapes and sizes (e.g. round, triangular, square or free form) provided that it is at least twice the surface area of the working electrode.
- In all of the architectures described, the electrodes are prepared from a 0.020″ diameter wire having the desired modified reactive surface. The electrodes are secured inside the non-conductive body by brazing. The counter electrode is preferably made of gold or platinum.
- III. Analyte Measuring Device
- A preferred embodiment of an analyte measuring device including a sensor head according to the present invention is shown in
FIG. 6A . In this embodiment, aceramic body 1 andceramic head 10 houses the sensor electronics that include acircuit board 2, amicroprocessor 3, abattery 4, and anantenna 5. Furthermore, theceramic body 1 andhead 10 possess a matching taper joint 6 that is sealed with epoxy. The electrodes are subsequently connected to the circuit board via a socket 8. - As indicated in detail in
FIG. 6B , three electrodes protrude through theceramic head 10, aplatinum working electrode 21, aplatinum counter electrode 22 and a silver/silverchloride reference electrode 20. Each of these is hermetically brazed 26 to theceramic head 10 and further secured withepoxy 28. Thesensing region 24 is covered with a multi-region membrane described above and theceramic head 10 contains agroove 29 so that the membrane may be affixed into place with an o-ring. - IV. Experimental
- The following examples serve to illustrate certain preferred embodiments and aspects of the present invention and are not to be construed as limiting the scope thereof
- In the preceding description and the experimental disclosure which follows, the following abbreviations apply: Eq and Eqs (equivalents); mEq (milliequivalents); M (molar); mM (millimolar) μM (micromolar); N (Normal); mol (moles); mmol (millimoles); μmol (micromoles); nmol (nanomoles); g (grams); mg (milligrams); μg (micrograms); Kg (kilograms); L (liters); mL (milliliters); dL (deciliters); μL (microliters); cm (centimeters); mm (millimeters); μm (micrometers); nm (nanometers); h and hr (hours); min. (minutes); s and sec. (seconds); ° C. (degrees Centigrade); Astor Wax (Titusville, Pa.); BASF Wyandotte Corporation (Parsippany, N.J.); Data Sciences, Inc. (St. Paul, Minn.); DuPont (DuPont Co., Wilmington, Del.); Exxon Chemical (Houston, Tex.); GAF Corporation (New York, N.Y.); Markwell Medical (Racine, Wis.); Meadox Medical, Inc. (Oakland, N.J.); Mobay (Mobay Corporation, Pittsburgh, Pa.); NuSil Technologies (Carpenteria, Calif.) Sandoz (East Hanover, N.J.); and Union Carbide (Union Carbide Corporation; Chicago, Ill.).
- Preparation of the Multi-region Membrane
- A. Preparation of the First Region
- The cell disruptive domain may be an ePTFE filtration membrane and the cell impermeable domain may then be coated on this domain layer. The cell impermeable domain was prepared by placing approximately 706 gm of dimethylacetamide (DMAC) into a 3 L stainless steel bowl to which a polycarbonateurethane solution (1325 g, Chronoflex AR 25% solids in DMAC and 5100 cp) and polyvinylpyrrolidone (125 g, Plasdone K-90 D) are added. The bowl was then fitted to a planetary mixer with a paddle type blade and the contents were stirred for 1 hour at room temperature. This solution was then coated on the cell disruptive domain by knife edge drawn at a gap of 0.006″ and dried at 60° C. for 24 hours.
- Alternatively, the polyurethane polyvinylpyrrolidone solution prepared above can be coated onto a PET release liner using a knife over roll coating machine. This material is then dried at 305° F. for approximately 2 minutes. Next the ePTFE membrane is immersed in 50:50 (w/v) mixture of THF/DMAC and then placed atop the coated polyurethane polyvinylpyrrolidone material. Light pressure atop the assembly intimately embeds the ePTFE into the polyurethane polyvinylpyrrolidone. The membrane is then dried at 60° C. for 24 hours.
- B. Preparation of the Glucose Exclusion Domain
- An oxime cured silicone dispersion (NuSil Technologies, MED-6607) was cast onto a polypropylene sheet and cured at 40° C. for three days.
- C. Preparation of the Third Region
- The “third region” or “further region” includes a resistance domain, an immobilized enzyme domain, an interference domain and an hydrogel domain. The resistance domain was prepared by placing approximately 281 gm of dimethylacetamide into a 3 L stainless steel bowl to which a solution of polyetherurethaneurea (344 gm of Chronothane H, 29,750 cp at 25% solids in DMAC). To this mixture was added another polyetherurethaneurea (312 gm, Chronothane 1020, 6275 cp at 25% solids in DMAC.) The bowl was fitted to a planetary mixer with a paddle type blade and the contents were stirred for 30 minutes at room temperature. The resistance domain coating solutions produced is coated onto a PET release liner (Douglas Hansen Co., Inc. Minneapolis, Minn.) using a knife over roll set at a 0.012″ gap. This film is then dried at 305° F. The final film is approximately 0.0015″ thick.
- The immobilized enzyme domain was prepared by placing 304 gm polyurethane latex (Bayhydrol 140 AQ, Bayer, Pittsburgh, Pa.) into a 3 L stainless steel bowl to which 51 gm of pyrogen free water and 5.85 gm of glucose oxidase (Sigma type VII from Aspergillus niger) is added. The bowl was then fitted to a planetary mixer with a whisk type blade and the mixture was stirred for 15 minutes. Approximately 24 hr prior to coating a solution of glutaraldehyde (15.4 mL of a 2.5% solution in pyrogen free water) and 14 mL of pyrogen free water was added to the mixture. The solution was mixed by inverting a capped glass bottle by hand for about 3 minutes at room temperature. This mixture was then coated over the resistance domain with a #10 Mayer rod and dried above room temperature preferably at about 50° C.
- The interference domain was prepared by placing 187 gm of tetrahydrofuran into a 500 mL glass bottle to which an 18.7 gm aliphatic polyetherurethane (Tecoflex SG-85A, Thermedics Inc., Woburn, Mass.) was added. The bottle was placed onto a roller at approximately 3 rpm within an oven set at 37° C. The mixture was allowed to roll for 24 hr. This mixture was coated over the dried enzyme domain using a flexible knife and dried above room temperature preferably at about 50° C.
- The hydrogel domain was prepared by placing 388 gm of polyurethane latex (Bayhydrol 123, Bayer, Pittsburgh, Pa. in a 3 L stainless steel bowl to which 125 gm of pyrogen free water and 12.5 gm polyvinylpyrrolidone (Plasdone K-90D) was added. The bowl was then fitted to a planetary mixer with a paddle type blade and stirred for 1 hr at room temperature. Within 30 minutes of coating approximately 13.1 mL of carbodiimide (UCARLNK) was added and the solution was mixed by inverting a capped polyethylene jar by hand for about 3 min at room temperature. This mixture was coated over the dried interference domain with a #10 Mayer rod and dried above room temperature preferably at about 50° C.
- In order to affix this multi-region membrane to a sensor head, it is first placed into buffer for about 2 minutes. It is then stretched over the nonconductive body of sensor head and affixed into place with an o-ring.
- In vitro Evaluation of Sensor Devices
- This example describes experiments directed at sensor function of several sensor devices contemplated by the present invention.
- In vitro testing of the sensor devices was accomplished in a manner similar to that previously described. [Gilligan et al., Diabetes Care 17:882-887 (1994)]. Briefly, devices were powered on and placed into a polyethylene container containing phosphate buffer (450 ml, pH 7.30) at 37° C. The container was placed onto a shaker (Lab Line Rotator, model 1314) set to
speed 2. The sensors were allowed to equilibrate for at least 30 minutes and their output value recorded. After this time, a glucose solution (9.2 ml of 100 mg/ml glucose in buffer) was added in order to raise the glucose concentration to 200 mg/dl within the container. The sensors were allowed to equilibrate for at least 30 minutes and their output value recorded. Again, a glucose solution (9.4 ml of 100 mg/ml glucose in buffer) was added in order to raise the glucose concentration to 400 mg/dl within the container. The sensors were allowed to equilibrate for at least 30 minutes and their output value recorded. In this way, the sensitivity of the sensor to glucose is given as the slope of sensor output versus glucose concentration. The container was then fitted with an O2 meter (WTW, model Oxi-340) and a gas purge. A mixture of compressed air and nitrogen was used to decrease the O2 concentration. Sensor output was recorded at an ambient O2 level, then sensor output was recorded for the following O2 concentrations; 1 mg/L, 0.85 to 0.75 mg/L, 0.65 to 0.55 mg/L and 0.40 to 0.30 mg/L. In this way, the function of the sensor could be compared to its function at ambient O2 . - Sensor devices like the one shown in
FIGS. 6A and 6B , which included inventive sensor heads having a multi-region membrane with the architecture shown inFIG. 2B , were tested in vitro. Eight of these devices were fitted with membranes that possessed a 0.020″ diameter hole, four with a 0.0015″ thick polyurethane (Chronoflex AR, CardioTech International Inc.) and four with a 0.032″ thick silicone (MED-1511, NuSil Technologies Inc.). The hole was positioned above the working electrode and both membranes were secured to the device with an o-ring. Four control devices were also tested which were fitted with a multi-region membrane which lackedregion 31 shown in FIB. 2B. - As discussed above, for oxygen to be consumed in the
sensing region 32 above the electrodes, glucose is required. By placingregion 31 shown inFIG. 2B , which includes a glucose blocking domain, above all areas other than above the workingelectrode 21, oxygen consumption in areas other than working electrode areas is limited. In contrast, by eliminatingregion 31 in the control devices, less overall oxygen becomes available to electrode surfaces due to the increased availability of glucose. - The devices were activated, placed into a 500 ml-polyethylene container with sodium phosphate buffered solution (300 ml, pH 7.3) and allowed to equilibrate. Each device's baseline value was recorded. Then 12 ml of glucose solution (100 mg/ml in sodium phosphate buffer) was added to the container so that the total glucose concentration became 400 mg/dL. After this, the container was covered and fitted with an oxygen sensor and a source of nitrogen and compressed air. In this way, the oxygen concentration was controlled with a gas sparge. A glucose value was recorded for each device at decreasing oxygen concentrations from ambient to approximately 0.1 mg/L.
-
FIG. 7 graphically represents the formation of a device of the present invention utilizing the multi-region membrane architecture inFIG. 2B in vitro. The data is expressed in percent Device Function at 400 mg/dL glucose vs. oxygen concentration. The percent function of the device is simply the device output at any given oxygen concentration divided by that device's output at ambient oxygen. The results fromFIG. 7 indicate that inventive sensor devices containing the silicone membrane have better function at lower oxygen concentrations relative to both the control devices and the devices containing the polyurethane membrane. For example, at an oxygen concentration of about 0.5 mg/L, devices containing the silicone membrane are providing 100% output as compared to 80% output for the control devices. - The Effect of Varying the Size and Material of the Counter Electrode on Sensor Response and Accuracy
- An in vitro testing procedure used in this example was similar to that described in Example 2. Six devices similar to the one shown in
FIG. 6A and 6B were fitted with the multi-region membrane described herein. Two of these tested devices were comparative devices that possessed Pt counter electrodes having a 0.020″ diameter; this diameter provided for an electrochemically reactive surface of the counter electrode which was substantially equal to the surface area of the working electrode, as schematically shown inFIG. 8 . InFIG. 8 , the electrode-membrane region includes two distinct regions, the compositions and functions of which have already been described.Region 32 includes an immobilized enzyme.Region 33 includes a cell disruptive domain and a cell impermeable domain. The top ends of electrodes 21 (working), 20 (reference) and 22 (counter) are in contact with anelectrolyte phase 30, a free-flowing phase. Two other tested devices possessed Pt counter electrodes having a 0.060″ diameter. Finally, two additional devices possessed Au counter electrodes having a 0.060″ diameter. The 0.006″ diameter devices provided for an electrochemically reactive surface of the counter electrode which was approximately six times the surface area of the working electrode. Each of the devices including counter electrodes of 0.060″ diameter include a multi-region membrane above the electrode region which is similar to that shown inFIG. 8 . - The devices were activated, placed into a 500 ml-polyethylene container with sodium phosphate buffered solution (300 ml, pH 7.3) and allowed to equilibrate. Each device's baseline value was recorded. Then 12 ml of glucose solution (100 mg/ml in sodium phosphate buffer) was added to the container so that the total glucose concentration became 400 mg/dL. After this, the container was covered and fitted with an oxygen sensor and a source of nitrogen and compressed air. In this way, the oxygen concentration was controlled with a gas sparge. A counter electrode voltage was recorded for each device at decreasing oxygen concentrations from ambient to approximately 0.1 mg/L.
-
FIG. 9 graphically presents the counter electrode voltage as a function of oxygen concentration and 400 mg/dL glucose. This figure demonstrates that both the large Pt and Au counter electrode devices do not begin to reach the circuitry limits at low oxygen concentrations. Therefore, increased performance and accuracy can be obtained from a counter electrode that has an electrochemical reactive surface greater than the surface area of the working electrode. - The description and experimental materials presented above are intended to be illustrative of the present invention while not limiting the scope thereof It will be apparent to those skilled in the art that variations and modifications can be made without departing from the spirit and scope of the present invention.
Claims (19)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/021,162 US7471972B2 (en) | 2001-07-27 | 2004-12-22 | Sensor head for use with implantable devices |
US12/260,017 US8509871B2 (en) | 2001-07-27 | 2008-10-28 | Sensor head for use with implantable devices |
US13/943,622 US9328371B2 (en) | 2001-07-27 | 2013-07-16 | Sensor head for use with implantable devices |
US15/059,086 US9804114B2 (en) | 2001-07-27 | 2016-03-02 | Sensor head for use with implantable devices |
US15/720,329 US20180024086A1 (en) | 2001-07-27 | 2017-09-29 | Sensor head for use with implantable devices |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/916,711 US20030032874A1 (en) | 2001-07-27 | 2001-07-27 | Sensor head for use with implantable devices |
US11/021,162 US7471972B2 (en) | 2001-07-27 | 2004-12-22 | Sensor head for use with implantable devices |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/916,711 Continuation US20030032874A1 (en) | 2001-07-27 | 2001-07-27 | Sensor head for use with implantable devices |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/260,017 Division US8509871B2 (en) | 2001-07-27 | 2008-10-28 | Sensor head for use with implantable devices |
Publications (2)
Publication Number | Publication Date |
---|---|
US20050103625A1 true US20050103625A1 (en) | 2005-05-19 |
US7471972B2 US7471972B2 (en) | 2008-12-30 |
Family
ID=25437709
Family Applications (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/916,711 Abandoned US20030032874A1 (en) | 2001-07-27 | 2001-07-27 | Sensor head for use with implantable devices |
US11/021,162 Expired - Lifetime US7471972B2 (en) | 2001-07-27 | 2004-12-22 | Sensor head for use with implantable devices |
US12/260,017 Active 2025-02-15 US8509871B2 (en) | 2001-07-27 | 2008-10-28 | Sensor head for use with implantable devices |
US13/943,622 Expired - Fee Related US9328371B2 (en) | 2001-07-27 | 2013-07-16 | Sensor head for use with implantable devices |
US15/059,086 Expired - Lifetime US9804114B2 (en) | 2001-07-27 | 2016-03-02 | Sensor head for use with implantable devices |
US15/720,329 Abandoned US20180024086A1 (en) | 2001-07-27 | 2017-09-29 | Sensor head for use with implantable devices |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/916,711 Abandoned US20030032874A1 (en) | 2001-07-27 | 2001-07-27 | Sensor head for use with implantable devices |
Family Applications After (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/260,017 Active 2025-02-15 US8509871B2 (en) | 2001-07-27 | 2008-10-28 | Sensor head for use with implantable devices |
US13/943,622 Expired - Fee Related US9328371B2 (en) | 2001-07-27 | 2013-07-16 | Sensor head for use with implantable devices |
US15/059,086 Expired - Lifetime US9804114B2 (en) | 2001-07-27 | 2016-03-02 | Sensor head for use with implantable devices |
US15/720,329 Abandoned US20180024086A1 (en) | 2001-07-27 | 2017-09-29 | Sensor head for use with implantable devices |
Country Status (7)
Country | Link |
---|---|
US (6) | US20030032874A1 (en) |
EP (2) | EP1411823B1 (en) |
JP (1) | JP4295615B2 (en) |
AT (1) | ATE332666T1 (en) |
AU (1) | AU2002317584A1 (en) |
DE (1) | DE60213096D1 (en) |
WO (1) | WO2003011131A2 (en) |
Cited By (71)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060211921A1 (en) * | 2003-04-04 | 2006-09-21 | Brauker James H | Optimized sensor geometry for an implantable glucose sensor |
US20060252027A1 (en) * | 2005-05-05 | 2006-11-09 | Petisce James R | Cellulosic-based resistance domain for an analyte sensor |
EP1785086A2 (en) | 2005-11-12 | 2007-05-16 | Roche Diagnostics GmbH | Implantable electrode system, method and device for measuring the concentration of an analyte in a human or animal body |
US20070173709A1 (en) * | 2005-04-08 | 2007-07-26 | Petisce James R | Membranes for an analyte sensor |
US20070179568A1 (en) * | 2006-01-31 | 2007-08-02 | Sdgi Holdings, Inc. | Methods for detecting osteolytic conditions in the body |
WO2007102842A2 (en) | 2006-03-09 | 2007-09-13 | Dexcom, Inc. | Systems and methods for processing analyte sensor data |
US20070227907A1 (en) * | 2006-04-04 | 2007-10-04 | Rajiv Shah | Methods and materials for controlling the electrochemistry of analyte sensors |
US20070238998A1 (en) * | 2006-04-11 | 2007-10-11 | Sdgi Holdings, Inc. | Volumetric measurement and visual feedback of tissues |
US20070249919A1 (en) * | 1998-04-30 | 2007-10-25 | Abbott Diabetes Care, Inc. | Analyte monitoring device and methods of use |
US20080214910A1 (en) * | 2007-03-01 | 2008-09-04 | Buck Harvey B | System and method for operating an electrochemical analyte sensor |
US20090062633A1 (en) * | 2004-05-03 | 2009-03-05 | Dexcorn, Inc. | Implantable analyte sensor |
US20090099433A1 (en) * | 2006-06-19 | 2009-04-16 | Arnulf Staib | Amperometric sensor and method for its manufacturing |
US20090156919A1 (en) * | 2004-07-13 | 2009-06-18 | Dexcom, Inc. | Transcutaneous analyte sensor |
US20090247855A1 (en) * | 2008-03-28 | 2009-10-01 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
US7651596B2 (en) | 2005-04-08 | 2010-01-26 | Dexcom, Inc. | Cellulosic-based interference domain for an analyte sensor |
US20100025238A1 (en) * | 2008-07-31 | 2010-02-04 | Medtronic Minimed, Inc. | Analyte sensor apparatuses having improved electrode configurations and methods for making and using them |
US20100030045A1 (en) * | 2008-07-31 | 2010-02-04 | Medtronic Minimed, Inc. | Analyte sensor apparatuses comprising multiple implantable sensor elements and methods for making and using them |
US20100041971A1 (en) * | 2004-05-03 | 2010-02-18 | Dexcom, Inc. | Implantable analyte sensor |
US7783333B2 (en) | 2004-07-13 | 2010-08-24 | Dexcom, Inc. | Transcutaneous medical device with variable stiffness |
US7792562B2 (en) | 1997-03-04 | 2010-09-07 | Dexcom, Inc. | Device and method for determining analyte levels |
US7831287B2 (en) | 2006-10-04 | 2010-11-09 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US7857760B2 (en) | 2004-07-13 | 2010-12-28 | Dexcom, Inc. | Analyte sensor |
US7905833B2 (en) | 2004-07-13 | 2011-03-15 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8050731B2 (en) | 2002-05-22 | 2011-11-01 | Dexcom, Inc. | Techniques to improve polyurethane membranes for implantable glucose sensors |
US8052601B2 (en) | 2003-08-01 | 2011-11-08 | Dexcom, Inc. | System and methods for processing analyte sensor data |
US8064977B2 (en) | 2002-05-22 | 2011-11-22 | Dexcom, Inc. | Silicone based membranes for use in implantable glucose sensors |
EP2407093A1 (en) | 2006-02-22 | 2012-01-18 | DexCom, Inc. | Analyte sensor |
US8133178B2 (en) | 2006-02-22 | 2012-03-13 | Dexcom, Inc. | Analyte sensor |
US8155723B2 (en) | 1997-03-04 | 2012-04-10 | Dexcom, Inc. | Device and method for determining analyte levels |
US8160671B2 (en) | 2003-12-05 | 2012-04-17 | Dexcom, Inc. | Calibration techniques for a continuous analyte sensor |
USRE43399E1 (en) | 2003-07-25 | 2012-05-22 | Dexcom, Inc. | Electrode systems for electrochemical sensors |
US8229535B2 (en) | 2008-02-21 | 2012-07-24 | Dexcom, Inc. | Systems and methods for blood glucose monitoring and alert delivery |
CN102628832A (en) * | 2011-02-03 | 2012-08-08 | 爱科来株式会社 | Analyzing device, sensor testing device and testing method |
US8280475B2 (en) | 2004-07-13 | 2012-10-02 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8287454B2 (en) | 1998-04-30 | 2012-10-16 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8287453B2 (en) | 2003-12-05 | 2012-10-16 | Dexcom, Inc. | Analyte sensor |
US8346337B2 (en) | 1998-04-30 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8364229B2 (en) | 2003-07-25 | 2013-01-29 | Dexcom, Inc. | Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise |
EP2561807A1 (en) | 2005-03-10 | 2013-02-27 | DexCom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US8396528B2 (en) | 2008-03-25 | 2013-03-12 | Dexcom, Inc. | Analyte sensor |
US8423114B2 (en) | 2006-10-04 | 2013-04-16 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US8465425B2 (en) | 1998-04-30 | 2013-06-18 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8527026B2 (en) | 1997-03-04 | 2013-09-03 | Dexcom, Inc. | Device and method for determining analyte levels |
US8565848B2 (en) | 2004-07-13 | 2013-10-22 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8583204B2 (en) | 2008-03-28 | 2013-11-12 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
US8612159B2 (en) | 1998-04-30 | 2013-12-17 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8622905B2 (en) | 2003-08-01 | 2014-01-07 | Dexcom, Inc. | System and methods for processing analyte sensor data |
US8652043B2 (en) | 2001-01-02 | 2014-02-18 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8682408B2 (en) | 2008-03-28 | 2014-03-25 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
US8688188B2 (en) | 1998-04-30 | 2014-04-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8744546B2 (en) | 2005-05-05 | 2014-06-03 | Dexcom, Inc. | Cellulosic-based resistance domain for an analyte sensor |
US8792955B2 (en) | 2004-05-03 | 2014-07-29 | Dexcom, Inc. | Transcutaneous analyte sensor |
EP2796090A1 (en) | 2006-10-04 | 2014-10-29 | DexCom, Inc. | Analyte sensor |
EP2796093A1 (en) | 2007-03-26 | 2014-10-29 | DexCom, Inc. | Analyte sensor |
US8974386B2 (en) | 1998-04-30 | 2015-03-10 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9066695B2 (en) | 1998-04-30 | 2015-06-30 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9247900B2 (en) | 2004-07-13 | 2016-02-02 | Dexcom, Inc. | Analyte sensor |
US9451908B2 (en) | 2006-10-04 | 2016-09-27 | Dexcom, Inc. | Analyte sensor |
EP3092949A1 (en) | 2011-09-23 | 2016-11-16 | Dexcom, Inc. | Systems and methods for processing and transmitting sensor data |
US9700252B2 (en) | 2006-06-19 | 2017-07-11 | Roche Diabetes Care, Inc. | Amperometric sensor and method for its manufacturing |
US9763609B2 (en) | 2003-07-25 | 2017-09-19 | Dexcom, Inc. | Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise |
US9986942B2 (en) | 2004-07-13 | 2018-06-05 | Dexcom, Inc. | Analyte sensor |
EP3536241A1 (en) | 2011-04-08 | 2019-09-11 | Dexcom, Inc. | Systems and methods for processing and transmitting sensor data |
US10791928B2 (en) | 2007-05-18 | 2020-10-06 | Dexcom, Inc. | Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise |
US10980461B2 (en) | 2008-11-07 | 2021-04-20 | Dexcom, Inc. | Advanced analyte sensor calibration and error detection |
US11000215B1 (en) | 2003-12-05 | 2021-05-11 | Dexcom, Inc. | Analyte sensor |
EP4098177A1 (en) | 2007-10-09 | 2022-12-07 | DexCom, Inc. | Integrated insulin delivery system with continuous glucose sensor |
US11633133B2 (en) | 2003-12-05 | 2023-04-25 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
EP4218548A1 (en) | 2006-03-09 | 2023-08-02 | Dexcom, Inc. | Systems and methods for processing analyte sensor data |
US11730407B2 (en) | 2008-03-28 | 2023-08-22 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
EP4250312A2 (en) | 2007-10-25 | 2023-09-27 | DexCom, Inc. | Systems and methods for processing sensor data |
Families Citing this family (311)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5593852A (en) * | 1993-12-02 | 1997-01-14 | Heller; Adam | Subcutaneous glucose electrode |
US7899511B2 (en) | 2004-07-13 | 2011-03-01 | Dexcom, Inc. | Low oxygen in vivo analyte sensor |
US20050033132A1 (en) | 1997-03-04 | 2005-02-10 | Shults Mark C. | Analyte measuring device |
US7192450B2 (en) * | 2003-05-21 | 2007-03-20 | Dexcom, Inc. | Porous membranes for use with implantable devices |
US9155496B2 (en) * | 1997-03-04 | 2015-10-13 | Dexcom, Inc. | Low oxygen in vivo analyte sensor |
US6134461A (en) * | 1998-03-04 | 2000-10-17 | E. Heller & Company | Electrochemical analyte |
AU2002309528A1 (en) | 2001-04-02 | 2002-10-15 | Therasense, Inc. | Blood glucose tracking apparatus and methods |
US6702857B2 (en) | 2001-07-27 | 2004-03-09 | Dexcom, Inc. | Membrane for use with implantable devices |
US20030032874A1 (en) * | 2001-07-27 | 2003-02-13 | Dexcom, Inc. | Sensor head for use with implantable devices |
US8010174B2 (en) * | 2003-08-22 | 2011-08-30 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
US7828728B2 (en) * | 2003-07-25 | 2010-11-09 | Dexcom, Inc. | Analyte sensor |
US9282925B2 (en) * | 2002-02-12 | 2016-03-15 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
US8260393B2 (en) | 2003-07-25 | 2012-09-04 | Dexcom, Inc. | Systems and methods for replacing signal data artifacts in a glucose sensor data stream |
US9247901B2 (en) | 2003-08-22 | 2016-02-02 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
US7379765B2 (en) * | 2003-07-25 | 2008-05-27 | Dexcom, Inc. | Oxygen enhancing membrane systems for implantable devices |
US9492111B2 (en) * | 2002-04-22 | 2016-11-15 | Medtronic Minimed, Inc. | Methods and materials for stabilizing analyte sensors |
US20060258761A1 (en) * | 2002-05-22 | 2006-11-16 | Robert Boock | Silicone based membranes for use in implantable glucose sensors |
US7993108B2 (en) | 2002-10-09 | 2011-08-09 | Abbott Diabetes Care Inc. | Variable volume, shape memory actuated insulin dispensing pump |
EP2383470A1 (en) | 2002-10-09 | 2011-11-02 | Abbott Diabetes Care Inc. | Plunger pump actuated by a shape memory element |
US7727181B2 (en) * | 2002-10-09 | 2010-06-01 | Abbott Diabetes Care Inc. | Fluid delivery device with autocalibration |
US7381184B2 (en) | 2002-11-05 | 2008-06-03 | Abbott Diabetes Care Inc. | Sensor inserter assembly |
EP1578262A4 (en) | 2002-12-31 | 2007-12-05 | Therasense Inc | Continuous glucose monitoring system and methods of use |
US7587287B2 (en) * | 2003-04-04 | 2009-09-08 | Abbott Diabetes Care Inc. | Method and system for transferring analyte test data |
US7679407B2 (en) * | 2003-04-28 | 2010-03-16 | Abbott Diabetes Care Inc. | Method and apparatus for providing peak detection circuitry for data communication systems |
US7875293B2 (en) | 2003-05-21 | 2011-01-25 | Dexcom, Inc. | Biointerface membranes incorporating bioactive agents |
US8460243B2 (en) * | 2003-06-10 | 2013-06-11 | Abbott Diabetes Care Inc. | Glucose measuring module and insulin pump combination |
US8066639B2 (en) | 2003-06-10 | 2011-11-29 | Abbott Diabetes Care Inc. | Glucose measuring device for use in personal area network |
US8071028B2 (en) * | 2003-06-12 | 2011-12-06 | Abbott Diabetes Care Inc. | Method and apparatus for providing power management in data communication systems |
US7695239B2 (en) * | 2003-07-14 | 2010-04-13 | Fortrend Engineering Corporation | End effector gripper arms having corner grippers which reorient reticle during transfer |
US7722536B2 (en) * | 2003-07-15 | 2010-05-25 | Abbott Diabetes Care Inc. | Glucose measuring device integrated into a holster for a personal area network device |
WO2005010518A1 (en) * | 2003-07-23 | 2005-02-03 | Dexcom, Inc. | Rolled electrode array and its method for manufacture |
WO2007120442A2 (en) * | 2003-07-25 | 2007-10-25 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
WO2005019795A2 (en) * | 2003-07-25 | 2005-03-03 | Dexcom, Inc. | Electrochemical sensors including electrode systems with increased oxygen generation |
US20050176136A1 (en) * | 2003-11-19 | 2005-08-11 | Dexcom, Inc. | Afinity domain for analyte sensor |
US7424318B2 (en) * | 2003-12-05 | 2008-09-09 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US7460898B2 (en) * | 2003-12-05 | 2008-12-02 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US7366556B2 (en) * | 2003-12-05 | 2008-04-29 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US8423113B2 (en) * | 2003-07-25 | 2013-04-16 | Dexcom, Inc. | Systems and methods for processing sensor data |
US20050056552A1 (en) * | 2003-07-25 | 2005-03-17 | Simpson Peter C. | Increasing bias for oxygen production in an electrode system |
US7467003B2 (en) * | 2003-12-05 | 2008-12-16 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US7591801B2 (en) | 2004-02-26 | 2009-09-22 | Dexcom, Inc. | Integrated delivery device for continuous glucose sensor |
US8275437B2 (en) * | 2003-08-01 | 2012-09-25 | Dexcom, Inc. | Transcutaneous analyte sensor |
US7774145B2 (en) | 2003-08-01 | 2010-08-10 | Dexcom, Inc. | Transcutaneous analyte sensor |
US7933639B2 (en) | 2003-08-01 | 2011-04-26 | Dexcom, Inc. | System and methods for processing analyte sensor data |
US8160669B2 (en) | 2003-08-01 | 2012-04-17 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8761856B2 (en) | 2003-08-01 | 2014-06-24 | Dexcom, Inc. | System and methods for processing analyte sensor data |
US8369919B2 (en) * | 2003-08-01 | 2013-02-05 | Dexcom, Inc. | Systems and methods for processing sensor data |
US8886273B2 (en) * | 2003-08-01 | 2014-11-11 | Dexcom, Inc. | Analyte sensor |
US20140121989A1 (en) | 2003-08-22 | 2014-05-01 | Dexcom, Inc. | Systems and methods for processing analyte sensor data |
WO2005032362A2 (en) * | 2003-09-30 | 2005-04-14 | Roche Diagnostics Gmbh | Sensor with increaseed biocompatibility |
US20050090607A1 (en) * | 2003-10-28 | 2005-04-28 | Dexcom, Inc. | Silicone composition for biocompatible membrane |
US7299082B2 (en) * | 2003-10-31 | 2007-11-20 | Abbott Diabetes Care, Inc. | Method of calibrating an analyte-measurement device, and associated methods, devices and systems |
USD902408S1 (en) | 2003-11-05 | 2020-11-17 | Abbott Diabetes Care Inc. | Analyte sensor control unit |
WO2005051170A2 (en) * | 2003-11-19 | 2005-06-09 | Dexcom, Inc. | Integrated receiver for continuous analyte sensor |
WO2005057173A2 (en) | 2003-12-08 | 2005-06-23 | Dexcom, Inc. | Systems and methods for improving electrochemical analyte sensors |
WO2005057175A2 (en) * | 2003-12-09 | 2005-06-23 | Dexcom, Inc. | Signal processing for continuous analyte sensor |
EP1701654B1 (en) * | 2003-12-18 | 2016-11-09 | Metronom Health, Inc. | Implantable biosensor and methods of use thereof |
US20050182451A1 (en) * | 2004-01-12 | 2005-08-18 | Adam Griffin | Implantable device with improved radio frequency capabilities |
US7637868B2 (en) * | 2004-01-12 | 2009-12-29 | Dexcom, Inc. | Composite material for implantable device |
WO2005079257A2 (en) * | 2004-02-12 | 2005-09-01 | Dexcom, Inc. | Biointerface with macro- and micro- architecture |
WO2005089103A2 (en) | 2004-02-17 | 2005-09-29 | Therasense, Inc. | Method and system for providing data communication in continuous glucose monitoring and management system |
US8808228B2 (en) | 2004-02-26 | 2014-08-19 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
WO2005084257A2 (en) * | 2004-02-26 | 2005-09-15 | Vpn Solutions, Llc | Composite thin-film glucose sensor |
US8277713B2 (en) * | 2004-05-03 | 2012-10-02 | Dexcom, Inc. | Implantable analyte sensor |
US20060010098A1 (en) | 2004-06-04 | 2006-01-12 | Goodnow Timothy T | Diabetes care host-client architecture and data management system |
US20060015020A1 (en) * | 2004-07-06 | 2006-01-19 | Dexcom, Inc. | Systems and methods for manufacture of an analyte-measuring device including a membrane system |
EP2329770B2 (en) | 2004-07-13 | 2024-04-10 | DexCom, Inc. | Transcutaneous analyte sensor |
US20080242961A1 (en) * | 2004-07-13 | 2008-10-02 | Dexcom, Inc. | Transcutaneous analyte sensor |
US20090105569A1 (en) | 2006-04-28 | 2009-04-23 | Abbott Diabetes Care, Inc. | Introducer Assembly and Methods of Use |
US9398882B2 (en) | 2005-09-30 | 2016-07-26 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor and data processing device |
US9572534B2 (en) | 2010-06-29 | 2017-02-21 | Abbott Diabetes Care Inc. | Devices, systems and methods for on-skin or on-body mounting of medical devices |
US7731657B2 (en) * | 2005-08-30 | 2010-06-08 | Abbott Diabetes Care Inc. | Analyte sensor introducer and methods of use |
US8029441B2 (en) | 2006-02-28 | 2011-10-04 | Abbott Diabetes Care Inc. | Analyte sensor transmitter unit configuration for a data monitoring and management system |
US10226207B2 (en) | 2004-12-29 | 2019-03-12 | Abbott Diabetes Care Inc. | Sensor inserter having introducer |
US9636450B2 (en) | 2007-02-19 | 2017-05-02 | Udo Hoss | Pump system modular components for delivering medication and analyte sensing at seperate insertion sites |
US7883464B2 (en) | 2005-09-30 | 2011-02-08 | Abbott Diabetes Care Inc. | Integrated transmitter unit and sensor introducer mechanism and methods of use |
US9788771B2 (en) | 2006-10-23 | 2017-10-17 | Abbott Diabetes Care Inc. | Variable speed sensor insertion devices and methods of use |
US20090082693A1 (en) * | 2004-12-29 | 2009-03-26 | Therasense, Inc. | Method and apparatus for providing temperature sensor module in a data communication system |
US8571624B2 (en) | 2004-12-29 | 2013-10-29 | Abbott Diabetes Care Inc. | Method and apparatus for mounting a data transmission device in a communication system |
US7697967B2 (en) | 2005-12-28 | 2010-04-13 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor insertion |
US20070027381A1 (en) * | 2005-07-29 | 2007-02-01 | Therasense, Inc. | Inserter and methods of use |
US8333714B2 (en) | 2006-09-10 | 2012-12-18 | Abbott Diabetes Care Inc. | Method and system for providing an integrated analyte sensor insertion device and data processing unit |
US9259175B2 (en) | 2006-10-23 | 2016-02-16 | Abbott Diabetes Care, Inc. | Flexible patch for fluid delivery and monitoring body analytes |
US8512243B2 (en) | 2005-09-30 | 2013-08-20 | Abbott Diabetes Care Inc. | Integrated introducer and transmitter assembly and methods of use |
US9743862B2 (en) | 2011-03-31 | 2017-08-29 | Abbott Diabetes Care Inc. | Systems and methods for transcutaneously implanting medical devices |
US7545272B2 (en) | 2005-02-08 | 2009-06-09 | Therasense, Inc. | RF tag on test strips, test strip vials and boxes |
US20090076360A1 (en) | 2007-09-13 | 2009-03-19 | Dexcom, Inc. | Transcutaneous analyte sensor |
US20060224141A1 (en) | 2005-03-21 | 2006-10-05 | Abbott Diabetes Care, Inc. | Method and system for providing integrated medication infusion and analyte monitoring system |
US8060174B2 (en) | 2005-04-15 | 2011-11-15 | Dexcom, Inc. | Analyte sensing biointerface |
US8112240B2 (en) | 2005-04-29 | 2012-02-07 | Abbott Diabetes Care Inc. | Method and apparatus for providing leak detection in data monitoring and management systems |
US7768408B2 (en) | 2005-05-17 | 2010-08-03 | Abbott Diabetes Care Inc. | Method and system for providing data management in data monitoring system |
US7620437B2 (en) | 2005-06-03 | 2009-11-17 | Abbott Diabetes Care Inc. | Method and apparatus for providing rechargeable power in data monitoring and management systems |
CN102440785A (en) | 2005-08-31 | 2012-05-09 | 弗吉尼亚大学专利基金委员会 | Sensor signal processing method and sensor signal processing device |
US7756561B2 (en) | 2005-09-30 | 2010-07-13 | Abbott Diabetes Care Inc. | Method and apparatus for providing rechargeable power in data monitoring and management systems |
US9521968B2 (en) | 2005-09-30 | 2016-12-20 | Abbott Diabetes Care Inc. | Analyte sensor retention mechanism and methods of use |
US8880138B2 (en) * | 2005-09-30 | 2014-11-04 | Abbott Diabetes Care Inc. | Device for channeling fluid and methods of use |
US7583190B2 (en) | 2005-10-31 | 2009-09-01 | Abbott Diabetes Care Inc. | Method and apparatus for providing data communication in data monitoring and management systems |
US7766829B2 (en) | 2005-11-04 | 2010-08-03 | Abbott Diabetes Care Inc. | Method and system for providing basal profile modification in analyte monitoring and management systems |
CA2636034A1 (en) * | 2005-12-28 | 2007-10-25 | Abbott Diabetes Care Inc. | Medical device insertion |
US8515518B2 (en) | 2005-12-28 | 2013-08-20 | Abbott Diabetes Care Inc. | Analyte monitoring |
US8353881B2 (en) | 2005-12-28 | 2013-01-15 | Abbott Diabetes Care Inc. | Infusion sets for the delivery of a therapeutic substance to a patient |
US8160670B2 (en) | 2005-12-28 | 2012-04-17 | Abbott Diabetes Care Inc. | Analyte monitoring: stabilizer for subcutaneous glucose sensor with incorporated antiglycolytic agent |
US11298058B2 (en) | 2005-12-28 | 2022-04-12 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor insertion |
WO2007084130A1 (en) | 2006-01-17 | 2007-07-26 | Dexcom, Inc. | Low oxygen in vivo analyte sensor |
US9757061B2 (en) * | 2006-01-17 | 2017-09-12 | Dexcom, Inc. | Low oxygen in vivo analyte sensor |
US7736310B2 (en) | 2006-01-30 | 2010-06-15 | Abbott Diabetes Care Inc. | On-body medical device securement |
US8344966B2 (en) * | 2006-01-31 | 2013-01-01 | Abbott Diabetes Care Inc. | Method and system for providing a fault tolerant display unit in an electronic device |
US7826879B2 (en) * | 2006-02-28 | 2010-11-02 | Abbott Diabetes Care Inc. | Analyte sensors and methods of use |
US7885698B2 (en) | 2006-02-28 | 2011-02-08 | Abbott Diabetes Care Inc. | Method and system for providing continuous calibration of implantable analyte sensors |
US7981034B2 (en) | 2006-02-28 | 2011-07-19 | Abbott Diabetes Care Inc. | Smart messages and alerts for an infusion delivery and management system |
US8226891B2 (en) | 2006-03-31 | 2012-07-24 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods therefor |
US7618369B2 (en) | 2006-10-02 | 2009-11-17 | Abbott Diabetes Care Inc. | Method and system for dynamically updating calibration parameters for an analyte sensor |
US8224415B2 (en) * | 2009-01-29 | 2012-07-17 | Abbott Diabetes Care Inc. | Method and device for providing offset model based calibration for analyte sensor |
US8473022B2 (en) * | 2008-01-31 | 2013-06-25 | Abbott Diabetes Care Inc. | Analyte sensor with time lag compensation |
US7630748B2 (en) | 2006-10-25 | 2009-12-08 | Abbott Diabetes Care Inc. | Method and system for providing analyte monitoring |
US7653425B2 (en) | 2006-08-09 | 2010-01-26 | Abbott Diabetes Care Inc. | Method and system for providing calibration of an analyte sensor in an analyte monitoring system |
US7801582B2 (en) * | 2006-03-31 | 2010-09-21 | Abbott Diabetes Care Inc. | Analyte monitoring and management system and methods therefor |
US9339217B2 (en) | 2011-11-25 | 2016-05-17 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods of use |
US8374668B1 (en) | 2007-10-23 | 2013-02-12 | Abbott Diabetes Care Inc. | Analyte sensor with lag compensation |
US8219173B2 (en) | 2008-09-30 | 2012-07-10 | Abbott Diabetes Care Inc. | Optimizing analyte sensor calibration |
US8346335B2 (en) | 2008-03-28 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte sensor calibration management |
US7620438B2 (en) | 2006-03-31 | 2009-11-17 | Abbott Diabetes Care Inc. | Method and system for powering an electronic device |
US9326709B2 (en) | 2010-03-10 | 2016-05-03 | Abbott Diabetes Care Inc. | Systems, devices and methods for managing glucose levels |
US8478557B2 (en) | 2009-07-31 | 2013-07-02 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte monitoring system calibration accuracy |
US8583205B2 (en) | 2008-03-28 | 2013-11-12 | Abbott Diabetes Care Inc. | Analyte sensor calibration management |
US9675290B2 (en) | 2012-10-30 | 2017-06-13 | Abbott Diabetes Care Inc. | Sensitivity calibration of in vivo sensors used to measure analyte concentration |
US8140312B2 (en) | 2007-05-14 | 2012-03-20 | Abbott Diabetes Care Inc. | Method and system for determining analyte levels |
US9392969B2 (en) | 2008-08-31 | 2016-07-19 | Abbott Diabetes Care Inc. | Closed loop control and signal attenuation detection |
US20080064937A1 (en) | 2006-06-07 | 2008-03-13 | Abbott Diabetes Care, Inc. | Analyte monitoring system and method |
US20080004601A1 (en) * | 2006-06-28 | 2008-01-03 | Abbott Diabetes Care, Inc. | Analyte Monitoring and Therapy Management System and Methods Therefor |
US20090171269A1 (en) * | 2006-06-29 | 2009-07-02 | Abbott Diabetes Care, Inc. | Infusion Device and Methods Therefor |
US20090105571A1 (en) * | 2006-06-30 | 2009-04-23 | Abbott Diabetes Care, Inc. | Method and System for Providing Data Communication in Data Management Systems |
US9119582B2 (en) | 2006-06-30 | 2015-09-01 | Abbott Diabetes Care, Inc. | Integrated analyte sensor and infusion device and methods therefor |
US8932216B2 (en) | 2006-08-07 | 2015-01-13 | Abbott Diabetes Care Inc. | Method and system for providing data management in integrated analyte monitoring and infusion system |
US8206296B2 (en) * | 2006-08-07 | 2012-06-26 | Abbott Diabetes Care Inc. | Method and system for providing integrated analyte monitoring and infusion system therapy management |
EP2068699A4 (en) * | 2006-10-04 | 2012-11-14 | Dexcom Inc | Dual electrode system for a continuous analyte sensor |
CN102772212A (en) | 2006-10-26 | 2012-11-14 | 雅培糖尿病护理公司 | Method, device and system for detection of sensitivity decline in analyte sensors |
US20080119710A1 (en) * | 2006-10-31 | 2008-05-22 | Abbott Diabetes Care, Inc. | Medical devices and methods of using the same |
US8579853B2 (en) | 2006-10-31 | 2013-11-12 | Abbott Diabetes Care Inc. | Infusion devices and methods |
US20080161666A1 (en) * | 2006-12-29 | 2008-07-03 | Abbott Diabetes Care, Inc. | Analyte devices and methods |
US20080199894A1 (en) | 2007-02-15 | 2008-08-21 | Abbott Diabetes Care, Inc. | Device and method for automatic data acquisition and/or detection |
US8121857B2 (en) * | 2007-02-15 | 2012-02-21 | Abbott Diabetes Care Inc. | Device and method for automatic data acquisition and/or detection |
US8732188B2 (en) | 2007-02-18 | 2014-05-20 | Abbott Diabetes Care Inc. | Method and system for providing contextual based medication dosage determination |
US8930203B2 (en) | 2007-02-18 | 2015-01-06 | Abbott Diabetes Care Inc. | Multi-function analyte test device and methods therefor |
US8123686B2 (en) | 2007-03-01 | 2012-02-28 | Abbott Diabetes Care Inc. | Method and apparatus for providing rolling data in communication systems |
DK1972275T3 (en) * | 2007-03-20 | 2016-02-08 | Hoffmann La Roche | A system for in-vivo measurement of an analyte concentration |
CA2683959C (en) * | 2007-04-14 | 2017-08-29 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in medical communication system |
CA2683863C (en) | 2007-04-14 | 2019-01-15 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in medical communication system |
US8140142B2 (en) | 2007-04-14 | 2012-03-20 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in medical communication system |
CA2683953C (en) | 2007-04-14 | 2016-08-02 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in medical communication system |
WO2008130895A2 (en) | 2007-04-14 | 2008-10-30 | Abbott Diabetes Care, Inc. | Method and apparatus for providing dynamic multi-stage signal amplification in a medical device |
EP2146625B1 (en) | 2007-04-14 | 2019-08-14 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in medical communication system |
US8461985B2 (en) | 2007-05-08 | 2013-06-11 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8665091B2 (en) | 2007-05-08 | 2014-03-04 | Abbott Diabetes Care Inc. | Method and device for determining elapsed sensor life |
US7928850B2 (en) | 2007-05-08 | 2011-04-19 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8456301B2 (en) | 2007-05-08 | 2013-06-04 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8444560B2 (en) | 2007-05-14 | 2013-05-21 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8239166B2 (en) | 2007-05-14 | 2012-08-07 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8600681B2 (en) | 2007-05-14 | 2013-12-03 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8103471B2 (en) | 2007-05-14 | 2012-01-24 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US10002233B2 (en) * | 2007-05-14 | 2018-06-19 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8260558B2 (en) | 2007-05-14 | 2012-09-04 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US20080312845A1 (en) * | 2007-05-14 | 2008-12-18 | Abbott Diabetes Care, Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8560038B2 (en) | 2007-05-14 | 2013-10-15 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US7996158B2 (en) | 2007-05-14 | 2011-08-09 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US9125548B2 (en) * | 2007-05-14 | 2015-09-08 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
WO2008150917A1 (en) * | 2007-05-31 | 2008-12-11 | Abbott Diabetes Care, Inc. | Insertion devices and methods |
US20080306434A1 (en) | 2007-06-08 | 2008-12-11 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
US20080319294A1 (en) * | 2007-06-21 | 2008-12-25 | Abbott Diabetes Care, Inc. | Health management devices and methods |
JP5680960B2 (en) | 2007-06-21 | 2015-03-04 | アボット ダイアベティス ケア インコーポレイテッドAbbott Diabetes Care Inc. | Health care device and method |
AU2008265542B2 (en) * | 2007-06-21 | 2014-07-24 | Abbott Diabetes Care Inc. | Health monitor |
US8641618B2 (en) * | 2007-06-27 | 2014-02-04 | Abbott Diabetes Care Inc. | Method and structure for securing a monitoring device element |
US8085151B2 (en) | 2007-06-28 | 2011-12-27 | Abbott Diabetes Care Inc. | Signal converting cradle for medical condition monitoring and management system |
US8160900B2 (en) | 2007-06-29 | 2012-04-17 | Abbott Diabetes Care Inc. | Analyte monitoring and management device and method to analyze the frequency of user interaction with the device |
US7768386B2 (en) * | 2007-07-31 | 2010-08-03 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8834366B2 (en) | 2007-07-31 | 2014-09-16 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor calibration |
US20090036760A1 (en) * | 2007-07-31 | 2009-02-05 | Abbott Diabetes Care, Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8377031B2 (en) | 2007-10-23 | 2013-02-19 | Abbott Diabetes Care Inc. | Closed loop control system with safety parameters and methods |
US8409093B2 (en) * | 2007-10-23 | 2013-04-02 | Abbott Diabetes Care Inc. | Assessing measures of glycemic variability |
US8216138B1 (en) | 2007-10-23 | 2012-07-10 | Abbott Diabetes Care Inc. | Correlation of alternative site blood and interstitial fluid glucose concentrations to venous glucose concentration |
US8417312B2 (en) | 2007-10-25 | 2013-04-09 | Dexcom, Inc. | Systems and methods for processing sensor data |
US20090164190A1 (en) * | 2007-12-19 | 2009-06-25 | Abbott Diabetes Care, Inc. | Physiological condition simulation device and method |
US20090164239A1 (en) | 2007-12-19 | 2009-06-25 | Abbott Diabetes Care, Inc. | Dynamic Display Of Glucose Information |
US20090259118A1 (en) * | 2008-03-31 | 2009-10-15 | Abbott Diabetes Care Inc. | Shallow Implantable Analyte Sensor with Rapid Physiological Response |
EP2982383B1 (en) | 2008-04-10 | 2019-05-15 | Abbott Diabetes Care, Inc. | Method for sterilizing an analyte sensor |
US20090300616A1 (en) * | 2008-05-30 | 2009-12-03 | Abbott Diabetes Care, Inc. | Automated task execution for an analyte monitoring system |
US8924159B2 (en) | 2008-05-30 | 2014-12-30 | Abbott Diabetes Care Inc. | Method and apparatus for providing glycemic control |
US8591410B2 (en) | 2008-05-30 | 2013-11-26 | Abbott Diabetes Care Inc. | Method and apparatus for providing glycemic control |
US7826382B2 (en) | 2008-05-30 | 2010-11-02 | Abbott Diabetes Care Inc. | Close proximity communication device and methods |
US20090320978A1 (en) * | 2008-06-27 | 2009-12-31 | Martinez Johnny C | Sound-emitting wallet |
CA2729126C (en) | 2008-07-02 | 2017-04-11 | Cma Microdialysis Ab | On-line measuring system of body substances |
WO2010009172A1 (en) | 2008-07-14 | 2010-01-21 | Abbott Diabetes Care Inc. | Closed loop control system interface and methods |
EP2149957B1 (en) * | 2008-07-30 | 2017-06-14 | Harman Becker Automotive Systems GmbH | Priority based power distribution arrangement |
US8622988B2 (en) | 2008-08-31 | 2014-01-07 | Abbott Diabetes Care Inc. | Variable rate closed loop control and methods |
US8734422B2 (en) | 2008-08-31 | 2014-05-27 | Abbott Diabetes Care Inc. | Closed loop control with improved alarm functions |
US9943644B2 (en) * | 2008-08-31 | 2018-04-17 | Abbott Diabetes Care Inc. | Closed loop control with reference measurement and methods thereof |
US20100057040A1 (en) * | 2008-08-31 | 2010-03-04 | Abbott Diabetes Care, Inc. | Robust Closed Loop Control And Methods |
US8560039B2 (en) | 2008-09-19 | 2013-10-15 | Dexcom, Inc. | Particle-containing membrane and particulate electrode for analyte sensors |
US8986208B2 (en) | 2008-09-30 | 2015-03-24 | Abbott Diabetes Care Inc. | Analyte sensor sensitivity attenuation mitigation |
US20100082364A1 (en) * | 2008-09-30 | 2010-04-01 | Abbott Diabetes Care, Inc. | Medical Information Management |
US9326707B2 (en) * | 2008-11-10 | 2016-05-03 | Abbott Diabetes Care Inc. | Alarm characterization for analyte monitoring devices and systems |
JP5470010B2 (en) * | 2008-12-22 | 2014-04-16 | シスメックス株式会社 | In vivo component measuring method and in vivo component measuring apparatus |
US8103456B2 (en) | 2009-01-29 | 2012-01-24 | Abbott Diabetes Care Inc. | Method and device for early signal attenuation detection using blood glucose measurements |
US8560082B2 (en) | 2009-01-30 | 2013-10-15 | Abbott Diabetes Care Inc. | Computerized determination of insulin pump therapy parameters using real time and retrospective data processing |
US9402544B2 (en) | 2009-02-03 | 2016-08-02 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
US20100198033A1 (en) | 2009-02-05 | 2010-08-05 | Peter Krulevitch | Flexible indwelling biosensor, flexible indwelling biosensor insertion device, and related methods |
CN102438517B (en) * | 2009-02-26 | 2015-03-25 | 雅培糖尿病护理公司 | Improved analyte sensors and methods of making and using the same |
EP2410910A4 (en) | 2009-03-27 | 2014-10-15 | Dexcom Inc | Methods and systems for promoting glucose management |
US20100247775A1 (en) * | 2009-03-31 | 2010-09-30 | Abbott Diabetes Care Inc. | Precise Fluid Dispensing Method and Device |
US8497777B2 (en) * | 2009-04-15 | 2013-07-30 | Abbott Diabetes Care Inc. | Analyte monitoring system having an alert |
EP2425210A4 (en) * | 2009-04-28 | 2013-01-09 | Abbott Diabetes Care Inc | Dynamic analyte sensor calibration based on sensor stability profile |
US9226701B2 (en) | 2009-04-28 | 2016-01-05 | Abbott Diabetes Care Inc. | Error detection in critical repeating data in a wireless sensor system |
WO2010129375A1 (en) | 2009-04-28 | 2010-11-11 | Abbott Diabetes Care Inc. | Closed loop blood glucose control algorithm analysis |
US8368556B2 (en) | 2009-04-29 | 2013-02-05 | Abbott Diabetes Care Inc. | Method and system for providing data communication in continuous glucose monitoring and management system |
EP2425209A4 (en) | 2009-04-29 | 2013-01-09 | Abbott Diabetes Care Inc | Method and system for providing real time analyte sensor calibration with retrospective backfill |
US9184490B2 (en) | 2009-05-29 | 2015-11-10 | Abbott Diabetes Care Inc. | Medical device antenna systems having external antenna configurations |
US8613892B2 (en) | 2009-06-30 | 2013-12-24 | Abbott Diabetes Care Inc. | Analyte meter with a moveable head and methods of using the same |
LT3689237T (en) | 2009-07-23 | 2021-09-27 | Abbott Diabetes Care, Inc. | Method of manufacturing and system for continuous analyte measurement |
EP4404212A2 (en) | 2009-07-23 | 2024-07-24 | Abbott Diabetes Care Inc. | Real time management of data relating to physiological control of glucose levels |
CN102473276B (en) | 2009-08-31 | 2016-04-13 | 雅培糖尿病护理公司 | Medical treatment device and method |
WO2011026147A1 (en) | 2009-08-31 | 2011-03-03 | Abbott Diabetes Care Inc. | Analyte signal processing device and methods |
FI4070729T3 (en) | 2009-08-31 | 2024-06-04 | Abbott Diabetes Care Inc | Displays for a medical device |
US8993331B2 (en) | 2009-08-31 | 2015-03-31 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods for managing power and noise |
WO2011041469A1 (en) | 2009-09-29 | 2011-04-07 | Abbott Diabetes Care Inc. | Method and apparatus for providing notification function in analyte monitoring systems |
WO2011041463A2 (en) | 2009-09-30 | 2011-04-07 | Dexcom, Inc. | Transcutaneous analyte sensor |
WO2011041531A1 (en) | 2009-09-30 | 2011-04-07 | Abbott Diabetes Care Inc. | Interconnect for on-body analyte monitoring device |
US20110082356A1 (en) * | 2009-10-01 | 2011-04-07 | Medtronic Minimed, Inc. | Analyte sensor apparatuses having interference rejection membranes and methods for making and using them |
WO2011053881A1 (en) | 2009-10-30 | 2011-05-05 | Abbott Diabetes Care Inc. | Method and apparatus for detecting false hypoglycemic conditions |
US20110184258A1 (en) * | 2010-01-28 | 2011-07-28 | Abbott Diabetes Care Inc. | Balloon Catheter Analyte Measurement Sensors and Methods for Using the Same |
USD924406S1 (en) | 2010-02-01 | 2021-07-06 | Abbott Diabetes Care Inc. | Analyte sensor inserter |
PL2544582T3 (en) * | 2010-03-11 | 2017-08-31 | F.Hoffmann-La Roche Ag | Method for the electrochemical measurement of an analyte concentration in vivo, and fuel cell for this purpose |
LT3622883T (en) | 2010-03-24 | 2021-08-25 | Abbott Diabetes Care, Inc. | Medical device inserters and processes of inserting and using medical devices |
CN102843969B (en) | 2010-04-16 | 2015-05-13 | 爱科来株式会社 | Sensor and method for removal of interfering substance |
US8635046B2 (en) | 2010-06-23 | 2014-01-21 | Abbott Diabetes Care Inc. | Method and system for evaluating analyte sensor response characteristics |
US11064921B2 (en) | 2010-06-29 | 2021-07-20 | Abbott Diabetes Care Inc. | Devices, systems and methods for on-skin or on-body mounting of medical devices |
US10092229B2 (en) | 2010-06-29 | 2018-10-09 | Abbott Diabetes Care Inc. | Calibration of analyte measurement system |
WO2012048168A2 (en) | 2010-10-07 | 2012-04-12 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods |
US10136845B2 (en) | 2011-02-28 | 2018-11-27 | Abbott Diabetes Care Inc. | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
EP2680754B1 (en) | 2011-02-28 | 2019-04-24 | Abbott Diabetes Care, Inc. | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
JP6321540B2 (en) | 2011-07-26 | 2018-05-09 | グリセンス インコーポレイテッド | Implantable analyte sensor with hermetically sealed housing and method of manufacturing the sensor |
EP4218570A3 (en) * | 2011-08-26 | 2023-10-04 | DexCom, Inc. | Polymer membranes for continuous analyte sensors |
US9069536B2 (en) | 2011-10-31 | 2015-06-30 | Abbott Diabetes Care Inc. | Electronic devices having integrated reset systems and methods thereof |
WO2013066849A1 (en) | 2011-10-31 | 2013-05-10 | Abbott Diabetes Care Inc. | Model based variable risk false glucose threshold alarm prevention mechanism |
CA2840640C (en) | 2011-11-07 | 2020-03-24 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods |
US8710993B2 (en) | 2011-11-23 | 2014-04-29 | Abbott Diabetes Care Inc. | Mitigating single point failure of devices in an analyte monitoring system and methods thereof |
US9317656B2 (en) | 2011-11-23 | 2016-04-19 | Abbott Diabetes Care Inc. | Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereof |
EP3300658B1 (en) | 2011-12-11 | 2024-01-17 | Abbott Diabetes Care, Inc. | Analyte sensor methods |
US9931065B2 (en) | 2012-04-04 | 2018-04-03 | Dexcom, Inc. | Transcutaneous analyte sensors, applicators therefor, and associated methods |
US20130321425A1 (en) | 2012-06-05 | 2013-12-05 | Dexcom, Inc. | Reporting modules |
US10598627B2 (en) | 2012-06-29 | 2020-03-24 | Dexcom, Inc. | Devices, systems, and methods to compensate for effects of temperature on implantable sensors |
US10881339B2 (en) | 2012-06-29 | 2021-01-05 | Dexcom, Inc. | Use of sensor redundancy to detect sensor failures |
US20140012118A1 (en) | 2012-07-09 | 2014-01-09 | Dexcom, Inc. | Systems and methods for leveraging smartphone features in continuous glucose monitoring |
US10660550B2 (en) | 2015-12-29 | 2020-05-26 | Glysens Incorporated | Implantable sensor apparatus and methods |
US10561353B2 (en) | 2016-06-01 | 2020-02-18 | Glysens Incorporated | Biocompatible implantable sensor apparatus and methods |
US20140190839A1 (en) * | 2012-08-06 | 2014-07-10 | Google Inc. | Contact lenses having two-electrode electrochemical sensors |
US10132793B2 (en) | 2012-08-30 | 2018-11-20 | Abbott Diabetes Care Inc. | Dropout detection in continuous analyte monitoring data during data excursions |
US9968306B2 (en) | 2012-09-17 | 2018-05-15 | Abbott Diabetes Care Inc. | Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems |
EP2901153A4 (en) | 2012-09-26 | 2016-04-27 | Abbott Diabetes Care Inc | Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data |
US9788765B2 (en) | 2012-09-28 | 2017-10-17 | Dexcom, Inc. | Zwitterion surface modifications for continuous sensors |
US20140129151A1 (en) | 2012-11-07 | 2014-05-08 | Dexcom, Inc. | Systems and methods for managing glycemic variability |
US9585563B2 (en) | 2012-12-31 | 2017-03-07 | Dexcom, Inc. | Remote monitoring of analyte measurements |
US9730620B2 (en) | 2012-12-31 | 2017-08-15 | Dexcom, Inc. | Remote monitoring of analyte measurements |
EP2943784A4 (en) | 2013-01-11 | 2016-12-14 | Univ Northeastern | Saliva glucose monitoring system |
JP2014178143A (en) * | 2013-03-13 | 2014-09-25 | Dainippon Printing Co Ltd | Concentration measurement sensor, concentration measurement sensor sheet, and manufacturing method thereof |
US10335075B2 (en) | 2013-03-14 | 2019-07-02 | Dexcom, Inc. | Advanced calibration for analyte sensors |
US9445445B2 (en) | 2013-03-14 | 2016-09-13 | Dexcom, Inc. | Systems and methods for processing and transmitting sensor data |
EP4220654A1 (en) | 2013-03-14 | 2023-08-02 | Dexcom, Inc. | Systems and methods for processing and transmitting sensor data |
US9737250B2 (en) | 2013-03-15 | 2017-08-22 | Dexcom, Inc. | Membrane for continuous analyte sensors |
US10433773B1 (en) | 2013-03-15 | 2019-10-08 | Abbott Diabetes Care Inc. | Noise rejection methods and apparatus for sparsely sampled analyte sensor data |
US9474475B1 (en) | 2013-03-15 | 2016-10-25 | Abbott Diabetes Care Inc. | Multi-rate analyte sensor data collection with sample rate configurable signal processing |
WO2014152034A1 (en) | 2013-03-15 | 2014-09-25 | Abbott Diabetes Care Inc. | Sensor fault detection using analyte sensor data pattern comparison |
US9761874B2 (en) | 2013-12-30 | 2017-09-12 | Verily Life Sciences Llc | Fabrication methods for batteries |
EP3089666B1 (en) | 2013-12-31 | 2020-08-19 | Abbott Diabetes Care Inc. | Self-powered analyte sensor and devices using the same |
EP3125761B1 (en) | 2014-03-30 | 2020-09-30 | Abbott Diabetes Care Inc. | Method and apparatus for determining meal start and peak events in analyte monitoring systems |
EP3128902B1 (en) | 2014-04-10 | 2023-08-30 | Dexcom, Inc. | Sensor for continuous analyte monitoring |
US9956393B2 (en) | 2015-02-24 | 2018-05-01 | Elira, Inc. | Systems for increasing a delay in the gastric emptying time for a patient using a transcutaneous electro-dermal patch |
US10765863B2 (en) | 2015-02-24 | 2020-09-08 | Elira, Inc. | Systems and methods for using a transcutaneous electrical stimulation device to deliver titrated therapy |
US10335302B2 (en) | 2015-02-24 | 2019-07-02 | Elira, Inc. | Systems and methods for using transcutaneous electrical stimulation to enable dietary interventions |
US10376145B2 (en) | 2015-02-24 | 2019-08-13 | Elira, Inc. | Systems and methods for enabling a patient to achieve a weight loss objective using an electrical dermal patch |
US10864367B2 (en) | 2015-02-24 | 2020-12-15 | Elira, Inc. | Methods for using an electrical dermal patch in a manner that reduces adverse patient reactions |
US20220062621A1 (en) | 2015-02-24 | 2022-03-03 | Elira, Inc. | Electrical Stimulation-Based Weight Management System |
CA3227448A1 (en) | 2015-02-24 | 2016-09-01 | Elira, Inc. | Systems and methods for enabling appetite modulation and/or improving dietary compliance using an electro-dermal patch |
US10213139B2 (en) | 2015-05-14 | 2019-02-26 | Abbott Diabetes Care Inc. | Systems, devices, and methods for assembling an applicator and sensor control device |
EP3294134B1 (en) | 2015-05-14 | 2020-07-08 | Abbott Diabetes Care Inc. | Inserter system for a compact medical device and corresponding method |
US10780222B2 (en) | 2015-06-03 | 2020-09-22 | Pacific Diabetes Technologies Inc | Measurement of glucose in an insulin delivery catheter by minimizing the adverse effects of insulin preservatives |
US11553883B2 (en) | 2015-07-10 | 2023-01-17 | Abbott Diabetes Care Inc. | System, device and method of dynamic glucose profile response to physiological parameters |
MX2018002587A (en) | 2015-09-02 | 2019-02-07 | Metronom Health Inc | Systems and methods for continuous health monitoring using an opto-enzymatic analyte sensor. |
US20170112533A1 (en) | 2015-10-21 | 2017-04-27 | Dexcom, Inc. | Transcutaneous analyte sensors, applicators therefor, and associated methods |
WO2017116692A1 (en) | 2015-12-28 | 2017-07-06 | Dexcom, Inc. | Systems and methods for remote and host monitoring communications |
EP4218566A1 (en) | 2015-12-30 | 2023-08-02 | Dexcom, Inc. | Enzyme immobilized adhesive layer for analyte sensors |
EP3797685B8 (en) | 2016-03-31 | 2022-06-15 | Dexcom, Inc. | Communication systems between a sensor electronics unit and a display device of an analyte monitoring system |
US10638962B2 (en) | 2016-06-29 | 2020-05-05 | Glysens Incorporated | Bio-adaptable implantable sensor apparatus and methods |
CN110461217B (en) | 2017-01-23 | 2022-09-16 | 雅培糖尿病护理公司 | Systems, devices, and methods for analyte sensor insertion |
US11596330B2 (en) | 2017-03-21 | 2023-03-07 | Abbott Diabetes Care Inc. | Methods, devices and system for providing diabetic condition diagnosis and therapy |
US11045142B1 (en) | 2017-04-29 | 2021-06-29 | Biolinq, Inc. | Heterogeneous integration of silicon-fabricated solid microneedle sensors and CMOS circuitry |
ES2963745T3 (en) | 2017-06-23 | 2024-04-01 | Dexcom Inc | Transcutaneous analyte sensors, applicators thereof and needle cone that include anti-twist function |
JP7383286B2 (en) * | 2017-06-23 | 2023-11-20 | パーキュセンス | Object sensor |
US10638979B2 (en) | 2017-07-10 | 2020-05-05 | Glysens Incorporated | Analyte sensor data evaluation and error reduction apparatus and methods |
US11903708B2 (en) * | 2017-09-28 | 2024-02-20 | California Institute Of Technology | Switchable low voltage electrochemical sensing for interfering species rejection |
US11331022B2 (en) | 2017-10-24 | 2022-05-17 | Dexcom, Inc. | Pre-connected analyte sensors |
CN212438615U (en) | 2017-10-24 | 2021-02-02 | 德克斯康公司 | Wearable device |
US11278668B2 (en) | 2017-12-22 | 2022-03-22 | Glysens Incorporated | Analyte sensor and medicant delivery data evaluation and error reduction apparatus and methods |
US11255839B2 (en) | 2018-01-04 | 2022-02-22 | Glysens Incorporated | Apparatus and methods for analyte sensor mismatch correction |
USD926325S1 (en) | 2018-06-22 | 2021-07-27 | Dexcom, Inc. | Wearable medical monitoring device |
USD1002852S1 (en) | 2019-06-06 | 2023-10-24 | Abbott Diabetes Care Inc. | Analyte sensor device |
US20210032671A1 (en) * | 2019-08-02 | 2021-02-04 | Bionime Corporation | Method for Reducing Measurement Interference of Micro Biosensor |
CN111096754B (en) * | 2019-12-31 | 2024-08-30 | 上海硕创生物医药科技有限公司 | Biological sensor |
DK4048152T3 (en) | 2020-07-29 | 2024-03-11 | Biolinq Incorporated | SYSTEM FOR CONTINUOUS ANALYTE MONITORING WITH MICRON NEEDLE ARRANGEMENT |
USD999913S1 (en) | 2020-12-21 | 2023-09-26 | Abbott Diabetes Care Inc | Analyte sensor inserter |
WO2022240700A1 (en) | 2021-05-08 | 2022-11-17 | Biolinq Incorporated | Fault detection for microneedle array based continuous analyte monitoring device |
CN114460147A (en) * | 2022-02-11 | 2022-05-10 | 深圳市溢鑫科技研发有限公司 | Vertical graphene electrochemical microelectrode structure |
Citations (93)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3933593A (en) * | 1971-02-22 | 1976-01-20 | Beckman Instruments, Inc. | Rate sensing batch analysis method |
US4073713A (en) * | 1975-09-24 | 1978-02-14 | The Yellow Springs Instrument Company, Inc. | Membrane for enzyme electrodes |
US4076656A (en) * | 1971-11-30 | 1978-02-28 | Debell & Richardson, Inc. | Method of producing porous plastic materials |
US4197840A (en) * | 1975-11-06 | 1980-04-15 | Bbc Brown Boveri & Company, Limited | Permanent magnet device for implantation |
US4255500A (en) * | 1979-03-29 | 1981-03-10 | General Electric Company | Vibration resistant electrochemical cell having deformed casing and method of making same |
US4259540A (en) * | 1978-05-30 | 1981-03-31 | Bell Telephone Laboratories, Incorporated | Filled cables |
US4324257A (en) * | 1978-02-20 | 1982-04-13 | U.S. Philips Corporation | Device for the transcutaneous measurement of the partial oxygen pressure in blood |
US4374013A (en) * | 1980-03-05 | 1983-02-15 | Enfors Sven Olof | Oxygen stabilized enzyme electrode |
US4431507A (en) * | 1981-01-14 | 1984-02-14 | Matsushita Electric Industrial Co., Ltd. | Enzyme electrode |
US4431004A (en) * | 1981-10-27 | 1984-02-14 | Bessman Samuel P | Implantable glucose sensor |
US4436094A (en) * | 1981-03-09 | 1984-03-13 | Evreka, Inc. | Monitor for continuous in vivo measurement of glucose concentration |
US4508680A (en) * | 1982-06-08 | 1985-04-02 | National Aerospace Laboratory Of Science And Technology Agency | Method of manufacturing a rocket combustion chamber |
US4577642A (en) * | 1985-02-27 | 1986-03-25 | Medtronic, Inc. | Drug dispensing body implantable lead employing molecular sieves and methods of fabrication |
US4650547A (en) * | 1983-05-19 | 1987-03-17 | The Regents Of The University Of California | Method and membrane applicable to implantable sensor |
US4721677A (en) * | 1985-09-18 | 1988-01-26 | Children's Hospital Medical Center | Implantable gas-containing biosensor and method for measuring an analyte such as glucose |
US4803243A (en) * | 1986-03-26 | 1989-02-07 | Shin-Etsu Chemical Co., Ltd. | Block-graft copolymer |
US4810470A (en) * | 1987-06-19 | 1989-03-07 | Miles Inc. | Volume independent diagnostic device |
US4823808A (en) * | 1987-07-06 | 1989-04-25 | Clegg Charles T | Method for control of obesity, overweight and eating disorders |
US4890620A (en) * | 1985-09-20 | 1990-01-02 | The Regents Of The University Of California | Two-dimensional diffusion glucose substrate sensing electrode |
US4902294A (en) * | 1986-12-03 | 1990-02-20 | Olivier Gosserez | Implantable mammary prosthesis adapted to combat the formation of a retractile shell |
US4984929A (en) * | 1987-01-08 | 1991-01-15 | Julius Blum Gesellschaft M.B.H. | Fitting for fastening the rail member of a drawer |
US4986671A (en) * | 1989-04-12 | 1991-01-22 | Luxtron Corporation | Three-parameter optical fiber sensor and system |
US4994167A (en) * | 1986-04-15 | 1991-02-19 | Markwell Medical Institute, Inc. | Biological fluid measuring device |
US5002572A (en) * | 1986-09-11 | 1991-03-26 | Picha George J | Biological implant with textured surface |
US5007929A (en) * | 1986-11-04 | 1991-04-16 | Medical Products Development, Inc. | Open-cell, silicone-elastomer medical implant |
US5101814A (en) * | 1989-08-11 | 1992-04-07 | Palti Yoram Prof | System for monitoring and controlling blood glucose |
US5190041A (en) * | 1989-08-11 | 1993-03-02 | Palti Yoram Prof | System for monitoring and controlling blood glucose |
US5282848A (en) * | 1990-08-28 | 1994-02-01 | Meadox Medicals, Inc. | Self-supporting woven vascular graft |
US5285513A (en) * | 1992-11-30 | 1994-02-08 | At&T Bell Laboratories | Optical fiber cable provided with stabilized waterblocking material |
US5299571A (en) * | 1993-01-22 | 1994-04-05 | Eli Lilly And Company | Apparatus and method for implantation of sensors |
US5304468A (en) * | 1986-08-13 | 1994-04-19 | Lifescan, Inc. | Reagent test strip and apparatus for determination of blood glucose |
US5307263A (en) * | 1992-11-17 | 1994-04-26 | Raya Systems, Inc. | Modular microprocessor-based health monitoring system |
US5380536A (en) * | 1990-10-15 | 1995-01-10 | The Board Of Regents, The University Of Texas System | Biocompatible microcapsules |
US5384028A (en) * | 1992-08-28 | 1995-01-24 | Nec Corporation | Biosensor with a data memory |
US5390671A (en) * | 1994-03-15 | 1995-02-21 | Minimed Inc. | Transcutaneous sensor insertion set |
US5391250A (en) * | 1994-03-15 | 1995-02-21 | Minimed Inc. | Method of fabricating thin film sensors |
US5397848A (en) * | 1991-04-25 | 1995-03-14 | Allergan, Inc. | Enhancing the hydrophilicity of silicone polymers |
US5482473A (en) * | 1994-05-09 | 1996-01-09 | Minimed Inc. | Flex circuit connector |
US5484404A (en) * | 1994-05-06 | 1996-01-16 | Alfred E. Mann Foundation For Scientific Research | Replaceable catheter system for physiological sensors, tissue stimulating electrodes and/or implantable fluid delivery systems |
US5491474A (en) * | 1991-05-22 | 1996-02-13 | Polar Electro Oy | Telemetric transmitter unit |
US5496453A (en) * | 1991-05-17 | 1996-03-05 | Kyoto Daiichi Kagaku Co., Ltd. | Biosensor and method of quantitative analysis using the same |
US5497772A (en) * | 1993-11-19 | 1996-03-12 | Alfred E. Mann Foundation For Scientific Research | Glucose monitoring system |
US5590651A (en) * | 1995-01-17 | 1997-01-07 | Temple University - Of The Commonwealth System Of Higher Education | Breathable liquid elimination analysis |
US5593440A (en) * | 1990-10-31 | 1997-01-14 | Baxter International Inc. | Tissue implant systems and methods for sustaining viable high cell densities within a host |
US5593852A (en) * | 1993-12-02 | 1997-01-14 | Heller; Adam | Subcutaneous glucose electrode |
US5607565A (en) * | 1995-03-27 | 1997-03-04 | Coulter Corporation | Apparatus for measuring analytes in a fluid sample |
US5611900A (en) * | 1995-07-20 | 1997-03-18 | Michigan State University | Microbiosensor used in-situ |
US5624537A (en) * | 1994-09-20 | 1997-04-29 | The University Of British Columbia - University-Industry Liaison Office | Biosensor and interface membrane |
US5708354A (en) * | 1996-12-18 | 1998-01-13 | Mcdermott Technology, Inc. | Portable electromagnetic acoustic transducer pulser controller |
US5706807A (en) * | 1991-05-13 | 1998-01-13 | Applied Medical Research | Sensor device covered with foam membrane |
US5711861A (en) * | 1995-11-22 | 1998-01-27 | Ward; W. Kenneth | Device for monitoring changes in analyte concentration |
US5713888A (en) * | 1990-10-31 | 1998-02-03 | Baxter International, Inc. | Tissue implant systems |
US5733336A (en) * | 1990-10-31 | 1998-03-31 | Baxter International, Inc. | Ported tissue implant systems and methods of using same |
US5735273A (en) * | 1995-09-12 | 1998-04-07 | Cygnus, Inc. | Chemical signal-impermeable mask |
US5741330A (en) * | 1990-10-31 | 1998-04-21 | Baxter International, Inc. | Close vascularization implant material |
US5861019A (en) * | 1997-07-25 | 1999-01-19 | Medtronic Inc. | Implantable medical device microstrip telemetry antenna |
US5871514A (en) * | 1997-08-01 | 1999-02-16 | Medtronic, Inc. | Attachment apparatus for an implantable medical device employing ultrasonic energy |
US5882494A (en) * | 1995-03-27 | 1999-03-16 | Minimed, Inc. | Polyurethane/polyurea compositions containing silicone for biosensor membranes |
US6011984A (en) * | 1995-11-22 | 2000-01-04 | Minimed Inc. | Detection of biological molecules using chemical amplification and optical sensors |
US6013113A (en) * | 1998-03-06 | 2000-01-11 | Wilson Greatbatch Ltd. | Slotted insulator for unsealed electrode edges in electrochemical cells |
US6016448A (en) * | 1998-10-27 | 2000-01-18 | Medtronic, Inc. | Multilevel ERI for implantable medical devices |
US6049727A (en) * | 1996-07-08 | 2000-04-11 | Animas Corporation | Implantable sensor and system for in vivo measurement and control of fluid constituent levels |
US6175752B1 (en) * | 1998-04-30 | 2001-01-16 | Therasense, Inc. | Analyte monitoring device and methods of use |
US6180416B1 (en) * | 1998-09-30 | 2001-01-30 | Cygnus, Inc. | Method and device for predicting physiological values |
US6187062B1 (en) * | 1998-06-16 | 2001-02-13 | Alcatel | Current collection through thermally sprayed tabs at the ends of a spirally wound electrochemical cell |
US6187614B1 (en) * | 1996-03-07 | 2001-02-13 | Matsushita Electronics Corporation | Electronic component, method for making the same, and lead frame and mold assembly for use therein |
US6189536B1 (en) * | 1999-04-15 | 2001-02-20 | Medtronic Inc. | Method for protecting implantable devices |
US6200772B1 (en) * | 1997-08-23 | 2001-03-13 | Sensalyse Holdings Limited | Modified polyurethane membrane sensors and analytical methods |
US6201980B1 (en) * | 1998-10-05 | 2001-03-13 | The Regents Of The University Of California | Implantable medical sensor system |
US6206856B1 (en) * | 1998-11-04 | 2001-03-27 | Sakharam D. Mahurkar | Safety syringe |
US6208894B1 (en) * | 1997-02-26 | 2001-03-27 | Alfred E. Mann Foundation For Scientific Research And Advanced Bionics | System of implantable devices for monitoring and/or affecting body parameters |
US6214185B1 (en) * | 1997-04-17 | 2001-04-10 | Avl Medical Instruments | Sensor with PVC cover membrane |
US20020022883A1 (en) * | 2000-06-13 | 2002-02-21 | Burg Karen J.L. | Tissue engineering composite |
US6360888B1 (en) * | 1999-02-25 | 2002-03-26 | Minimed Inc. | Glucose sensor package system |
US20030002874A1 (en) * | 2001-06-14 | 2003-01-02 | Takeshi Uesaka | Photographing device, recording medium, program, camera and camera production method |
US20030006669A1 (en) * | 2001-05-22 | 2003-01-09 | Sri International | Rolled electroactive polymers |
US6512939B1 (en) * | 1997-10-20 | 2003-01-28 | Medtronic Minimed, Inc. | Implantable enzyme-based monitoring systems adapted for long term use |
US20030023317A1 (en) * | 2001-07-27 | 2003-01-30 | Dexcom, Inc. | Membrane for use with implantable devices |
US20030032874A1 (en) * | 2001-07-27 | 2003-02-13 | Dexcom, Inc. | Sensor head for use with implantable devices |
US6520997B1 (en) * | 1999-12-08 | 2003-02-18 | Baxter International Inc. | Porous three dimensional structure |
US20030036803A1 (en) * | 2001-08-14 | 2003-02-20 | Mcghan Jim J. | Medical implant having bioabsorbable textured surface |
US6527729B1 (en) * | 1999-11-10 | 2003-03-04 | Pacesetter, Inc. | Method for monitoring patient using acoustic sensor |
US6537318B1 (en) * | 1998-04-06 | 2003-03-25 | Konjac Technologies, Llc | Use of glucomannan hydrocolloid as filler material in prostheses |
US20040010207A1 (en) * | 2002-07-15 | 2004-01-15 | Flaherty J. Christopher | Self-contained, automatic transcutaneous physiologic sensing system |
US20040015134A1 (en) * | 1998-11-13 | 2004-01-22 | Elan Pharma International, Ltd. | Drug delivery systems and methods |
US20040011671A1 (en) * | 1997-03-04 | 2004-01-22 | Dexcom, Inc. | Device and method for determining analyte levels |
US6683535B1 (en) * | 2000-08-09 | 2004-01-27 | Alderon Industries, Llc | Water detection system and method |
US20040030294A1 (en) * | 2001-11-28 | 2004-02-12 | Mahurkar Sakharam D. | Retractable needle single use safety syringe |
US6694191B2 (en) * | 2000-01-21 | 2004-02-17 | Medtronic Minimed, Inc. | Ambulatory medical apparatus and method having telemetry modifiable control software |
US6695860B1 (en) * | 2000-11-13 | 2004-02-24 | Isense Corp. | Transcutaneous sensor insertion device |
US20040039406A1 (en) * | 1998-06-01 | 2004-02-26 | Jessen Jonh W. | Method and apparatus for placing and maintaining a percutaneous tube into a body cavity |
US6699218B2 (en) * | 2000-11-09 | 2004-03-02 | Insulet Corporation | Transcutaneous delivery means |
US20040045879A1 (en) * | 1997-03-04 | 2004-03-11 | Dexcom, Inc. | Device and method for determining analyte levels |
Family Cites Families (819)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19852258A1 (en) | 1998-11-11 | 2000-05-18 | Agfa Gevaert Ag | Radiation-sensitive recording material for the production of waterless offset printing plates |
US1564641A (en) | 1922-04-10 | 1925-12-08 | Chicago Miniature Lamp Works | Detector for wireless systems |
US2402306A (en) | 1943-10-07 | 1946-06-18 | Turkel Henry | Retaining guard guide for needles |
US2719797A (en) | 1950-05-23 | 1955-10-04 | Baker & Co Inc | Platinizing tantalum |
US2830020A (en) * | 1956-10-01 | 1958-04-08 | American Cyanamid Co | Lubricating oils thickened with metal salts of cyanuric acid |
US3220960A (en) | 1960-12-21 | 1965-11-30 | Wichterle Otto | Cross-linked hydrophilic polymers and articles made therefrom |
US3210578A (en) | 1962-01-12 | 1965-10-05 | Westinghouse Electric Corp | Multispeed motor connector |
US3381371A (en) | 1965-09-27 | 1968-05-07 | Sanders Associates Inc | Method of constructing lightweight antenna |
US3562352A (en) * | 1968-09-06 | 1971-02-09 | Avco Corp | Polysiloxane-polyurethane block copolymers |
US3607329A (en) | 1969-04-22 | 1971-09-21 | Us Interior | Cellulose acetate butyrate semipermeable membranes and their production |
JPS4810633B1 (en) * | 1969-04-25 | 1973-04-05 | ||
USRE31916E (en) | 1970-11-10 | 1985-06-18 | Becton Dickinson & Company | Electrochemical detection cell |
US3746588A (en) | 1971-03-29 | 1973-07-17 | Aerojet General Co | Sterilization of nitroparaffin-amine explosives |
US3791871A (en) | 1971-04-14 | 1974-02-12 | Lockheed Aircraft Corp | Electrochemical cell |
CH559912A5 (en) | 1971-09-09 | 1975-03-14 | Hoffmann La Roche | |
US3943918A (en) | 1971-12-02 | 1976-03-16 | Tel-Pac, Inc. | Disposable physiological telemetric device |
US3775182A (en) | 1972-02-25 | 1973-11-27 | Du Pont | Tubular electrochemical cell with coiled electrodes and compressed central spindle |
GB1442303A (en) | 1972-09-08 | 1976-07-14 | Radiometer As | Cell for electro-chemical analysis |
CS164231B2 (en) | 1972-09-28 | 1975-11-07 | ||
US3929971A (en) | 1973-03-30 | 1975-12-30 | Research Corp | Porous biomaterials and method of making same |
US3826244A (en) | 1973-07-20 | 1974-07-30 | Us Health Education & Welfare | Thumbtack microelectrode and method of making same |
US4267145A (en) | 1974-01-03 | 1981-05-12 | E. I. Du Pont De Nemours And Company | Process for preparing cold water-soluble films from PVA by melt extrusion |
US3898984A (en) | 1974-02-04 | 1975-08-12 | Us Navy | Ambulatory patient monitoring system |
US4067322A (en) | 1974-07-19 | 1978-01-10 | Johnson Joseph H | Disposable, pre-gel body electrodes |
US3966580A (en) | 1974-09-16 | 1976-06-29 | The University Of Utah | Novel protein-immobilizing hydrophobic polymeric membrane, process for producing same and apparatus employing same |
US3957613A (en) | 1974-11-01 | 1976-05-18 | General Electric Company | Miniature probe having multifunctional electrodes for sensing ions and gases |
US3982530A (en) | 1975-04-22 | 1976-09-28 | Egon Storch | Penial appliance |
US4052754A (en) | 1975-08-14 | 1977-10-11 | Homsy Charles A | Implantable structure |
US4040908A (en) | 1976-03-12 | 1977-08-09 | Children's Hospital Medical Center | Polarographic analysis of cholesterol and other macromolecular substances |
US4037563A (en) | 1976-03-29 | 1977-07-26 | John M. Pflueger | Aquarium viewing window |
US4024312A (en) | 1976-06-23 | 1977-05-17 | Johnson & Johnson | Pressure-sensitive adhesive tape having extensible and elastic backing composed of a block copolymer |
US4136250A (en) * | 1977-07-20 | 1979-01-23 | Ciba-Geigy Corporation | Polysiloxane hydrogels |
JPS5921500B2 (en) | 1978-01-28 | 1984-05-21 | 東洋紡績株式会社 | Enzyme membrane for oxygen electrode |
US4172770A (en) | 1978-03-27 | 1979-10-30 | Technicon Instruments Corporation | Flow-through electrochemical system analytical method |
DE2820474C2 (en) * | 1978-05-10 | 1983-11-10 | Fresenius AG, 6380 Bad Homburg | Electrochemical probe |
US4215703A (en) | 1978-08-29 | 1980-08-05 | Willson James K V | Variable stiffness guide wire |
US4292423A (en) | 1979-04-19 | 1981-09-29 | Wacker-Chemie Gmbh | Process for the preparation of organopolysiloxanes |
US4253469A (en) | 1979-04-20 | 1981-03-03 | The Narda Microwave Corporation | Implantable temperature probe |
DE2932761A1 (en) * | 1979-08-13 | 1981-02-26 | Akzo Gmbh | POLYCARBONATE-POLYAETHER-COPOLYMER MEMBRANE |
JPS5627643A (en) | 1979-08-14 | 1981-03-18 | Toshiba Corp | Electrochemical measuring device |
US4260725A (en) * | 1979-12-10 | 1981-04-07 | Bausch & Lomb Incorporated | Hydrophilic contact lens made from polysiloxanes which are thermally bonded to polymerizable groups and which contain hydrophilic sidechains |
US4403984A (en) | 1979-12-28 | 1983-09-13 | Biotek, Inc. | System for demand-based adminstration of insulin |
US4686137A (en) | 1980-02-29 | 1987-08-11 | Thoratec Laboratories Corp. | Moisture vapor permeable materials |
US4861830A (en) | 1980-02-29 | 1989-08-29 | Th. Goldschmidt Ag | Polymer systems suitable for blood-contacting surfaces of a biomedical device, and methods for forming |
US5120813A (en) | 1980-02-29 | 1992-06-09 | Th. Goldschmidt Ag | Moisture vapor permeable materials |
EP0047013B1 (en) | 1980-09-02 | 1986-01-22 | Medtronic, Inc. | Subcutaneously implantable lead with drug dispenser means |
IE51643B1 (en) | 1980-10-15 | 1987-01-21 | Smith & Nephew Ass | Coated articles and materials suitable for coating |
US4353888A (en) * | 1980-12-23 | 1982-10-12 | Sefton Michael V | Encapsulation of live animal cells |
JPS5929693Y2 (en) | 1980-12-25 | 1984-08-25 | オリンパス光学工業株式会社 | Cell collection device for endoscope |
JPS57156004A (en) | 1981-03-20 | 1982-09-27 | Nitto Electric Ind Co Ltd | Gas separating membrane |
JPS57156005A (en) | 1981-03-20 | 1982-09-27 | Nitto Electric Ind Co Ltd | Selective permeable membrane |
JPS57156005U (en) | 1981-03-26 | 1982-09-30 | ||
JPS57156004U (en) | 1981-03-26 | 1982-09-30 | ||
US4442841A (en) | 1981-04-30 | 1984-04-17 | Mitsubishi Rayon Company Limited | Electrode for living bodies |
US4378016A (en) | 1981-07-15 | 1983-03-29 | Biotek, Inc. | Artificial endocrine gland containing hormone-producing cells |
US4402694A (en) | 1981-07-16 | 1983-09-06 | Biotek, Inc. | Body cavity access device containing a hormone source |
US4419535A (en) | 1981-07-31 | 1983-12-06 | Hara Robert J O | Multi-cable conduit for floors and walls |
US4453537A (en) * | 1981-08-04 | 1984-06-12 | Spitzer Daniel E | Apparatus for powering a body implant device |
DE3278334D1 (en) | 1981-10-23 | 1988-05-19 | Genetics Int Inc | Sensor for components of a liquid mixture |
US4418148A (en) | 1981-11-05 | 1983-11-29 | Miles Laboratories, Inc. | Multilayer enzyme electrode membrane |
US4415666A (en) | 1981-11-05 | 1983-11-15 | Miles Laboratories, Inc. | Enzyme electrode membrane |
NL193256C (en) | 1981-11-10 | 1999-04-02 | Cordis Europ | Sensor system. |
US4454295A (en) | 1981-11-16 | 1984-06-12 | Uco Optics, Inc. | Cured cellulose ester, method of curing same, and use thereof |
JPS5886172A (en) | 1981-11-18 | 1983-05-23 | テルモ株式会社 | Medical substance moving apparatus |
US4494950A (en) | 1982-01-19 | 1985-01-22 | The Johns Hopkins University | Plural module medication delivery system |
JPS58137840U (en) | 1982-03-12 | 1983-09-16 | 三菱自動車工業株式会社 | Injection timing control device |
US4482666A (en) | 1982-03-12 | 1984-11-13 | Apace Research Limited | Emulsions of liquid hydrocarbons with water and/or alcohols |
JPS58163402A (en) | 1982-03-20 | 1983-09-28 | Nitto Electric Ind Co Ltd | Gas separation membrane |
JPS58163403A (en) | 1982-03-23 | 1983-09-28 | Nitto Electric Ind Co Ltd | Gas separation membrane |
US4403847A (en) | 1982-03-29 | 1983-09-13 | Eastman Kodak Company | Electrographic transfer apparatus |
US4493714A (en) * | 1982-05-06 | 1985-01-15 | Teijin Limited | Ultrathin film, process for production thereof, and use thereof for concentrating a specified gas in a gaseous mixture |
EP0098592A3 (en) | 1982-07-06 | 1985-08-21 | Fujisawa Pharmaceutical Co., Ltd. | Portable artificial pancreas |
DE3228551A1 (en) | 1982-07-30 | 1984-02-02 | Siemens AG, 1000 Berlin und 8000 München | METHOD FOR DETERMINING SUGAR CONCENTRATION |
JPS5929693A (en) | 1982-08-10 | 1984-02-16 | Asahi Glass Co Ltd | Fluorine-containing diisocyanate containing siloxane bond |
US4571292A (en) | 1982-08-12 | 1986-02-18 | Case Western Reserve University | Apparatus for electrochemical measurements |
JPS5949803A (en) | 1982-09-17 | 1984-03-22 | Teijin Ltd | Permselective membrane for separation of gas |
JPS5949805A (en) | 1982-09-17 | 1984-03-22 | Teijin Ltd | Permselective membrane for separation of gas |
JPS5949805U (en) | 1982-09-27 | 1984-04-02 | 株式会社東芝 | High frequency heating cooking device |
JPS5949803U (en) | 1982-09-27 | 1984-04-02 | リンナイ株式会社 | Oven cooking device operating device |
JPS5959221A (en) | 1982-09-29 | 1984-04-05 | Teijin Ltd | Prearation of composite perrmeable membrane for separating gas |
JPS5959221U (en) | 1982-10-12 | 1984-04-18 | 和光産業株式会社 | Plate fixing device in multi-blade fan assembly machine |
JPS591929Y2 (en) | 1982-10-25 | 1984-01-19 | ロ−レルバンクマシン株式会社 | Cumulative coin support rod of coin wrapping machine |
AU573730B2 (en) | 1982-10-25 | 1988-06-23 | Antarctic Pharma Ab | Enzyme composition from euphausiaceae (antarctic krill) as cleaning agent |
JPS5987004A (en) | 1982-11-08 | 1984-05-19 | Nitto Electric Ind Co Ltd | Gas separation membrane |
JPS58163403U (en) | 1982-11-27 | 1983-10-31 | ナイガイ株式会社 | Single drive source packaging machine |
JPS5987004U (en) | 1982-12-01 | 1984-06-12 | 古河電気工業株式会社 | Airtight penetration for optical transmission line |
US5059654A (en) | 1983-02-14 | 1991-10-22 | Cuno Inc. | Affinity matrices of modified polysaccharide supports |
JPS59128406U (en) | 1983-02-19 | 1984-08-29 | 倉敷化工株式会社 | Suspension rubber bushing for automobiles |
US4506680A (en) | 1983-03-17 | 1985-03-26 | Medtronic, Inc. | Drug dispensing body implantable lead |
US5682884A (en) | 1983-05-05 | 1997-11-04 | Medisense, Inc. | Strip electrode with screen printing |
CA1226036A (en) | 1983-05-05 | 1987-08-25 | Irving J. Higgins | Analytical equipment and sensor electrodes therefor |
CA1219040A (en) | 1983-05-05 | 1987-03-10 | Elliot V. Plotkin | Measurement of enzyme-catalysed reactions |
JPS59209608A (en) | 1983-05-12 | 1984-11-28 | Teijin Ltd | Permselective membrane |
JPS59209610A (en) | 1983-05-12 | 1984-11-28 | Teijin Ltd | Permselective membrane |
JPS59209609A (en) | 1983-05-12 | 1984-11-28 | Teijin Ltd | Permselective membrane |
JPS59211459A (en) | 1983-05-17 | 1984-11-30 | 帝人株式会社 | Pasturization of blood treating device |
US4484987A (en) * | 1983-05-19 | 1984-11-27 | The Regents Of The University Of California | Method and membrane applicable to implantable sensor |
JPH0693160B2 (en) * | 1983-05-31 | 1994-11-16 | シャープ株式会社 | LCD drive circuit |
WO1985000463A1 (en) | 1983-07-05 | 1985-01-31 | Matsushita Electric Industrial Co., Ltd. | Aluminum electrolytic capacitor and method of manufacture thereof |
US4655880A (en) | 1983-08-01 | 1987-04-07 | Case Western Reserve University | Apparatus and method for sensing species, substances and substrates using oxidase |
US4578215A (en) | 1983-08-12 | 1986-03-25 | Micro-Circuits Company | Electrical conductivity-enhancing and protecting material |
US4554927A (en) | 1983-08-30 | 1985-11-26 | Thermometrics Inc. | Pressure and temperature sensor |
GB2149918A (en) | 1983-11-03 | 1985-06-19 | John Anderson | Sudden infant death syndrome monitor |
JPS60146219A (en) | 1984-01-11 | 1985-08-01 | Toray Ind Inc | Contact lens |
US4739380A (en) | 1984-01-19 | 1988-04-19 | Integrated Ionics, Inc. | Integrated ambient sensing devices and methods of manufacture |
JPS60136214U (en) | 1984-02-23 | 1985-09-10 | いすゞ自動車株式会社 | Height adjustment device for vehicles with air spring suspension |
US4527999A (en) | 1984-03-23 | 1985-07-09 | Abcor, Inc. | Separation membrane and method of preparing and using same |
US4753652A (en) | 1984-05-04 | 1988-06-28 | Children's Medical Center Corporation | Biomaterial implants which resist calcification |
US4883057A (en) | 1984-05-09 | 1989-11-28 | Research Foundation, The City University Of New York | Cathodic electrochemical current arrangement with telemetric application |
JPS60245623A (en) | 1984-05-18 | 1985-12-05 | Nippon Yunikaa Kk | Production of flexible polyether-urethane foam of low gas permeability |
US4583976A (en) * | 1984-05-31 | 1986-04-22 | E. R. Squibb & Sons, Inc. | Catheter support |
US4644046A (en) * | 1984-06-20 | 1987-02-17 | Teijin Limited | Ultrathin film, process for production thereof, and use thereof for concentrating a specific gas from a gas mixture |
CA1258496A (en) | 1984-07-30 | 1989-08-15 | Teruyoshi Uchida | Insulated noble metal wire and porous membrane as po.sub.2 bioelectrode |
US5171689A (en) * | 1984-11-08 | 1992-12-15 | Matsushita Electric Industrial Co., Ltd. | Solid state bio-sensor |
US4602922A (en) | 1984-11-09 | 1986-07-29 | Research Foundation Of State University Of New York | Method of making membranes for gas separation and the composite membranes |
US4702732A (en) | 1984-12-24 | 1987-10-27 | Trustees Of Boston University | Electrodes, electrode assemblies, methods, and systems for tissue stimulation and transdermal delivery of pharmacologically active ligands |
US4963595A (en) | 1985-01-04 | 1990-10-16 | Thoratec Laboratories Corporation | Polysiloxane-polylactone block copolymers |
US5235003A (en) | 1985-01-04 | 1993-08-10 | Thoratec Laboratories Corporation | Polysiloxane-polylactone block copolymers |
US4958148A (en) | 1985-03-22 | 1990-09-18 | Elmwood Sensors, Inc. | Contrast enhancing transparent touch panel device |
US4787398A (en) * | 1985-04-08 | 1988-11-29 | Garid, Inc. | Glucose medical monitoring system |
JPS61238319A (en) | 1985-04-17 | 1986-10-23 | Dainippon Ink & Chem Inc | Selective gas permeable membrane |
US4781798A (en) | 1985-04-19 | 1988-11-01 | The Regents Of The University Of California | Transparent multi-oxygen sensor array and method of using same |
GB8514176D0 (en) | 1985-06-05 | 1985-07-10 | Ici Plc | Membrane |
US4671288A (en) | 1985-06-13 | 1987-06-09 | The Regents Of The University Of California | Electrochemical cell sensor for continuous short-term use in tissues and blood |
US4938860A (en) | 1985-06-28 | 1990-07-03 | Miles Inc. | Electrode for electrochemical sensors |
US5364770A (en) * | 1985-08-29 | 1994-11-15 | Genencor International Inc. | Heterologous polypeptides expressed in aspergillus |
US4805624A (en) * | 1985-09-09 | 1989-02-21 | The Montefiore Hospital Association Of Western Pa | Low-potential electrochemical redox sensors |
JPS6274406A (en) | 1985-09-30 | 1987-04-06 | Teijin Ltd | Separating membrane |
US4689309A (en) | 1985-09-30 | 1987-08-25 | Miles Laboratories, Inc. | Test device, method of manufacturing same and method of determining a component in a sample |
JPS6283849A (en) | 1985-10-04 | 1987-04-17 | Reiji Yoshinaka | Method of purifying collagen |
JPS6283649A (en) | 1985-10-08 | 1987-04-17 | Matsushita Electric Ind Co Ltd | Blood-sugar measuring device |
JPS6274406U (en) | 1985-10-29 | 1987-05-13 | ||
JPS62102815A (en) | 1985-10-30 | 1987-05-13 | Agency Of Ind Science & Technol | Gas permselective membrane |
US4647643A (en) * | 1985-11-08 | 1987-03-03 | Becton, Dickinson And Company | Soft non-blocking polyurethanes |
JPS6283849U (en) | 1985-11-12 | 1987-05-28 | ||
JPS6283649U (en) | 1985-11-14 | 1987-05-28 | ||
JPH0341047Y2 (en) | 1985-12-19 | 1991-08-29 | ||
JPS62174260A (en) * | 1986-01-20 | 1987-07-31 | Shin Etsu Chem Co Ltd | Fluorosilicone rubber composition |
US4684538A (en) | 1986-02-21 | 1987-08-04 | Loctite Corporation | Polysiloxane urethane compounds and adhesive compositions, and method of making and using the same |
US4776944A (en) | 1986-03-20 | 1988-10-11 | Jiri Janata | Chemical selective sensors utilizing admittance modulated membranes |
JPH0696106B2 (en) | 1986-03-31 | 1994-11-30 | 帝人株式会社 | Gas separation membrane |
US4685463A (en) | 1986-04-03 | 1987-08-11 | Williams R Bruce | Device for continuous in vivo measurement of blood glucose concentrations |
US4757022A (en) * | 1986-04-15 | 1988-07-12 | Markwell Medical Institute, Inc. | Biological fluid measuring device |
US4909908A (en) * | 1986-04-24 | 1990-03-20 | Pepi Ross | Electrochemical cncentration detector method |
US4795542A (en) * | 1986-04-24 | 1989-01-03 | St. Jude Medical, Inc. | Electrochemical concentration detector device |
ATE127923T1 (en) | 1986-04-30 | 1995-09-15 | Igen Inc | ELECTROCHEMILUMINESCENCE TEST METHODS. |
US4703756A (en) * | 1986-05-06 | 1987-11-03 | The Regents Of The University Of California | Complete glucose monitoring system with an implantable, telemetered sensor module |
US4731726A (en) | 1986-05-19 | 1988-03-15 | Healthware Corporation | Patient-operated glucose monitor and diabetes management system |
GB8612861D0 (en) | 1986-05-27 | 1986-07-02 | Cambridge Life Sciences | Immobilised enzyme biosensors |
US4763658A (en) | 1986-06-04 | 1988-08-16 | Solutech, Inc. | Dialysis system 2nd method |
US4726381A (en) | 1986-06-04 | 1988-02-23 | Solutech, Inc. | Dialysis system and method |
US4750496A (en) | 1987-01-28 | 1988-06-14 | Xienta, Inc. | Method and apparatus for measuring blood glucose concentration |
US4781733A (en) | 1986-07-23 | 1988-11-01 | Bend Research, Inc. | Semipermeable thin-film membranes comprising siloxane, alkoxysilyl and aryloxysilyl oligomers and copolymers |
AU617667B2 (en) | 1986-11-04 | 1991-12-05 | Allergan, Inc. | Open-cell, silicone-elastomer medical implant and method for making |
JPS63130661A (en) | 1986-11-20 | 1988-06-02 | Toppan Printing Co Ltd | Non-porous moisture-permeable waterproof film |
US4954381A (en) | 1986-12-30 | 1990-09-04 | The Research Foundation Of The State University Of New York | Preparation of porous substrates having well defined morphology |
DE3700119A1 (en) | 1987-01-03 | 1988-07-14 | Inst Diabetestechnologie Gemei | IMPLANTABLE ELECTROCHEMICAL SENSOR |
JPS63130661U (en) | 1987-02-18 | 1988-08-26 | ||
EP0284518B1 (en) | 1987-03-27 | 1992-10-07 | Isao Karube | Miniaturized oxygen electrode and miniaturized biosensor and production process thereof |
US4935345A (en) | 1987-04-07 | 1990-06-19 | Arizona Board Of Regents | Implantable microelectronic biochemical sensor incorporating thin film thermopile |
US4832034A (en) | 1987-04-09 | 1989-05-23 | Pizziconi Vincent B | Method and apparatus for withdrawing, collecting and biosensing chemical constituents from complex fluids |
US4759828A (en) | 1987-04-09 | 1988-07-26 | Nova Biomedical Corporation | Glucose electrode and method of determining glucose |
US5352348A (en) | 1987-04-09 | 1994-10-04 | Nova Biomedical Corporation | Method of using enzyme electrode |
US4961954A (en) | 1987-04-10 | 1990-10-09 | University Of Florida | Surface modified surgical instruments, devices, implants, contact lenses and the like |
US6387379B1 (en) | 1987-04-10 | 2002-05-14 | University Of Florida | Biofunctional surface modified ocular implants, surgical instruments, medical devices, prostheses, contact lenses and the like |
US5100689A (en) * | 1987-04-10 | 1992-03-31 | University Of Florida | Surface modified surgical instruments, devices, implants, contact lenses and the like |
US5094876A (en) * | 1987-04-10 | 1992-03-10 | University Of Florida | Surface modified surgical instruments, devices, implants, contact lenses and the like |
IT1215491B (en) | 1987-05-15 | 1990-02-14 | Enricerche Spa | BIOSENSOR WITH ENZYMATIC MEMBRANE CHEMICALLY CONNECTED TO A SEMICONDUCTIVE DEVICE. |
US4880883A (en) | 1987-06-03 | 1989-11-14 | Wisconsin Alumni Research Foundation | Biocompatible polyurethanes modified with lower alkyl sulfonate and lower alkyl carboxylate |
US5286364A (en) * | 1987-06-08 | 1994-02-15 | Rutgers University | Surface-modified electochemical biosensor |
US5540828A (en) | 1987-06-08 | 1996-07-30 | Yacynych; Alexander | Method for making electrochemical sensors and biosensors having a polymer modified surface |
US4786657A (en) | 1987-07-02 | 1988-11-22 | Minnesota Mining And Manufacturing Company | Polyurethanes and polyurethane/polyureas crosslinked using 2-glyceryl acrylate or 2-glyceryl methacrylate |
JPH07122624B2 (en) * | 1987-07-06 | 1995-12-25 | ダイキン工業株式会社 | Biosensor |
US4805625A (en) | 1987-07-08 | 1989-02-21 | Ad-Tech Medical Instrument Corporation | Sphenoidal electrode and insertion method |
FI77569C (en) | 1987-07-13 | 1989-04-10 | Huhtamaeki Oy | ANORDINATION FOR THE PURPOSE OF THE OPERATIONS AND THE OPERATIONS OF ELLER EN VAEVNAD. |
JPH0824830B2 (en) | 1987-07-13 | 1996-03-13 | 帝人株式会社 | Separation membrane |
JPH07114937B2 (en) | 1987-07-13 | 1995-12-13 | 帝人株式会社 | Separation membrane |
DE3725728A1 (en) | 1987-08-04 | 1989-02-16 | Freudenberg Carl Fa | MEDICAL DEVICE AND METHOD FOR THE PRODUCTION THEREOF |
US5221724A (en) | 1987-08-12 | 1993-06-22 | Wisconsin Alumni Research Foundation | Polysiloxane polyurea urethanes |
GB2209836A (en) | 1987-09-16 | 1989-05-24 | Cambridge Life Sciences | Multilayer enzyme electrode membrane and method of making same |
US4974929A (en) | 1987-09-22 | 1990-12-04 | Baxter International, Inc. | Fiber optical probe connector for physiologic measurement devices |
NL8702370A (en) | 1987-10-05 | 1989-05-01 | Groningen Science Park | METHOD AND SYSTEM FOR GLUCOSE DETERMINATION AND USEABLE MEASURING CELL ASSEMBLY. |
DE3736652A1 (en) | 1987-10-29 | 1989-05-11 | Bayer Ag | PROCESS FOR PREPARING COATINGS |
US5242835A (en) | 1987-11-03 | 1993-09-07 | Radiometer A/S | Method and apparatus for determining the concentration of oxygen |
GB8725936D0 (en) | 1987-11-05 | 1987-12-09 | Genetics Int Inc | Sensing system |
US5128408A (en) | 1987-11-16 | 1992-07-07 | Toyo Boseki Kabushiki Kaisha | Gas-permeable material with excellent compatibility with blood |
US4852573A (en) | 1987-12-04 | 1989-08-01 | Kennedy Philip R | Implantable neural electrode |
US4813424A (en) | 1987-12-23 | 1989-03-21 | University Of New Mexico | Long-life membrane electrode for non-ionic species |
US4890621A (en) | 1988-01-19 | 1990-01-02 | Northstar Research Institute, Ltd. | Continuous glucose monitoring and a system utilized therefor |
US5070169A (en) | 1988-02-26 | 1991-12-03 | Ciba-Geigy Corporation | Wettable, flexible, oxygen permeable contact lens containing block copolymer polysiloxane-polyoxyalkylene backbone units and use thereof |
US4822336A (en) * | 1988-03-04 | 1989-04-18 | Ditraglia John | Blood glucose level sensing |
US4955861A (en) | 1988-04-21 | 1990-09-11 | Therex Corp. | Dual access infusion and monitoring system |
US4908208A (en) * | 1988-04-22 | 1990-03-13 | Dow Corning Corporation | Matrix for release of active ingredients |
US4951657A (en) | 1988-04-22 | 1990-08-28 | Dow Corning Corporation | Heat sealable membrane for transdermal drug release |
US4793555A (en) | 1988-04-22 | 1988-12-27 | Dow Corning Corporation | Container, method and composition for controlling the release of a volatile liquid from an aqueous mixture |
US4952618A (en) | 1988-05-03 | 1990-08-28 | Minnesota Mining And Manufacturing Company | Hydrocolloid/adhesive composition |
US5034112A (en) | 1988-05-19 | 1991-07-23 | Nissan Motor Company, Ltd. | Device for measuring concentration of nitrogen oxide in combustion gas |
US5342693A (en) | 1988-06-08 | 1994-08-30 | Cardiopulmonics, Inc. | Multifunctional thrombo-resistant coating and methods of manufacture |
JPH022913A (en) | 1988-06-16 | 1990-01-08 | Bridgestone Corp | Modified electrode |
CA1299653C (en) | 1988-07-07 | 1992-04-28 | Markwell Medical Institute, Inc. | Biological fluid measuring device |
GB8817997D0 (en) | 1988-07-28 | 1988-09-01 | Cambridge Life Sciences | Enzyme electrodes & improvements in manufacture thereof |
EP0353328A1 (en) | 1988-08-03 | 1990-02-07 | Dräger Nederland B.V. | A polarographic-amperometric three-electrode sensor |
US5438984A (en) | 1988-09-08 | 1995-08-08 | Sudor Partners | Apparatus and method for the collection of analytes on a dermal patch |
US4960594A (en) | 1988-09-22 | 1990-10-02 | Derma-Lock Medical Corporation | Polyurethane foam dressing |
US4983702A (en) | 1988-09-28 | 1991-01-08 | Ciba-Geigy Corporation | Crosslinked siloxane-urethane polymer contact lens |
NL8802481A (en) * | 1988-10-10 | 1990-05-01 | Texas Instruments Holland | TRANSPONDER AND METHOD FOR MAKING THE SAME |
US5212050A (en) | 1988-11-14 | 1993-05-18 | Mier Randall M | Method of forming a permselective layer |
US5063081A (en) | 1988-11-14 | 1991-11-05 | I-Stat Corporation | Method of manufacturing a plurality of uniform microfabricated sensing devices having an immobilized ligand receptor |
US6306594B1 (en) | 1988-11-14 | 2001-10-23 | I-Stat Corporation | Methods for microdispensing patterened layers |
US5200051A (en) | 1988-11-14 | 1993-04-06 | I-Stat Corporation | Wholly microfabricated biosensors and process for the manufacture and use thereof |
AU4951690A (en) | 1988-12-30 | 1990-08-01 | David M. Anderson | Stabilized microporous materials and hydrogel materials |
US5269891A (en) | 1989-03-09 | 1993-12-14 | Novo Nordisk A/S | Method and apparatus for determination of a constituent in a fluid |
JPH02298855A (en) | 1989-03-20 | 1990-12-11 | Assoc Univ Inc | Electrochemical biosensor using immobilized enzyme and redox polymer |
US5089112A (en) | 1989-03-20 | 1992-02-18 | Associated Universities, Inc. | Electrochemical biosensor based on immobilized enzymes and redox polymers |
US4953552A (en) | 1989-04-21 | 1990-09-04 | Demarzo Arthur P | Blood glucose monitoring system |
EP0396788A1 (en) | 1989-05-08 | 1990-11-14 | Dräger Nederland B.V. | Process and sensor for measuring the glucose content of glucosecontaining fluids |
US4907145A (en) * | 1989-05-11 | 1990-03-06 | Belmont Instrument Corporation | Sine wave inverter |
US4988341A (en) * | 1989-06-05 | 1991-01-29 | Eastman Kodak Company | Sterilizing dressing device and method for skin puncture |
US5034461A (en) | 1989-06-07 | 1991-07-23 | Bausch & Lomb Incorporated | Novel prepolymers useful in biomedical devices |
US5045601A (en) | 1989-06-13 | 1991-09-03 | Biointerface Technologies, Inc. | Pressure-sensitive adhesive compositions suitable for medical uses |
US4927407A (en) | 1989-06-19 | 1990-05-22 | Regents Of The University Of Minnesota | Cardiac assist pump with steady rate supply of fluid lubricant |
US5115056A (en) | 1989-06-20 | 1992-05-19 | Ciba-Geigy Corporation | Fluorine and/or silicone containing poly(alkylene-oxide)-block copolymers and contact lenses thereof |
US5334681A (en) | 1989-06-20 | 1994-08-02 | Ciba-Geigy Corporation | Fluorine and/or silicone containing poly(alkylene-oxide)-block copolymer hydrogels and contact lenses thereof |
CH677149A5 (en) | 1989-07-07 | 1991-04-15 | Disetronic Ag | |
US5431160A (en) | 1989-07-19 | 1995-07-11 | University Of New Mexico | Miniature implantable refillable glucose sensor and material therefor |
US5264104A (en) | 1989-08-02 | 1993-11-23 | Gregg Brian A | Enzyme electrodes |
FR2650756B1 (en) | 1989-08-11 | 1991-10-31 | Inst Francais Du Petrole | GAS SEPARATION MEMBRANE |
US5050612A (en) | 1989-09-12 | 1991-09-24 | Matsumura Kenneth N | Device for computer-assisted monitoring of the body |
US5002590A (en) * | 1989-09-19 | 1991-03-26 | Bend Research, Inc. | Countercurrent dehydration by hollow fibers |
FR2652736A1 (en) | 1989-10-06 | 1991-04-12 | Neftel Frederic | IMPLANTABLE DEVICE FOR EVALUATING THE RATE OF GLUCOSE. |
JPH03133440A (en) | 1989-10-18 | 1991-06-06 | Nishitomo:Kk | Clinical thermometer for ladies |
US5010141A (en) * | 1989-10-25 | 1991-04-23 | Ciba-Geigy Corporation | Reactive silicone and/or fluorine containing hydrophilic prepolymers and polymers thereof |
US5067491A (en) | 1989-12-08 | 1991-11-26 | Becton, Dickinson And Company | Barrier coating on blood contacting devices |
JP3105243B2 (en) | 1989-12-14 | 2000-10-30 | ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア | How to increase the useful life of an implantable sensor |
US5985129A (en) * | 1989-12-14 | 1999-11-16 | The Regents Of The University Of California | Method for increasing the service life of an implantable sensor |
FR2656423A1 (en) | 1989-12-22 | 1991-06-28 | Rhone Poulenc Chimie | Electrochemical biosensor |
US5243696A (en) | 1989-12-29 | 1993-09-07 | General Signal Corporation | Programmable electronic display for a chart recorder |
US5183549A (en) * | 1990-01-26 | 1993-02-02 | Commtech International Management Corporation | Multi-analyte sensing electrolytic cell |
US5108819A (en) * | 1990-02-14 | 1992-04-28 | Eli Lilly And Company | Thin film electrical component |
CA2011298C (en) * | 1990-03-01 | 1999-05-25 | Adrian William Alden | Dual polarization dipole array antenna |
US5031618A (en) | 1990-03-07 | 1991-07-16 | Medtronic, Inc. | Position-responsive neuro stimulator |
US5316008A (en) | 1990-04-06 | 1994-05-31 | Casio Computer Co., Ltd. | Measurement of electrocardiographic wave and sphygmus |
JPH07101215B2 (en) | 1990-04-11 | 1995-11-01 | 国立身体障害者リハビリテーションセンター総長 | Analytical method using biofunctional substance-immobilized electrode |
US5165407A (en) * | 1990-04-19 | 1992-11-24 | The University Of Kansas | Implantable glucose sensor |
GB9009409D0 (en) | 1990-04-26 | 1990-06-20 | Dow Corning | Film-forming copolymers and their use in water vapour permeable coatings |
US5331555A (en) | 1990-05-11 | 1994-07-19 | Sharp Kabushiki Kaisha | Electronic apparatus |
IT1248934B (en) | 1990-06-01 | 1995-02-11 | Fidia Spa | BIOCOMPATIBLE PERFORATED MEMBRANES, PROCESSES FOR THEIR PREPARATION, THEIR USE AS A SUPPORT FOR THE IN VITRO GROWTH OF EPITHELIAL CELLS, ARTIFICIAL LEATHER THUS OBTAINED AND THEIR USE IN LEATHER TRANSPLANTS |
US5147725A (en) | 1990-07-03 | 1992-09-15 | Corvita Corporation | Method for bonding silicone rubber and polyurethane materials and articles manufactured thereby |
US5202261A (en) | 1990-07-19 | 1993-04-13 | Miles Inc. | Conductive sensors and their use in diagnostic assays |
US5250439A (en) | 1990-07-19 | 1993-10-05 | Miles Inc. | Use of conductive sensors in diagnostic assays |
JPH0820412B2 (en) | 1990-07-20 | 1996-03-04 | 松下電器産業株式会社 | Quantitative analysis method and device using disposable sensor |
US5746898A (en) | 1990-08-10 | 1998-05-05 | Siemens Aktiengesellschaft | Electrochemical-enzymatic sensor |
KR960012335B1 (en) | 1990-09-17 | 1996-09-18 | 후지쓰 가부시끼가이샤 | Oxygen electrode |
WO1992007464A1 (en) | 1990-10-24 | 1992-05-14 | University Of Florida | Combined plasma and gamma radiation polymerization method for modifying surfaces |
US5344454A (en) * | 1991-07-24 | 1994-09-06 | Baxter International Inc. | Closed porous chambers for implanting tissue in a host |
US5135297A (en) | 1990-11-27 | 1992-08-04 | Bausch & Lomb Incorporated | Surface coating of polymer objects |
US5219965A (en) | 1990-11-27 | 1993-06-15 | Bausch & Lomb Incorporated | Surface modification of polymer objects |
US5354449A (en) | 1991-01-10 | 1994-10-11 | Band David M | pH electrode |
DE69228957T2 (en) | 1991-01-16 | 1999-10-07 | Toyo Boseki K.K., Osaka | Blood compatible material |
AU1356792A (en) | 1991-01-25 | 1992-08-27 | Markwell Medical Institute, Inc. | Implantable biological fluid measuring device |
US5348788A (en) | 1991-01-30 | 1994-09-20 | Interpore Orthopaedics, Inc. | Mesh sheet with microscopic projections and holes |
JPH04278450A (en) | 1991-03-04 | 1992-10-05 | Adam Heller | Biosensor and method for analyzing subject |
JPH08196626A (en) | 1991-04-25 | 1996-08-06 | Toyobo Co Ltd | Blood compatible artificial pulmonary membrane |
JP3084642B2 (en) | 1991-05-30 | 2000-09-04 | 株式会社ジェルテック | Pad for dressing and method of manufacturing the same |
JP2816262B2 (en) | 1991-07-09 | 1998-10-27 | 工業技術院長 | Carbon microsensor electrode and method of manufacturing the same |
US5766151A (en) | 1991-07-16 | 1998-06-16 | Heartport, Inc. | Endovascular system for arresting the heart |
US5453278A (en) * | 1991-07-24 | 1995-09-26 | Baxter International Inc. | Laminated barriers for tissue implants |
US5312361A (en) | 1991-09-13 | 1994-05-17 | Zadini Filiberto P | Automatic cannulation device |
US5482008A (en) | 1991-09-13 | 1996-01-09 | Stafford; Rodney A. | Electronic animal identification system |
DE4130742A1 (en) | 1991-09-16 | 1993-03-18 | Inst Diabetestechnologie Gemei | METHOD AND ARRANGEMENT FOR DETERMINING THE CONCENTRATION OF INGREDIENTS IN BODY LIQUIDS |
GB9120144D0 (en) | 1991-09-20 | 1991-11-06 | Imperial College | A dialysis electrode device |
US5322063A (en) * | 1991-10-04 | 1994-06-21 | Eli Lilly And Company | Hydrophilic polyurethane membranes for electrochemical glucose sensors |
US5155149A (en) | 1991-10-10 | 1992-10-13 | Boc Health Care, Inc. | Silicone polyurethane copolymers containing oxygen sensitive phosphorescent dye compounds |
US5605162A (en) | 1991-10-15 | 1997-02-25 | Advanced Cardiovascular Systems, Inc. | Method for using a variable stiffness guidewire |
US5249576A (en) | 1991-10-24 | 1993-10-05 | Boc Health Care, Inc. | Universal pulse oximeter probe |
EP0539625A1 (en) | 1991-10-28 | 1993-05-05 | Dräger Medical Electronics B.V. | Electrochemical sensor for measuring the glucose content of glucose containing fluids |
US5866217A (en) | 1991-11-04 | 1999-02-02 | Possis Medical, Inc. | Silicone composite vascular graft |
US5310469A (en) | 1991-12-31 | 1994-05-10 | Abbott Laboratories | Biosensor with a membrane containing biologically active material |
US5296144A (en) * | 1992-01-02 | 1994-03-22 | World Trade Corporation | Composite membrane of a hydrophilic asymmetric membrane coated with an organosiloxane block copolymer |
US5217594A (en) | 1992-01-15 | 1993-06-08 | Enzyme Technology Research Group, Inc. | Convenient determination of trace lead in whole blood and other fluids |
DE69215204T2 (en) | 1992-01-29 | 1997-03-13 | Hewlett Packard Gmbh | Process and system for monitoring vital functions |
US5582497A (en) | 1992-01-29 | 1996-12-10 | Wing Labo Co., Ltd. | Automatic warehouse system |
EP0624074A1 (en) | 1992-02-01 | 1994-11-17 | The Victoria University Of Manchester | Electrode |
NL9200207A (en) | 1992-02-05 | 1993-09-01 | Nedap Nv | IMPLANTABLE BIOMEDICAL SENSOR DEVICE, IN PARTICULAR FOR MEASUREMENT OF THE GLUCOSE CONCENTRATION. |
US5284140A (en) * | 1992-02-11 | 1994-02-08 | Eli Lilly And Company | Acrylic copolymer membranes for biosensors |
JPH05279447A (en) | 1992-03-31 | 1993-10-26 | Mitsubishi Rayon Co Ltd | Silicon-based block copolymer and membrane made thereof |
DE69319771T2 (en) | 1992-03-31 | 1999-04-22 | Dai Nippon Printing Co., Ltd., Tokio/Tokyo | Immobilized enzyme electrode, composition for its production and electrically conductive enzymes |
EP0676935B1 (en) | 1992-04-01 | 2001-11-07 | BAXTER INTERNATIONAL INC. (a Delaware corporation) | Angiogenic tissue implant systems |
US5324322A (en) | 1992-04-20 | 1994-06-28 | Case Western Reserve University | Thin film implantable electrode and method of manufacture |
US5589563A (en) | 1992-04-24 | 1996-12-31 | The Polymer Technology Group | Surface-modifying endgroups for biomedical polymers |
US5428123A (en) | 1992-04-24 | 1995-06-27 | The Polymer Technology Group | Copolymers and non-porous, semi-permeable membrane thereof and its use for permeating molecules of predetermined molecular weight range |
GB9211402D0 (en) | 1992-05-29 | 1992-07-15 | Univ Manchester | Sensor devices |
US5330521A (en) | 1992-06-29 | 1994-07-19 | Cohen Donald M | Low resistance implantable electrical leads |
US5208313A (en) | 1992-07-16 | 1993-05-04 | Surface Coatings, Inc. | Waterproof breathable polyurethane membranes and porous substrates protected therewith |
JPH0634596A (en) | 1992-07-20 | 1994-02-08 | Fujitsu Ltd | Oxygen electrode, biosensor and manufacture thereof |
US5330634A (en) | 1992-08-28 | 1994-07-19 | Via Medical Corporation | Calibration solutions useful for analyses of biological fluids and methods employing same |
US5298144A (en) | 1992-09-15 | 1994-03-29 | The Yellow Springs Instrument Company, Inc. | Chemically wired fructose dehydrogenase electrodes |
EP0670751B1 (en) | 1992-10-01 | 2001-12-12 | Australian Membrane And Biotechnology Research Institute | Improved sensor membranes |
GB9221099D0 (en) | 1992-10-07 | 1992-11-18 | Ecossensors Ltd | Improvements in and relating to gas permeable membranes for amperometric gas electrodes |
US5750029A (en) | 1992-10-16 | 1998-05-12 | Suprex Corporation | Method and apparatus for determination of analyte concentration |
US5387327A (en) | 1992-10-19 | 1995-02-07 | Duquesne University Of The Holy Ghost | Implantable non-enzymatic electrochemical glucose sensor |
US6256522B1 (en) * | 1992-11-23 | 2001-07-03 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Sensors for continuous monitoring of biochemicals and related method |
ZA938555B (en) | 1992-11-23 | 1994-08-02 | Lilly Co Eli | Technique to improve the performance of electrochemical sensors |
JPH06229973A (en) * | 1993-01-29 | 1994-08-19 | Kyoto Daiichi Kagaku:Kk | Current detection type dry ion selective electrode |
US5389430A (en) | 1993-02-05 | 1995-02-14 | Th. Goldschmidt Ag | Textiles coated with waterproof, moisture vapor permeable polymers |
WO1994022367A1 (en) | 1993-03-30 | 1994-10-13 | Pfizer Inc. | Radiotelemetry impedance plethysmography device |
US5411866A (en) | 1993-03-30 | 1995-05-02 | National Research Council Of Canada | Method and system for determining bioactive substances |
US5387329A (en) | 1993-04-09 | 1995-02-07 | Ciba Corning Diagnostics Corp. | Extended use planar sensors |
US5425717A (en) | 1993-05-07 | 1995-06-20 | The Kendall Company | Epidural catheter system utilizing splittable needle |
US5352351A (en) | 1993-06-08 | 1994-10-04 | Boehringer Mannheim Corporation | Biosensing meter with fail/safe procedures to prevent erroneous indications |
US5417395A (en) * | 1993-06-30 | 1995-05-23 | Medex, Inc. | Modular interconnecting component support plate |
US5706833A (en) | 1993-07-13 | 1998-01-13 | Daicel Chemical Industries, Ltd. | Tobacco filters and method of producing the same |
DE4427363A1 (en) | 1993-08-03 | 1995-03-09 | A & D Co Ltd | A disposable chemical sensor |
DE4329898A1 (en) | 1993-09-04 | 1995-04-06 | Marcus Dr Besson | Wireless medical diagnostic and monitoring device |
AU7607494A (en) | 1993-09-10 | 1995-03-27 | Ottawa Heart Institute Research Corporation | Electrohydraulic ventricular assist device |
FR2710413B1 (en) | 1993-09-21 | 1995-11-03 | Asulab Sa | Measuring device for removable sensors. |
WO1995008355A1 (en) * | 1993-09-24 | 1995-03-30 | Baxter International Inc. | Methods for enhancing vascularization of implant devices |
US5582184A (en) | 1993-10-13 | 1996-12-10 | Integ Incorporated | Interstitial fluid collection and constituent measurement |
US5545220A (en) | 1993-11-04 | 1996-08-13 | Lipomatrix Incorporated | Implantable prosthesis with open cell textured surface and method for forming same |
KR970010981B1 (en) | 1993-11-04 | 1997-07-05 | 엘지전자 주식회사 | Alcohol concentration measuring bio-sensor, manufacturing method and related apparatus |
US5791344A (en) * | 1993-11-19 | 1998-08-11 | Alfred E. Mann Foundation For Scientific Research | Patient monitoring system |
US5508509A (en) | 1993-11-30 | 1996-04-16 | Minnesota Mining And Manufacturing Company | Sensing elements and methods for uniformly making individual sensing elements |
US5421923A (en) * | 1993-12-03 | 1995-06-06 | Baxter International, Inc. | Ultrasonic welding horn with sonics dampening insert |
US5443080A (en) * | 1993-12-22 | 1995-08-22 | Americate Transtech, Inc. | Integrated system for biological fluid constituent analysis |
US5437824A (en) | 1993-12-23 | 1995-08-01 | Moghan Medical Corp. | Method of forming a molded silicone foam implant having open-celled interstices |
US5549675A (en) * | 1994-01-11 | 1996-08-27 | Baxter International, Inc. | Method for implanting tissue in a host |
DE4401400A1 (en) | 1994-01-19 | 1995-07-20 | Ernst Prof Dr Pfeiffer | Method and arrangement for continuously monitoring the concentration of a metabolite |
US5505713A (en) * | 1994-04-01 | 1996-04-09 | Minimed Inc. | Indwelling catheter with stable enzyme coating |
AUPM506894A0 (en) | 1994-04-14 | 1994-05-05 | Memtec Limited | Novel electrochemical cells |
AU692252B2 (en) * | 1994-04-15 | 1998-06-04 | Cobe Cardiovascular, Inc. | Biocompatible coated article |
US5569186A (en) * | 1994-04-25 | 1996-10-29 | Minimed Inc. | Closed loop infusion pump system with removable glucose sensor |
US5584876A (en) | 1994-04-29 | 1996-12-17 | W. L. Gore & Associates, Inc. | Cell excluding sheath for vascular grafts |
US5466356A (en) | 1994-04-29 | 1995-11-14 | Mine Safety Appliances Company | Potentiostat circuit for electrochemical cells |
DE4415896A1 (en) | 1994-05-05 | 1995-11-09 | Boehringer Mannheim Gmbh | Analysis system for monitoring the concentration of an analyte in the blood of a patient |
DE59509994D1 (en) | 1994-06-03 | 2002-02-21 | Metrohm Ag Herisau | Device for voltammetry, indicator electrode arrangement for such a device, in particular as part of a tape cassette, and row analysis method for voltammetry |
US5766839A (en) | 1994-06-17 | 1998-06-16 | Ysi Incorporated | Processes for preparing barrier layer films for use in enzyme electrodes and films made thereby |
DE4422068A1 (en) | 1994-06-23 | 1996-01-04 | Siemens Ag | Electro-catalytic glucose sensor in catheter form |
US5429735A (en) | 1994-06-27 | 1995-07-04 | Miles Inc. | Method of making and amperometric electrodes |
US5494562A (en) | 1994-06-27 | 1996-02-27 | Ciba Corning Diagnostics Corp. | Electrochemical sensors |
US5474552A (en) | 1994-06-27 | 1995-12-12 | Cb-Carmel Biotechnology Ltd. | Implantable drug delivery pump |
JPH10502638A (en) | 1994-07-08 | 1998-03-10 | バクスター、インターナショナル、インコーポレイテッド | Implantable device containing tumor cells for cancer treatment |
US6007845A (en) | 1994-07-22 | 1999-12-28 | Massachusetts Institute Of Technology | Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers |
US5513636A (en) | 1994-08-12 | 1996-05-07 | Cb-Carmel Biotechnology Ltd. | Implantable sensor chip |
US5462051A (en) | 1994-08-31 | 1995-10-31 | Colin Corporation | Medical communication system |
AT402452B (en) * | 1994-09-14 | 1997-05-26 | Avl Verbrennungskraft Messtech | PLANAR SENSOR FOR DETECTING A CHEMICAL PARAMETER OF A SAMPLE |
US5486776A (en) | 1994-09-29 | 1996-01-23 | Xilinx, Inc. | Antifuse-based programmable logic circuit |
US5552112A (en) | 1995-01-26 | 1996-09-03 | Quiclave, Llc | Method and system for sterilizing medical instruments |
US5807406A (en) * | 1994-10-07 | 1998-09-15 | Baxter International Inc. | Porous microfabricated polymer membrane structures |
CA2159052C (en) | 1994-10-28 | 2007-03-06 | Rainer Alex | Injection device |
IE72524B1 (en) | 1994-11-04 | 1997-04-23 | Elan Med Tech | Analyte-controlled liquid delivery device and analyte monitor |
AU3927295A (en) * | 1994-11-14 | 1996-06-06 | Novartis Ag | Randomly segmented thermoplastic polyurethanes as matrix for electrochemical analysis of ca++ ions |
US5670097A (en) | 1994-12-08 | 1997-09-23 | Minnesota Mining And Manufacturing Company | Method of making blood gas sensors overcoats using permeable polymeric compositions |
US5700559A (en) | 1994-12-16 | 1997-12-23 | Advanced Surface Technology | Durable hydrophilic surface coatings |
JP2807650B2 (en) | 1994-12-24 | 1998-10-08 | ベーリンガー・マンハイム・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | Equipment for tissue characterization |
US5837728A (en) | 1995-01-27 | 1998-11-17 | Molecular Design International | 9-cis retinoic acid esters and amides and uses thereof |
US5697366A (en) | 1995-01-27 | 1997-12-16 | Optical Sensors Incorporated | In situ calibration system for sensors located in a physiologic line |
US5676820A (en) | 1995-02-03 | 1997-10-14 | New Mexico State University Technology Transfer Corp. | Remote electrochemical sensor |
US5568806A (en) | 1995-02-16 | 1996-10-29 | Minimed Inc. | Transcutaneous sensor insertion set |
US5586553A (en) | 1995-02-16 | 1996-12-24 | Minimed Inc. | Transcutaneous sensor insertion set |
NZ306051A (en) | 1995-03-10 | 1999-11-29 | Meso Scale Technologies Llc | Testing using electrochemiluminescence |
US5582697A (en) | 1995-03-17 | 1996-12-10 | Matsushita Electric Industrial Co., Ltd. | Biosensor, and a method and a device for quantifying a substrate in a sample liquid using the same |
US5571401A (en) | 1995-03-27 | 1996-11-05 | California Institute Of Technology | Sensor arrays for detecting analytes in fluids |
US5786439A (en) | 1996-10-24 | 1998-07-28 | Minimed Inc. | Hydrophilic, swellable coatings for biosensors |
TW393498B (en) | 1995-04-04 | 2000-06-11 | Novartis Ag | The preparation and use of Polysiloxane-comprising perfluoroalkyl ethers |
DE29624309U1 (en) * | 1995-04-04 | 2002-01-03 | Commonwealth Scientific And Industrial Research Organisation, Campbell | Duration supporting lenses |
WO1996032076A1 (en) | 1995-04-11 | 1996-10-17 | Baxter Internatonal Inc. | Tissue implant systems |
FR2733104B1 (en) | 1995-04-12 | 1997-06-06 | Droz Francois | SMALL-DIMENSIONAL ANSWERING MACHINE AND METHOD FOR MANUFACTURING SUCH ANSWERING MACHINES |
US5620579A (en) | 1995-05-05 | 1997-04-15 | Bayer Corporation | Apparatus for reduction of bias in amperometric sensors |
US6060640A (en) | 1995-05-19 | 2000-05-09 | Baxter International Inc. | Multiple-layer, formed-in-place immunoisolation membrane structures for implantation of cells in host tissue |
US5584813A (en) | 1995-06-07 | 1996-12-17 | Minimed Inc. | Subcutaneous injection set |
US5626561A (en) | 1995-06-07 | 1997-05-06 | Gore Hybrid Technologies, Inc. | Implantable containment apparatus for a therapeutical device and method for loading and reloading the device therein |
US5743262A (en) | 1995-06-07 | 1998-04-28 | Masimo Corporation | Blood glucose monitoring system |
AU6251196A (en) | 1995-06-07 | 1996-12-30 | Gore Hybrid Technologies, Inc. | An implantable containment apparatus for a therapeutical dev ice and method for loading and reloading the device therein |
US5656707A (en) | 1995-06-16 | 1997-08-12 | Regents Of The University Of Minnesota | Highly cross-linked polymeric supports |
US5840148A (en) | 1995-06-30 | 1998-11-24 | Bio Medic Data Systems, Inc. | Method of assembly of implantable transponder |
US5995860A (en) | 1995-07-06 | 1999-11-30 | Thomas Jefferson University | Implantable sensor and system for measurement and control of blood constituent levels |
US5700902A (en) | 1995-07-27 | 1997-12-23 | Circe Biomedical, Inc. | Block copolymers |
US6001471A (en) | 1995-08-11 | 1999-12-14 | 3M Innovative Properties Company | Removable adhesive tape with controlled sequential release |
AUPN487495A0 (en) | 1995-08-18 | 1995-09-14 | Cardiac Crc Nominees Pty Limited | A multipolar transmural probe |
US5989409A (en) | 1995-09-11 | 1999-11-23 | Cygnus, Inc. | Method for glucose sensing |
JP2000501069A (en) | 1995-09-21 | 2000-02-02 | ノバルティス・アクチエンゲゼルシャフト | Polymer-bound fluorophores as photoion sensors |
CZ89998A3 (en) | 1995-09-26 | 1998-08-12 | Ameron International Corporation | Polysiloxane-polyurethane material |
US5628890A (en) * | 1995-09-27 | 1997-05-13 | Medisense, Inc. | Electrochemical sensor |
US5972199A (en) | 1995-10-11 | 1999-10-26 | E. Heller & Company | Electrochemical analyte sensors using thermostable peroxidase |
US5665222A (en) | 1995-10-11 | 1997-09-09 | E. Heller & Company | Soybean peroxidase electrochemical sensor |
US6689265B2 (en) | 1995-10-11 | 2004-02-10 | Therasense, Inc. | Electrochemical analyte sensors using thermostable soybean peroxidase |
US5855613A (en) | 1995-10-13 | 1999-01-05 | Islet Sheet Medical, Inc. | Retrievable bioartificial implants having dimensions allowing rapid diffusion of oxygen and rapid biological response to physiological change |
CN1086939C (en) | 1995-10-16 | 2002-07-03 | 普罗克特和甘保尔公司 | Conditioning shampoos containing polyalkylene glycol |
WO1997014406A2 (en) | 1995-10-16 | 1997-04-24 | The Procter & Gamble Company | Conditioning shampoo compositions having improved stability |
JP3592416B2 (en) | 1995-10-31 | 2004-11-24 | 晃敏 吉田 | Measuring device for intraocular substances |
WO1997017607A1 (en) | 1995-11-08 | 1997-05-15 | The Victoria University Of Manchester | Membrane for chemical and biosensors |
US6002954A (en) | 1995-11-22 | 1999-12-14 | The Regents Of The University Of California | Detection of biological molecules using boronate-based chemical amplification and optical sensors |
US6063637A (en) | 1995-12-13 | 2000-05-16 | California Institute Of Technology | Sensors for sugars and other metal binding analytes |
ATE223933T1 (en) | 1995-12-22 | 2002-09-15 | Novartis Erfind Verwalt Gmbh | POLYURETHANES FROM POLYSILOXANE-POLYOL MACROMERS |
EP0812150A4 (en) * | 1995-12-28 | 1999-03-10 | Cygnus Therapeutic Systems | Continuous monitoring of physiological analyte |
US5588560A (en) | 1996-01-11 | 1996-12-31 | Dow Corning Corporation | Ergonomeric dispenser for viscous materials |
US5795453A (en) | 1996-01-23 | 1998-08-18 | Gilmartin; Markas A. T. | Electrodes and metallo isoindole ringed compounds |
US5833603A (en) | 1996-03-13 | 1998-11-10 | Lipomatrix, Inc. | Implantable biosensing transponder |
US5932299A (en) | 1996-04-23 | 1999-08-03 | Katoot; Mohammad W. | Method for modifying the surface of an object |
US6407195B2 (en) | 1996-04-25 | 2002-06-18 | 3M Innovative Properties Company | Tackified polydiorganosiloxane oligourea segmented copolymers and a process for making same |
US6022463A (en) * | 1996-05-16 | 2000-02-08 | Sendx Medical, Inc. | Sensors with subminiature through holes |
US5776324A (en) | 1996-05-17 | 1998-07-07 | Encelle, Inc. | Electrochemical biosensors |
US5964261A (en) * | 1996-05-29 | 1999-10-12 | Baxter International Inc. | Implantation assembly |
US5914182A (en) | 1996-06-03 | 1999-06-22 | Gore Hybrid Technologies, Inc. | Materials and methods for the immobilization of bioactive species onto polymeric substrates |
JP2943700B2 (en) | 1996-07-10 | 1999-08-30 | 日本電気株式会社 | Biosensor |
US5707502A (en) | 1996-07-12 | 1998-01-13 | Chiron Diagnostics Corporation | Sensors for measuring analyte concentrations and methods of making same |
US6325978B1 (en) | 1998-08-04 | 2001-12-04 | Ntc Technology Inc. | Oxygen monitoring and apparatus |
US5703359A (en) | 1996-07-29 | 1997-12-30 | Leybold Inficon, Inc. | Composite membrane and support assembly |
US6054142A (en) | 1996-08-01 | 2000-04-25 | Cyto Therapeutics, Inc. | Biocompatible devices with foam scaffolds |
US5804048A (en) | 1996-08-15 | 1998-09-08 | Via Medical Corporation | Electrode assembly for assaying glucose |
US6018013A (en) * | 1996-09-03 | 2000-01-25 | Nkk Corporation | Coating composition and method for producing precoated steel sheets |
US5885566A (en) * | 1996-09-25 | 1999-03-23 | University Of Florida | Surface modified surgical instruments, medical devices, implants, contact lenses and the like |
US5963132A (en) | 1996-10-11 | 1999-10-05 | Avid Indentification Systems, Inc. | Encapsulated implantable transponder |
DE19642453C2 (en) | 1996-10-15 | 1998-07-23 | Bosch Gmbh Robert | Arrangement for gas sensor electrodes |
US6001068A (en) | 1996-10-22 | 1999-12-14 | Terumo Kabushiki Kaisha | Guide wire having tubular connector with helical slits |
TW381971B (en) | 1996-10-30 | 2000-02-11 | Mercury Diagnostics Inc | Synchronized analyte testing system |
JP4451931B2 (en) | 1996-11-12 | 2010-04-14 | ホアットマン,インコーポレーテッド | Hydrophilic polymer phase change membrane |
JP2000507457A (en) | 1996-11-14 | 2000-06-20 | ラジオメーター・メディカル・アクティーゼルスカブ | Enzyme sensor |
WO1998024358A2 (en) | 1996-12-04 | 1998-06-11 | Enact Health Management Systems | System for downloading and reporting medical information |
US6071249A (en) | 1996-12-06 | 2000-06-06 | Abbott Laboratories | Method and apparatus for obtaining blood for diagnostic tests |
US5811487A (en) | 1996-12-16 | 1998-09-22 | Dow Corning Corporation | Thickening silicones with elastomeric silicone polyethers |
US5964993A (en) | 1996-12-19 | 1999-10-12 | Implanted Biosystems Inc. | Glucose sensor |
US5914026A (en) | 1997-01-06 | 1999-06-22 | Implanted Biosystems Inc. | Implantable sensor employing an auxiliary electrode |
US6093172A (en) | 1997-02-05 | 2000-07-25 | Minimed Inc. | Injector for a subcutaneous insertion set |
US5851197A (en) | 1997-02-05 | 1998-12-22 | Minimed Inc. | Injector for a subcutaneous infusion set |
US6607509B2 (en) | 1997-12-31 | 2003-08-19 | Medtronic Minimed, Inc. | Insertion device for an insertion set and method of using the same |
US5977241A (en) | 1997-02-26 | 1999-11-02 | Integument Technologies, Inc. | Polymer and inorganic-organic hybrid composites and methods for making same |
US20050033132A1 (en) | 1997-03-04 | 2005-02-10 | Shults Mark C. | Analyte measuring device |
US7657297B2 (en) | 2004-05-03 | 2010-02-02 | Dexcom, Inc. | Implantable analyte sensor |
US9155496B2 (en) | 1997-03-04 | 2015-10-13 | Dexcom, Inc. | Low oxygen in vivo analyte sensor |
US7192450B2 (en) * | 2003-05-21 | 2007-03-20 | Dexcom, Inc. | Porous membranes for use with implantable devices |
US7899511B2 (en) | 2004-07-13 | 2011-03-01 | Dexcom, Inc. | Low oxygen in vivo analyte sensor |
US6558321B1 (en) | 1997-03-04 | 2003-05-06 | Dexcom, Inc. | Systems and methods for remote monitoring and modulation of medical devices |
US6001067A (en) | 1997-03-04 | 1999-12-14 | Shults; Mark C. | Device and method for determining analyte levels |
FR2760962B1 (en) | 1997-03-20 | 1999-05-14 | Sillonville Francis Klefstad | REMOTE MEDICAL ASSISTANCE AND SURVEILLANCE SYSTEM |
US6270455B1 (en) | 1997-03-28 | 2001-08-07 | Health Hero Network, Inc. | Networked system for interactive communications and remote monitoring of drug delivery |
US5961451A (en) | 1997-04-07 | 1999-10-05 | Motorola, Inc. | Noninvasive apparatus having a retaining member to retain a removable biosensor |
US6059946A (en) | 1997-04-14 | 2000-05-09 | Matsushita Electric Industrial Co., Ltd. | Biosensor |
US5944661A (en) | 1997-04-16 | 1999-08-31 | Giner, Inc. | Potential and diffusion controlled solid electrolyte sensor for continuous measurement of very low levels of transdermal alcohol |
US6115634A (en) | 1997-04-30 | 2000-09-05 | Medtronic, Inc. | Implantable medical device and method of manufacture |
US5779665A (en) | 1997-05-08 | 1998-07-14 | Minimed Inc. | Transdermal introducer assembly |
US6018033A (en) * | 1997-05-13 | 2000-01-25 | Purdue Research Foundation | Hydrophilic, hydrophobic, and thermoreversible saccharide gels and forms, and methods for producing same |
US7267665B2 (en) | 1999-06-03 | 2007-09-11 | Medtronic Minimed, Inc. | Closed loop system for controlling insulin infusion |
US5954643A (en) | 1997-06-09 | 1999-09-21 | Minimid Inc. | Insertion set for a transcutaneous sensor |
US6558351B1 (en) | 1999-06-03 | 2003-05-06 | Medtronic Minimed, Inc. | Closed loop system for controlling insulin infusion |
US6093167A (en) | 1997-06-16 | 2000-07-25 | Medtronic, Inc. | System for pancreatic stimulation and glucose measurement |
JP2002505008A (en) | 1997-06-16 | 2002-02-12 | エラン コーポレーション ピーエルシー | Methods for calibrating and testing sensors for in vivo measurement of analytes and devices for use in such methods |
US6013711A (en) | 1997-06-18 | 2000-01-11 | Ck Witco Corporation | Hydrophilic polysiloxane compositions |
US6309526B1 (en) | 1997-07-10 | 2001-10-30 | Matsushita Electric Industrial Co., Ltd. | Biosensor |
US5823802A (en) | 1997-07-30 | 1998-10-20 | General Motors Corporation | Electrical connector with combination seal and contact member |
US6584335B1 (en) | 1997-08-09 | 2003-06-24 | Roche Diagnostics Gmbh | Analytical device for in vivo analysis in the body of a patient |
US6731976B2 (en) | 1997-09-03 | 2004-05-04 | Medtronic, Inc. | Device and method to measure and communicate body parameters |
US5917346A (en) | 1997-09-12 | 1999-06-29 | Alfred E. Mann Foundation | Low power current to frequency converter circuit for use in implantable sensors |
US6259937B1 (en) * | 1997-09-12 | 2001-07-10 | Alfred E. Mann Foundation | Implantable substrate sensor |
US5999848A (en) | 1997-09-12 | 1999-12-07 | Alfred E. Mann Foundation | Daisy chainable sensors and stimulators for implantation in living tissue |
US6117290A (en) | 1997-09-26 | 2000-09-12 | Pepex Biomedical, Llc | System and method for measuring a bioanalyte such as lactate |
US6268161B1 (en) | 1997-09-30 | 2001-07-31 | M-Biotech, Inc. | Biosensor |
US7115884B1 (en) | 1997-10-06 | 2006-10-03 | Trustees Of Tufts College | Self-encoding fiber optic sensor |
US6585763B1 (en) | 1997-10-14 | 2003-07-01 | Vascusense, Inc. | Implantable therapeutic device and method |
US6409674B1 (en) | 1998-09-24 | 2002-06-25 | Data Sciences International, Inc. | Implantable sensor with wireless communication |
US6088608A (en) | 1997-10-20 | 2000-07-11 | Alfred E. Mann Foundation | Electrochemical sensor and integrity tests therefor |
US6104280A (en) | 1997-10-20 | 2000-08-15 | Micron Technology, Inc. | Method of manufacturing and testing an electronic device, and an electronic device |
US6119028A (en) | 1997-10-20 | 2000-09-12 | Alfred E. Mann Foundation | Implantable enzyme-based monitoring systems having improved longevity due to improved exterior surfaces |
US6579690B1 (en) | 1997-12-05 | 2003-06-17 | Therasense, Inc. | Blood analyte monitoring through subcutaneous measurement |
US6893552B1 (en) | 1997-12-29 | 2005-05-17 | Arrowhead Center, Inc. | Microsensors for glucose and insulin monitoring |
CA2575064C (en) | 1997-12-31 | 2010-02-02 | Medtronic Minimed, Inc. | Insertion device for an insertion set and method of using the same |
US6030827A (en) * | 1998-01-23 | 2000-02-29 | I-Stat Corporation | Microfabricated aperture-based sensor |
US7052131B2 (en) | 2001-09-10 | 2006-05-30 | J&J Vision Care, Inc. | Biomedical devices containing internal wetting agents |
US6134461A (en) | 1998-03-04 | 2000-10-17 | E. Heller & Company | Electrochemical analyte |
US6103033A (en) | 1998-03-04 | 2000-08-15 | Therasense, Inc. | Process for producing an electrochemical biosensor |
US5928130A (en) | 1998-03-16 | 1999-07-27 | Schmidt; Bruno | Apparatus and method for implanting radioactive seeds in tissue |
US5904708A (en) | 1998-03-19 | 1999-05-18 | Medtronic, Inc. | System and method for deriving relative physiologic signals |
GB9805896D0 (en) | 1998-03-20 | 1998-05-13 | Eglise David | Remote analysis system |
JP3104672B2 (en) | 1998-03-31 | 2000-10-30 | 日本電気株式会社 | Current detection type sensor element and method of manufacturing the same |
US6091975A (en) | 1998-04-01 | 2000-07-18 | Alza Corporation | Minimally invasive detecting device |
US6074775A (en) | 1998-04-02 | 2000-06-13 | The Procter & Gamble Company | Battery having a built-in controller |
US6534711B1 (en) | 1998-04-14 | 2003-03-18 | The Goodyear Tire & Rubber Company | Encapsulation package and method of packaging an electronic circuit module |
US6241863B1 (en) | 1998-04-27 | 2001-06-05 | Harold G. Monbouquette | Amperometric biosensors based on redox enzymes |
US6223080B1 (en) * | 1998-04-29 | 2001-04-24 | Medtronic, Inc. | Power consumption reduction in medical devices employing multiple digital signal processors and different supply voltages |
US6949816B2 (en) | 2003-04-21 | 2005-09-27 | Motorola, Inc. | Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same |
WO1999057734A1 (en) | 1998-05-04 | 1999-11-11 | Gamut Technology, Inc. | Flexible armored communication cable and method of manufacture |
DE69910003T2 (en) * | 1998-05-13 | 2004-04-22 | Cygnus, Inc., Redwood City | MONITORING PHYSIOLOGICAL ANALYSIS |
CA2311487C (en) * | 1998-05-13 | 2004-02-10 | Cygnus, Inc. | Signal processing for measurement of physiological analytes |
ATE246356T1 (en) * | 1998-05-13 | 2003-08-15 | Cygnus Therapeutic Systems | DEVICE FOR PREDICTING PHYSIOLOGICAL MEASUREMENTS |
US5969076A (en) | 1998-05-15 | 1999-10-19 | Bausch & Lomb Incorporated | Thermoplastic silicone-containing hydrogels |
US6129757A (en) | 1998-05-18 | 2000-10-10 | Scimed Life Systems | Implantable members for receiving therapeutically useful compositions |
US6702972B1 (en) * | 1998-06-09 | 2004-03-09 | Diametrics Medical Limited | Method of making a kink-resistant catheter |
US7344499B1 (en) * | 1998-06-10 | 2008-03-18 | Georgia Tech Research Corporation | Microneedle device for extraction and sensing of bodily fluids |
JP3293556B2 (en) | 1998-06-12 | 2002-06-17 | 住友電装株式会社 | Protector |
US6294281B1 (en) | 1998-06-17 | 2001-09-25 | Therasense, Inc. | Biological fuel cell and method |
US6290839B1 (en) | 1998-06-23 | 2001-09-18 | Clinical Micro Sensors, Inc. | Systems for electrophoretic transport and detection of analytes |
EP0967788A2 (en) | 1998-06-26 | 1999-12-29 | Hewlett-Packard Company | Dynamic generation of multi-resolution and tile-based images from flat compressed images |
US6495023B1 (en) | 1998-07-09 | 2002-12-17 | Michigan State University | Electrochemical methods for generation of a biological proton motive force and pyridine nucleotide cofactor regeneration |
US6272382B1 (en) * | 1998-07-31 | 2001-08-07 | Advanced Bionics Corporation | Fully implantable cochlear implant system |
US6558320B1 (en) | 2000-01-20 | 2003-05-06 | Medtronic Minimed, Inc. | Handheld personal data assistant (PDA) with a medical device and method of using the same |
US6248067B1 (en) | 1999-02-05 | 2001-06-19 | Minimed Inc. | Analyte sensor and holter-type monitor system and method of using the same |
JP3267936B2 (en) * | 1998-08-26 | 2002-03-25 | 松下電器産業株式会社 | Biosensor |
AU770909B2 (en) | 1998-08-26 | 2004-03-04 | Sensors For Medicine And Science, Inc. | Optical-based sensing devices |
US6039913A (en) * | 1998-08-27 | 2000-03-21 | Novartis Ag | Process for the manufacture of an ophthalmic molding |
US6740518B1 (en) | 1998-09-17 | 2004-05-25 | Clinical Micro Sensors, Inc. | Signal detection techniques for the detection of analytes |
US6254586B1 (en) * | 1998-09-25 | 2001-07-03 | Minimed Inc. | Method and kit for supplying a fluid to a subcutaneous placement site |
ATE241933T1 (en) * | 1998-09-30 | 2003-06-15 | Cygnus Therapeutic Systems | METHOD AND DEVICE FOR PREDICTING PHYSIOLOGICAL MEASUREMENT VALUES |
US6591125B1 (en) | 2000-06-27 | 2003-07-08 | Therasense, Inc. | Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator |
EP2229879A1 (en) | 1998-10-08 | 2010-09-22 | Medtronic MiniMed, Inc. | Telemetered characteristic monitor system |
US6338790B1 (en) | 1998-10-08 | 2002-01-15 | Therasense, Inc. | Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator |
EP0995805B9 (en) | 1998-10-23 | 2004-01-28 | Pierre Beuret | Heat treatment installation for a batch of metallic workpieces |
US6329488B1 (en) | 1998-11-10 | 2001-12-11 | C. R. Bard, Inc. | Silane copolymer coatings |
WO2000030698A1 (en) | 1998-11-20 | 2000-06-02 | University Of Connecticut | Apparatus and method for control of tissue/implant interactions |
US6066083A (en) | 1998-11-27 | 2000-05-23 | Syntheon Llc | Implantable brachytherapy device having at least partial deactivation capability |
WO2000033065A1 (en) | 1998-12-02 | 2000-06-08 | Ut-Battelle, Llc | In vivo biosensor apparatus and method of use |
WO2000038570A1 (en) | 1998-12-31 | 2000-07-06 | Ball Semiconductor, Inc. | Miniature implanted orthopedic sensors |
US6169155B1 (en) * | 1999-01-14 | 2001-01-02 | Dow Corning Corporation | Silicone gel composition and silicone gel produced therefrom |
US6309384B1 (en) | 1999-02-01 | 2001-10-30 | Adiana, Inc. | Method and apparatus for tubal occlusion |
US6424847B1 (en) | 1999-02-25 | 2002-07-23 | Medtronic Minimed, Inc. | Glucose monitor calibration methods |
ATE552771T1 (en) | 1999-02-25 | 2012-04-15 | Medtronic Minimed Inc | TEST PLUG AND CABLE FOR GLUCOSE MONITORING DEVICE |
US6230059B1 (en) * | 1999-03-17 | 2001-05-08 | Medtronic, Inc. | Implantable monitor |
KR100342165B1 (en) * | 1999-03-25 | 2002-06-27 | 배병우 | Solid-State Type Micro Reference Electrode with Self-Diagnostic Function |
US6285897B1 (en) | 1999-04-07 | 2001-09-04 | Endonetics, Inc. | Remote physiological monitoring system |
WO2000059376A1 (en) | 1999-04-07 | 2000-10-12 | Endonetics, Inc. | Implantable monitoring probe |
JP2002541441A (en) * | 1999-04-07 | 2002-12-03 | スペクトルクス,インコーポレイティド | Analytical device for continuous measurement of fluid properties |
US6223083B1 (en) * | 1999-04-16 | 2001-04-24 | Medtronic, Inc. | Receiver employing digital filtering for use with an implantable medical device |
US6368658B1 (en) * | 1999-04-19 | 2002-04-09 | Scimed Life Systems, Inc. | Coating medical devices using air suspension |
US6615078B1 (en) | 1999-04-22 | 2003-09-02 | Cygnus, Inc. | Methods and devices for removing interfering species |
US6475750B1 (en) | 1999-05-11 | 2002-11-05 | M-Biotech, Inc. | Glucose biosensor |
US6300002B1 (en) | 1999-05-13 | 2001-10-09 | Moltech Power Systems, Inc. | Notched electrode and method of making same |
US6546268B1 (en) | 1999-06-02 | 2003-04-08 | Ball Semiconductor, Inc. | Glucose sensor |
CN1243821C (en) | 1999-06-10 | 2006-03-01 | 松下电器产业株式会社 | Electrochemical device for moving particles covered with protein |
AU5747100A (en) | 1999-06-18 | 2001-01-09 | Therasense, Inc. | Mass transport limited in vivo analyte sensor |
GB2351153B (en) | 1999-06-18 | 2003-03-26 | Abbott Lab | Electrochemical sensor for analysis of liquid samples |
US7247138B2 (en) | 1999-07-01 | 2007-07-24 | Medtronic Minimed, Inc. | Reusable analyte sensor site and method of using the same |
US6368274B1 (en) | 1999-07-01 | 2002-04-09 | Medtronic Minimed, Inc. | Reusable analyte sensor site and method of using the same |
US6413393B1 (en) | 1999-07-07 | 2002-07-02 | Minimed, Inc. | Sensor including UV-absorbing polymer and method of manufacture |
DE19935063A1 (en) * | 1999-07-28 | 2001-02-01 | Basf Ag | Graft polymers as gas hydrate inhibitors |
US6471689B1 (en) | 1999-08-16 | 2002-10-29 | Thomas Jefferson University | Implantable drug delivery catheter system with capillary interface |
US6346583B1 (en) | 1999-08-25 | 2002-02-12 | General Electric Company | Polar solvent compatible polyethersiloxane elastomers |
US6358557B1 (en) * | 1999-09-10 | 2002-03-19 | Sts Biopolymers, Inc. | Graft polymerization of substrate surfaces |
US6312469B1 (en) | 1999-09-13 | 2001-11-06 | Medtronic Inc. | Lamina prosthesis for delivery of medical treatment |
US6343225B1 (en) | 1999-09-14 | 2002-01-29 | Implanted Biosystems, Inc. | Implantable glucose sensor |
AU7582200A (en) | 1999-09-15 | 2001-04-17 | Midtronic Minimed, Inc. | Glucose sensing molecules having selected fluorescent properties |
US6541107B1 (en) | 1999-10-25 | 2003-04-01 | Dow Corning Corporation | Nanoporous silicone resins having low dielectric constants |
US6616819B1 (en) | 1999-11-04 | 2003-09-09 | Therasense, Inc. | Small volume in vitro analyte sensor and methods |
JP3426549B2 (en) | 1999-11-12 | 2003-07-14 | 本田技研工業株式会社 | Exhaust pipe connection structure |
US8268143B2 (en) | 1999-11-15 | 2012-09-18 | Abbott Diabetes Care Inc. | Oxygen-effect free analyte sensor |
US6670115B1 (en) | 1999-11-24 | 2003-12-30 | Biotronic Technologies, Inc. | Devices and methods for detecting analytes using electrosensor having capture reagent |
DE19956822B4 (en) | 1999-11-25 | 2004-01-29 | Siemens Ag | Method for determining the NOx concentration |
GB9928071D0 (en) * | 1999-11-29 | 2000-01-26 | Polybiomed Ltd | Blood compatible medical articles |
US6612984B1 (en) | 1999-12-03 | 2003-09-02 | Kerr, Ii Robert A. | System and method for collecting and transmitting medical data |
US7369635B2 (en) | 2000-01-21 | 2008-05-06 | Medtronic Minimed, Inc. | Rapid discrimination preambles and methods for using the same |
US20020016535A1 (en) * | 2000-01-28 | 2002-02-07 | Martin W. Blake | Subcutaneous glucose measurement device |
AU2001236848A1 (en) | 2000-02-10 | 2001-08-20 | Minimed, Inc. | Improved analyte sensor and method of making the same |
US7003336B2 (en) | 2000-02-10 | 2006-02-21 | Medtronic Minimed, Inc. | Analyte sensor method of making the same |
US6484045B1 (en) | 2000-02-10 | 2002-11-19 | Medtronic Minimed, Inc. | Analyte sensor and method of making the same |
US6895263B2 (en) | 2000-02-23 | 2005-05-17 | Medtronic Minimed, Inc. | Real time self-adjusting calibration algorithm |
US6303670B1 (en) | 2000-02-25 | 2001-10-16 | Nippon Paper Industries Co., Ltd. | Cellulose based coating composition curable with ultraviolet ray |
ES2420279T3 (en) | 2000-03-02 | 2013-08-23 | Microchips, Inc. | Microfabricated devices and methods for storage and selective exposure of chemicals |
US6551496B1 (en) | 2000-03-03 | 2003-04-22 | Ysi Incorporated | Microstructured bilateral sensor |
US6733655B1 (en) | 2000-03-08 | 2004-05-11 | Oliver W. H. Davies | Measurement of substances in liquids |
US6498941B1 (en) | 2000-03-09 | 2002-12-24 | Advanced Cardiovascular Systems, Inc. | Catheter based probe and method of using same for detecting chemical analytes |
US6365670B1 (en) | 2000-03-10 | 2002-04-02 | Wacker Silicones Corporation | Organopolysiloxane gels for use in cosmetics |
AU2001260130A1 (en) | 2000-03-17 | 2001-09-24 | F. Hoffmann-La Roche Ag | Implantable analyte sensor |
US6405066B1 (en) | 2000-03-17 | 2002-06-11 | The Regents Of The University Of California | Implantable analyte sensor |
US6612111B1 (en) | 2000-03-27 | 2003-09-02 | Lifescan, Inc. | Method and device for sampling and analyzing interstitial fluid and whole blood samples |
WO2001088524A1 (en) | 2000-05-12 | 2001-11-22 | Therasense, Inc. | Electrodes with multilayer membranes and methods of using and making the electrodes |
US7181261B2 (en) | 2000-05-15 | 2007-02-20 | Silver James H | Implantable, retrievable, thrombus minimizing sensors |
US7769420B2 (en) | 2000-05-15 | 2010-08-03 | Silver James H | Sensors for detecting substances indicative of stroke, ischemia, or myocardial infarction |
US6442413B1 (en) * | 2000-05-15 | 2002-08-27 | James H. Silver | Implantable sensor |
US6885883B2 (en) | 2000-05-16 | 2005-04-26 | Cygnus, Inc. | Methods for improving performance and reliability of biosensors |
US6459917B1 (en) | 2000-05-22 | 2002-10-01 | Ashok Gowda | Apparatus for access to interstitial fluid, blood, or blood plasma components |
WO2001090733A1 (en) | 2000-05-23 | 2001-11-29 | Radiometer Medical A/S | A sensor membrane, a method for the preparation thereof, a sensor and a layered membrane structure for such sensor |
US6773565B2 (en) | 2000-06-22 | 2004-08-10 | Kabushiki Kaisha Riken | NOx sensor |
KR100409017B1 (en) | 2000-06-23 | 2003-12-06 | 주식회사 엘지화학 | Multi-component composite membrane and method for preparing the same |
US6400974B1 (en) | 2000-06-29 | 2002-06-04 | Sensors For Medicine And Science, Inc. | Implanted sensor processing system and method for processing implanted sensor output |
US6569521B1 (en) | 2000-07-06 | 2003-05-27 | 3M Innovative Properties Company | Stretch releasing pressure sensitive adhesive tape and articles |
US6477392B1 (en) | 2000-07-14 | 2002-11-05 | Futrex Inc. | Calibration of near infrared quantitative measurement device using optical measurement cross-products |
WO2002015299A1 (en) | 2000-08-12 | 2002-02-21 | Lg Chemical Co., Ltd. | Multi-component composite film method for preparing the same |
WO2002017210A2 (en) | 2000-08-18 | 2002-02-28 | Cygnus, Inc. | Formulation and manipulation of databases of analyte and associated values |
US6553241B2 (en) | 2000-08-31 | 2003-04-22 | Mallinckrodt Inc. | Oximeter sensor with digital memory encoding sensor expiration data |
US6793789B2 (en) | 2000-09-30 | 2004-09-21 | Geun Sig Cha | Reference electrode with a polymeric reference electrode membrane |
FR2815199B1 (en) | 2000-10-10 | 2003-01-17 | Canon Kk | CIRCULAR TURBOCODING METHODS OF LARGE MINIMUM DISTANCE, AND SYSTEMS FOR IMPLEMENTING THE SAME |
DE10060852A1 (en) | 2000-12-06 | 2002-06-20 | Hexal Ag | Active ingredient-impermeable cover layer or removable protective layer of a transdermal therapeutic system containing absorbents and channel formers |
JP2002189015A (en) | 2000-12-20 | 2002-07-05 | Sankyo Co Ltd | Reaction-current measuring method by enzyme electrode |
US6742635B2 (en) | 2000-12-20 | 2004-06-01 | Jr286 Inc. | Sports bag including an attached mat |
US6642015B2 (en) | 2000-12-29 | 2003-11-04 | Minimed Inc. | Hydrophilic polymeric material for coating biosensors |
US6560471B1 (en) | 2001-01-02 | 2003-05-06 | Therasense, Inc. | Analyte monitoring device and methods of use |
WO2002053193A2 (en) | 2001-01-02 | 2002-07-11 | The Charles Stark Draper Laboratory, Inc. | Tissue engineering of three-dimensional vascularized using microfabricated polymer assembly technology |
US6793802B2 (en) | 2001-01-04 | 2004-09-21 | Tyson Bioresearch, Inc. | Biosensors having improved sample application and measuring properties and uses thereof |
US6666821B2 (en) * | 2001-01-08 | 2003-12-23 | Medtronic, Inc. | Sensor system |
US7078582B2 (en) | 2001-01-17 | 2006-07-18 | 3M Innovative Properties Company | Stretch removable adhesive articles and methods |
US6547839B2 (en) | 2001-01-23 | 2003-04-15 | Skc Co., Ltd. | Method of making an electrochemical cell by the application of polysiloxane onto at least one of the cell components |
US6510329B2 (en) | 2001-01-24 | 2003-01-21 | Datex-Ohmeda, Inc. | Detection of sensor off conditions in a pulse oximeter |
US7014610B2 (en) | 2001-02-09 | 2006-03-21 | Medtronic, Inc. | Echogenic devices and methods of making and using such devices |
WO2002064027A2 (en) | 2001-02-15 | 2002-08-22 | The Regents Of The University Of California | Membrane and electrode structure for implantable sensor |
KR100406690B1 (en) * | 2001-03-05 | 2003-11-21 | 주식회사 엘지화학 | Electrochemical device using multicomponent composite membrane film |
US6952603B2 (en) | 2001-03-16 | 2005-10-04 | Roche Diagnostics Operations, Inc. | Subcutaneous analyte sensor |
FR2822383B1 (en) | 2001-03-23 | 2004-12-17 | Perouse Lab | PROSTHESIS FOR PLASTIC RECONSTRUCTION WITH IMPROVED HYDROPHILICITY PROPERTIES, AND METHOD FOR OBTAINING SAME |
US6576102B1 (en) | 2001-03-23 | 2003-06-10 | Virotek, L.L.C. | Electrochemical sensor and method thereof |
US6454710B1 (en) | 2001-04-11 | 2002-09-24 | Motorola, Inc. | Devices and methods for monitoring an analyte |
US6528584B2 (en) | 2001-04-12 | 2003-03-04 | The University Of Akron | Multi-component polymeric networks containing poly(ethylene glycol) |
DE10119036C1 (en) * | 2001-04-18 | 2002-12-12 | Disetronic Licensing Ag | Immersion sensor for measuring the concentration of an analyte using an oxidase |
US6613379B2 (en) | 2001-05-08 | 2003-09-02 | Isense Corp. | Implantable analyte sensor |
US6932894B2 (en) | 2001-05-15 | 2005-08-23 | Therasense, Inc. | Biosensor membranes composed of polymers containing heterocyclic nitrogens |
US20020177763A1 (en) | 2001-05-22 | 2002-11-28 | Burns David W. | Integrated lancets and methods |
US6960466B2 (en) | 2001-05-31 | 2005-11-01 | Instrumentation Laboratory Company | Composite membrane containing a cross-linked enzyme matrix for a biosensor |
US6501976B1 (en) | 2001-06-12 | 2002-12-31 | Lifescan, Inc. | Percutaneous biological fluid sampling and analyte measurement devices and methods |
US6837988B2 (en) | 2001-06-12 | 2005-01-04 | Lifescan, Inc. | Biological fluid sampling and analyte measurement devices and methods |
US6802827B2 (en) | 2001-06-26 | 2004-10-12 | Stig O. Andersson | Hypodermic implant device |
GB0115793D0 (en) | 2001-06-28 | 2001-08-22 | Univ Cranfield | A novel mediator for electrochemical detection |
JP2005505429A (en) | 2001-06-28 | 2005-02-24 | マイクロチップス・インコーポレーテッド | Method for hermetically sealing a microchip reservoir device |
US6569309B2 (en) | 2001-07-05 | 2003-05-27 | Asahi Kasei Kabushiki Kaisha | Fuel cell type reactor and method for producing a chemical compound by using the same |
US7150737B2 (en) | 2001-07-13 | 2006-12-19 | Sci/Med Life Systems, Inc. | Methods and apparatuses for navigating the subarachnoid space |
US7481759B2 (en) | 2001-08-03 | 2009-01-27 | Cardiac Pacemakers, Inc. | Systems and methods for treatment of coronary artery disease |
US7456025B2 (en) | 2001-08-28 | 2008-11-25 | Porex Corporation | Sintered polymer membrane for analyte detection device |
US7025760B2 (en) | 2001-09-07 | 2006-04-11 | Medtronic Minimed, Inc. | Method and system for non-vascular sensor implantation |
EP1426758B1 (en) | 2001-09-11 | 2011-08-10 | ARKRAY, Inc. | Instrument for measuring a concentration of a component in a liquid sample |
US6830562B2 (en) | 2001-09-27 | 2004-12-14 | Unomedical A/S | Injector device for placing a subcutaneous infusion set |
US6802957B2 (en) | 2001-09-28 | 2004-10-12 | Marine Biological Laboratory | Self-referencing enzyme-based microsensor and method of use |
US6809507B2 (en) | 2001-10-23 | 2004-10-26 | Medtronic Minimed, Inc. | Implantable sensor electrodes and electronic circuitry |
US6705833B2 (en) | 2001-11-15 | 2004-03-16 | Hewlett-Packard Development Company, L.P. | Airflow flapper valve |
JP2005510608A (en) | 2001-11-21 | 2005-04-21 | ポレックス,コーポレーション | Individual hydrophilic-hydrophobic porous material and method for producing the same |
US20050101841A9 (en) | 2001-12-04 | 2005-05-12 | Kimberly-Clark Worldwide, Inc. | Healthcare networks with biosensors |
US7248906B2 (en) * | 2001-12-17 | 2007-07-24 | Danfoss A/S | Method and device for monitoring analyte concentration by optical detection |
US6952604B2 (en) | 2001-12-21 | 2005-10-04 | Becton, Dickinson And Company | Minimally-invasive system and method for monitoring analyte levels |
US6872927B2 (en) | 2001-12-26 | 2005-03-29 | Lambda Technologies, Inc. | Systems and methods for processing pathogen-contaminated mail pieces |
US20050027182A1 (en) | 2001-12-27 | 2005-02-03 | Uzair Siddiqui | System for monitoring physiological characteristics |
US7399277B2 (en) | 2001-12-27 | 2008-07-15 | Medtronic Minimed, Inc. | System for monitoring physiological characteristics |
US7018336B2 (en) | 2001-12-27 | 2006-03-28 | Medtronic Minimed, Inc. | Implantable sensor flush sleeve |
US7956525B2 (en) | 2003-05-16 | 2011-06-07 | Nanomix, Inc. | Flexible nanostructure electronic devices |
US20050154272A1 (en) | 2002-01-23 | 2005-07-14 | Danfoss A/S | Method and device for monitoring analyte concentration by use of differential osmotic pressure measurement |
EP1474038A1 (en) | 2002-01-29 | 2004-11-10 | Sicel Technologies, Inc. | Implantable sensor housing and fabrication methods |
US7828728B2 (en) | 2003-07-25 | 2010-11-09 | Dexcom, Inc. | Analyte sensor |
US7379765B2 (en) * | 2003-07-25 | 2008-05-27 | Dexcom, Inc. | Oxygen enhancing membrane systems for implantable devices |
US8364229B2 (en) | 2003-07-25 | 2013-01-29 | Dexcom, Inc. | Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise |
US7613491B2 (en) | 2002-05-22 | 2009-11-03 | Dexcom, Inc. | Silicone based membranes for use in implantable glucose sensors |
US20030157409A1 (en) | 2002-02-21 | 2003-08-21 | Sui-Yang Huang | Polymer lithium battery with ionic electrolyte |
DE10211051A1 (en) | 2002-03-13 | 2003-10-02 | Fresenius Medical Care De Gmbh | Capillary membrane and device for producing the same |
US7470250B2 (en) | 2002-03-22 | 2008-12-30 | Novo Nordisk A/S | Apparatus for automatic insertion of a solid medicine |
ES2357318T3 (en) | 2002-03-22 | 2011-04-25 | Animas Technologies Llc | IMPROVEMENT OF THE PERFORMANCE OF AN ANALYTIC MONITORING DEVICE. |
US6936006B2 (en) | 2002-03-22 | 2005-08-30 | Novo Nordisk, A/S | Atraumatic insertion of a subcutaneous device |
GB2388898B (en) | 2002-04-02 | 2005-10-05 | Inverness Medical Ltd | Integrated sample testing meter |
US20030225437A1 (en) | 2002-04-04 | 2003-12-04 | Ferguson Patrick J. | Device for retaining material |
US7133712B2 (en) | 2002-04-05 | 2006-11-07 | Eyelab Group, Llc | Method and apparatus for non-invasive monitoring of blood substances using self-sampled tears |
AU2003221808A1 (en) | 2002-04-05 | 2003-10-27 | Powerzyme, Inc. | Analyte sensor |
US20070227907A1 (en) | 2006-04-04 | 2007-10-04 | Rajiv Shah | Methods and materials for controlling the electrochemistry of analyte sensors |
US7153265B2 (en) | 2002-04-22 | 2006-12-26 | Medtronic Minimed, Inc. | Anti-inflammatory biosensor for reduced biofouling and enhanced sensor performance |
US7813780B2 (en) | 2005-12-13 | 2010-10-12 | Medtronic Minimed, Inc. | Biosensors and methods for making and using them |
FI118172B (en) | 2002-04-22 | 2007-08-15 | Inion Ltd | Surgical implant |
US6743635B2 (en) | 2002-04-25 | 2004-06-01 | Home Diagnostics, Inc. | System and methods for blood glucose sensing |
US7008979B2 (en) * | 2002-04-30 | 2006-03-07 | Hydromer, Inc. | Coating composition for multiple hydrophilic applications |
EP1499705A2 (en) | 2002-05-01 | 2005-01-26 | Massachusetts Institute of Technology | Microfermentors for rapid screening and analysis of biochemical processes |
US7166235B2 (en) | 2002-05-09 | 2007-01-23 | The Procter & Gamble Company | Compositions comprising anionic functionalized polyorganosiloxanes for hydrophobically modifying surfaces and enhancing delivery of active agents to surfaces treated therewith |
NZ536331A (en) | 2002-05-09 | 2007-08-31 | Hemoteq Ag | Compounds and method for coating surfaces of medical devices such as stents in a haemocompatible manner |
US6801041B2 (en) | 2002-05-14 | 2004-10-05 | Abbott Laboratories | Sensor having electrode for determining the rate of flow of a fluid |
US7226978B2 (en) | 2002-05-22 | 2007-06-05 | Dexcom, Inc. | Techniques to improve polyurethane membranes for implantable glucose sensors |
US20060258761A1 (en) | 2002-05-22 | 2006-11-16 | Robert Boock | Silicone based membranes for use in implantable glucose sensors |
WO2003101862A1 (en) | 2002-05-31 | 2003-12-11 | Dow Corning Toray Silicone Co.,Ltd. | Cartridge for moisture-curable sealant |
US20030225324A1 (en) | 2002-06-03 | 2003-12-04 | Anderson Edward J. | Noninvasive detection of a physiologic Parameter within a body tissue of a patient |
US8996090B2 (en) * | 2002-06-03 | 2015-03-31 | Exostat Medical, Inc. | Noninvasive detection of a physiologic parameter within a body tissue of a patient |
WO2004003556A1 (en) | 2002-06-28 | 2004-01-08 | november Aktiengesellschaft Gesellschaft für Molekulare Medizin | Electrochemical detection method and device |
WO2004007756A1 (en) * | 2002-07-12 | 2004-01-22 | Novo Nordisk A/S | Minimising calibration problems of in vivo glucose sensors |
US20040068230A1 (en) | 2002-07-24 | 2004-04-08 | Medtronic Minimed, Inc. | System for providing blood glucose measurements to an infusion device |
US20040106741A1 (en) | 2002-09-17 | 2004-06-03 | Kriesel Joshua W. | Nanofilm compositions with polymeric components |
AU2003294229A1 (en) | 2002-10-11 | 2004-05-04 | Case Western Reserve University | Sliver type autonomous biosensors |
CN1859943B (en) | 2002-10-11 | 2010-09-29 | 贝克顿·迪金森公司 | System for controlling concentration of glucose in a patient |
US20050272989A1 (en) | 2004-06-04 | 2005-12-08 | Medtronic Minimed, Inc. | Analyte sensors and methods for making and using them |
US20040074785A1 (en) | 2002-10-18 | 2004-04-22 | Holker James D. | Analyte sensors and methods for making them |
US6737158B1 (en) | 2002-10-30 | 2004-05-18 | Gore Enterprise Holdings, Inc. | Porous polymeric membrane toughened composites |
KR100482285B1 (en) | 2002-10-30 | 2005-04-14 | 한국전자통신연구원 | Fluid-type multiple electrochemical system and the preparation thereof |
US7381184B2 (en) | 2002-11-05 | 2008-06-03 | Abbott Diabetes Care Inc. | Sensor inserter assembly |
EP1567559A4 (en) | 2002-11-12 | 2008-04-16 | Polymer Technology Group Inc | Control of polymer surface molecular architecture via amphipathic endgroups |
US20050032246A1 (en) * | 2002-11-14 | 2005-02-10 | Mcmaster University | Method of immobilizing membrane-associated molecules |
US20040111144A1 (en) * | 2002-12-06 | 2004-06-10 | Lawin Laurie R. | Barriers for polymeric coatings |
US20050266582A1 (en) | 2002-12-16 | 2005-12-01 | Modlin Douglas N | Microfluidic system with integrated permeable membrane |
US20040120848A1 (en) | 2002-12-20 | 2004-06-24 | Maria Teodorczyk | Method for manufacturing a sterilized and calibrated biosensor-based medical device |
US20040127818A1 (en) | 2002-12-27 | 2004-07-01 | Roe Steven N. | Precision depth control lancing tip |
EP1578262A4 (en) | 2002-12-31 | 2007-12-05 | Therasense Inc | Continuous glucose monitoring system and methods of use |
US20040133131A1 (en) | 2003-01-03 | 2004-07-08 | Kuhn David L. | In vivo ruminant health sensor |
US7120483B2 (en) | 2003-01-13 | 2006-10-10 | Isense Corporation | Methods for analyte sensing and measurement |
US7288609B1 (en) * | 2003-03-04 | 2007-10-30 | Advanced Cardiovascular Systems, Inc. | Coatings for drug delivery devices based on poly (orthoesters) |
US6965791B1 (en) | 2003-03-26 | 2005-11-15 | Sorenson Medical, Inc. | Implantable biosensor system, apparatus and method |
US7070580B2 (en) | 2003-04-01 | 2006-07-04 | Unomedical A/S | Infusion device and an adhesive sheet material and a release liner |
US7134999B2 (en) | 2003-04-04 | 2006-11-14 | Dexcom, Inc. | Optimized sensor geometry for an implantable glucose sensor |
US6797877B1 (en) | 2003-04-28 | 2004-09-28 | Jonn Maneely Company | Electrical metallic tube, coupling, and connector apparatus and method |
US7279174B2 (en) | 2003-05-08 | 2007-10-09 | Advanced Cardiovascular Systems, Inc. | Stent coatings comprising hydrophilic additives |
EP1626748B1 (en) | 2003-05-13 | 2012-07-11 | Medtronic, Inc. | Moisture curable materials for delivery of agents, methods, and medical devices |
EP1982772A1 (en) | 2003-05-16 | 2008-10-22 | Cinvention Ag | Bio-compatible coated medical implants |
US7687586B2 (en) * | 2003-05-21 | 2010-03-30 | Isense Corporation | Biosensor membrane material |
US7875293B2 (en) * | 2003-05-21 | 2011-01-25 | Dexcom, Inc. | Biointerface membranes incorporating bioactive agents |
US6789634B1 (en) | 2003-05-28 | 2004-09-14 | Smith International, Inc | Self-lubricating elastomeric seal with polarized graphite |
ES2614628T3 (en) | 2003-06-06 | 2017-06-01 | Human Auto Cell Limited | Matrix, cell implant, procedure for its preparation and use |
US20040254433A1 (en) | 2003-06-12 | 2004-12-16 | Bandis Steven D. | Sensor introducer system, apparatus and method |
US20050118344A1 (en) | 2003-12-01 | 2005-06-02 | Pacetti Stephen D. | Temperature controlled crimping |
DK200301027A (en) | 2003-07-04 | 2005-01-05 | Nkt Res & Innovation As | A method of producing interpenetrating polymer networks (IPNs) and applications of IPNs |
US8425926B2 (en) * | 2003-07-16 | 2013-04-23 | Yongxing Qiu | Antimicrobial medical devices |
WO2005010518A1 (en) | 2003-07-23 | 2005-02-03 | Dexcom, Inc. | Rolled electrode array and its method for manufacture |
WO2005019795A2 (en) | 2003-07-25 | 2005-03-03 | Dexcom, Inc. | Electrochemical sensors including electrode systems with increased oxygen generation |
US7467003B2 (en) | 2003-12-05 | 2008-12-16 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US20050176136A1 (en) | 2003-11-19 | 2005-08-11 | Dexcom, Inc. | Afinity domain for analyte sensor |
US7366556B2 (en) | 2003-12-05 | 2008-04-29 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
EP1649260A4 (en) | 2003-07-25 | 2010-07-07 | Dexcom Inc | Electrode systems for electrochemical sensors |
US7424318B2 (en) | 2003-12-05 | 2008-09-09 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US20050056552A1 (en) | 2003-07-25 | 2005-03-17 | Simpson Peter C. | Increasing bias for oxygen production in an electrode system |
WO2007120442A2 (en) | 2003-07-25 | 2007-10-25 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US7460898B2 (en) | 2003-12-05 | 2008-12-02 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
DE10335131A1 (en) | 2003-07-31 | 2005-02-24 | Blue Membranes Gmbh | Porous carbon moldings, e.g. for catalyst support; insulant, tube membrane, ex or in vivo cell culture substrate or scaffold or implant, are made by molding carbonizable polymer and removing filler or partial oxidation to form pores |
US8060173B2 (en) | 2003-08-01 | 2011-11-15 | Dexcom, Inc. | System and methods for processing analyte sensor data |
US8845536B2 (en) | 2003-08-01 | 2014-09-30 | Dexcom, Inc. | Transcutaneous analyte sensor |
US7774145B2 (en) | 2003-08-01 | 2010-08-10 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8275437B2 (en) | 2003-08-01 | 2012-09-25 | Dexcom, Inc. | Transcutaneous analyte sensor |
US7591801B2 (en) | 2004-02-26 | 2009-09-22 | Dexcom, Inc. | Integrated delivery device for continuous glucose sensor |
US7172075B1 (en) * | 2003-08-08 | 2007-02-06 | Accord Partner Limited | Defect free composite membranes, method for producing said membranes and use of the same |
US7287043B2 (en) * | 2003-08-21 | 2007-10-23 | International Business Machines Corporation | System and method for asynchronous data replication without persistence for distributed computing |
US7920906B2 (en) | 2005-03-10 | 2011-04-05 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US7723099B2 (en) | 2003-09-10 | 2010-05-25 | Abbott Point Of Care Inc. | Immunoassay device with immuno-reference electrode |
US7433727B2 (en) | 2003-09-24 | 2008-10-07 | Legacy Good Samaritan Hospital And Medical Center | Implantable biosensor |
WO2005032362A2 (en) * | 2003-09-30 | 2005-04-14 | Roche Diagnostics Gmbh | Sensor with increaseed biocompatibility |
US20050090607A1 (en) | 2003-10-28 | 2005-04-28 | Dexcom, Inc. | Silicone composition for biocompatible membrane |
EP1678491B1 (en) | 2003-10-31 | 2010-03-10 | Lifescan Scotland Ltd | A meter for use in a method of reducing interferences in an electrochemical sensor using two different applied potentials |
US7299082B2 (en) | 2003-10-31 | 2007-11-20 | Abbott Diabetes Care, Inc. | Method of calibrating an analyte-measurement device, and associated methods, devices and systems |
US20090012376A1 (en) | 2003-11-03 | 2009-01-08 | Children's Medical Center Corporation | Continuous Analyte Monitor and Method of Using Same |
US7329413B1 (en) | 2003-11-06 | 2008-02-12 | Advanced Cardiovascular Systems, Inc. | Coatings for drug delivery devices having gradient of hydration and methods for fabricating thereof |
US20050158356A1 (en) | 2003-11-20 | 2005-07-21 | Angiotech International Ag | Implantable sensors and implantable pumps and anti-scarring agents |
US7524455B2 (en) | 2003-11-24 | 2009-04-28 | General Electric Company | Methods for deposition of sensor regions onto optical storage media substrates and resulting devices |
US7807722B2 (en) | 2003-11-26 | 2010-10-05 | Advanced Cardiovascular Systems, Inc. | Biobeneficial coating compositions and methods of making and using thereof |
EP2239566B1 (en) | 2003-12-05 | 2014-04-23 | DexCom, Inc. | Calibration techniques for a continuous analyte sensor |
US8287453B2 (en) | 2003-12-05 | 2012-10-16 | Dexcom, Inc. | Analyte sensor |
WO2005057173A2 (en) | 2003-12-08 | 2005-06-23 | Dexcom, Inc. | Systems and methods for improving electrochemical analyte sensors |
US8147426B2 (en) | 2003-12-31 | 2012-04-03 | Nipro Diagnostics, Inc. | Integrated diagnostic test system |
EP1711548A1 (en) | 2004-01-08 | 2006-10-18 | Dutch Polymer Institute | Polyurethanes, polyurethaneureas and polyureas and use thereof |
US20050182451A1 (en) | 2004-01-12 | 2005-08-18 | Adam Griffin | Implantable device with improved radio frequency capabilities |
US7637868B2 (en) | 2004-01-12 | 2009-12-29 | Dexcom, Inc. | Composite material for implantable device |
US8165651B2 (en) | 2004-02-09 | 2012-04-24 | Abbott Diabetes Care Inc. | Analyte sensor, and associated system and method employing a catalytic agent |
US7699964B2 (en) | 2004-02-09 | 2010-04-20 | Abbott Diabetes Care Inc. | Membrane suitable for use in an analyte sensor, analyte sensor, and associated method |
AU2005220150A1 (en) | 2004-02-13 | 2005-09-15 | The University Of North Carolina At Chapel Hill | Functional materials and novel methods for the fabrication of microfluidic devices |
WO2005084257A2 (en) | 2004-02-26 | 2005-09-15 | Vpn Solutions, Llc | Composite thin-film glucose sensor |
AU2005216592B8 (en) * | 2004-02-28 | 2009-06-04 | Hemoteq Ag | Biocompatible coating, method, and use of medical surfaces |
DE602004011688D1 (en) | 2004-03-05 | 2008-03-20 | Egomedical Swiss Ag | ANALYSIS TEST SYSTEM FOR DETERMINING THE CONCENTRATION OF AN ANALYTE IN A PHYSIOLOGICAL LIQUID |
US20050245799A1 (en) | 2004-05-03 | 2005-11-03 | Dexcom, Inc. | Implantable analyte sensor |
US8277713B2 (en) | 2004-05-03 | 2012-10-02 | Dexcom, Inc. | Implantable analyte sensor |
US7241266B2 (en) | 2004-05-20 | 2007-07-10 | Digital Angel Corporation | Transducer for embedded bio-sensor using body energy as a power source |
US7118667B2 (en) | 2004-06-02 | 2006-10-10 | Jin Po Lee | Biosensors having improved sample application and uses thereof |
WO2005124348A1 (en) | 2004-06-09 | 2005-12-29 | Becton, Dickinson And Company | Multianalyte sensor |
US20060015020A1 (en) | 2004-07-06 | 2006-01-19 | Dexcom, Inc. | Systems and methods for manufacture of an analyte-measuring device including a membrane system |
US7246551B2 (en) | 2004-07-09 | 2007-07-24 | Protedyne Corporation | Liquid handling device with surface features at a seal |
US8452368B2 (en) | 2004-07-13 | 2013-05-28 | Dexcom, Inc. | Transcutaneous analyte sensor |
US20070045902A1 (en) | 2004-07-13 | 2007-03-01 | Brauker James H | Analyte sensor |
US20060016700A1 (en) | 2004-07-13 | 2006-01-26 | Dexcom, Inc. | Transcutaneous analyte sensor |
US7713574B2 (en) | 2004-07-13 | 2010-05-11 | Dexcom, Inc. | Transcutaneous analyte sensor |
US7857760B2 (en) | 2004-07-13 | 2010-12-28 | Dexcom, Inc. | Analyte sensor |
US7783333B2 (en) | 2004-07-13 | 2010-08-24 | Dexcom, Inc. | Transcutaneous medical device with variable stiffness |
US20080242961A1 (en) | 2004-07-13 | 2008-10-02 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8962165B2 (en) | 2006-05-02 | 2015-02-24 | The Penn State Research Foundation | Materials and configurations for scalable microbial fuel cells |
EP1784249A2 (en) | 2004-08-16 | 2007-05-16 | Novo Nordisk A/S | Multiphase biocompatible semi-permeable membrane for biosensors |
US7534330B2 (en) | 2004-08-24 | 2009-05-19 | University Of South Florida | Epoxy enhanced polymer membrane to increase durability of biosensors |
US7244443B2 (en) * | 2004-08-31 | 2007-07-17 | Advanced Cardiovascular Systems, Inc. | Polymers of fluorinated monomers and hydrophilic monomers |
US7229471B2 (en) | 2004-09-10 | 2007-06-12 | Advanced Cardiovascular Systems, Inc. | Compositions containing fast-leaching plasticizers for improved performance of medical devices |
US20060065527A1 (en) * | 2004-09-24 | 2006-03-30 | Sendx Medical, Inc. | Polymeric reference electrode |
US9011831B2 (en) * | 2004-09-30 | 2015-04-21 | Advanced Cardiovascular Systems, Inc. | Methacrylate copolymers for medical devices |
US20070299409A1 (en) | 2004-11-09 | 2007-12-27 | Angiotech Biocoatings Corp. | Antimicrobial Needle Coating For Extended Infusion |
JP2008522670A (en) * | 2004-12-06 | 2008-07-03 | サーモディクス,インコーポレイティド | Multifunctional medical article |
CN100367906C (en) * | 2004-12-08 | 2008-02-13 | 圣美迪诺医疗科技(湖州)有限公司 | Endermic implantating biological sensors |
US7604818B2 (en) | 2004-12-22 | 2009-10-20 | Advanced Cardiovascular Systems, Inc. | Polymers of fluorinated monomers and hydrocarbon monomers |
US20060142525A1 (en) | 2004-12-29 | 2006-06-29 | Bausch & Lomb Incorporated | Hydrogel copolymers for biomedical devices |
CA2593070A1 (en) | 2004-12-29 | 2006-07-06 | Bausch & Lomb Incorporated | Polysiloxane prepolymers for biomedical devices |
CN101094879B (en) | 2004-12-29 | 2011-08-10 | 博士伦公司 | Polysiloxane prepolymers for biomedical devices |
CA2590386A1 (en) | 2004-12-30 | 2006-07-06 | Cinvention Ag | Combination comprising an agent providing a signal, an implant material and a drug |
DE602006010509D1 (en) | 2005-01-17 | 2009-12-31 | Biomodics | PROCESS FOR COATING A POLYMER SURFACE WITH A POLYMERIC COATING AND OBJECT, CONTAINING A POLYMER-COATED POLYMER |
JP4810099B2 (en) * | 2005-01-20 | 2011-11-09 | 株式会社メニコン | Transparent gel and contact lens comprising the same |
US20060171980A1 (en) | 2005-02-01 | 2006-08-03 | Helmus Michael N | Implantable or insertable medical devices having optimal surface energy |
US7241586B2 (en) | 2005-02-17 | 2007-07-10 | Medtronic Minimed, Inc. | Polypeptide formulations and methods for making, using and characterizing them |
US8133178B2 (en) | 2006-02-22 | 2012-03-13 | Dexcom, Inc. | Analyte sensor |
US20090076360A1 (en) | 2007-09-13 | 2009-03-19 | Dexcom, Inc. | Transcutaneous analyte sensor |
EP1869414A4 (en) | 2005-03-29 | 2010-07-28 | Arkal Medical Inc | Devices, systems, methods and tools for continuous glucose monitoring |
US20060252027A1 (en) | 2005-05-05 | 2006-11-09 | Petisce James R | Cellulosic-based resistance domain for an analyte sensor |
WO2006110193A2 (en) | 2005-04-08 | 2006-10-19 | Dexcom, Inc. | Cellulosic-based interference domain for an analyte sensor |
US8744546B2 (en) | 2005-05-05 | 2014-06-03 | Dexcom, Inc. | Cellulosic-based resistance domain for an analyte sensor |
JP5022621B2 (en) | 2005-04-27 | 2012-09-12 | 三星エスディアイ株式会社 | Cylindrical lithium secondary battery |
US20060249446A1 (en) | 2005-05-04 | 2006-11-09 | Gary Yeager | Solvent-resistant composite membrane composition |
US20060263839A1 (en) | 2005-05-17 | 2006-11-23 | Isense Corporation | Combined drug delivery and analyte sensor apparatus |
US20060275859A1 (en) | 2005-05-17 | 2006-12-07 | Kjaer Thomas | Enzyme sensor including a water-containing spacer layer |
US7959791B2 (en) | 2005-05-17 | 2011-06-14 | Radiometer Medical Aps | Enzyme sensor with a cover membrane layer covered by a hydrophilic polymer |
US7725148B2 (en) | 2005-09-23 | 2010-05-25 | Medtronic Minimed, Inc. | Sensor with layered electrodes |
US20070123963A1 (en) | 2005-11-29 | 2007-05-31 | Peter Krulevitch | Method for producing flexible, stretchable, and implantable high-density microelectrode arrays |
US20070129524A1 (en) | 2005-12-06 | 2007-06-07 | Sunkara Hari B | Thermoplastic polyurethanes comprising polytrimethylene ether soft segments |
US7759408B2 (en) | 2005-12-21 | 2010-07-20 | Bausch & Lomb Incorporated | Silicon-containing monomers end-capped with polymerizable cationic hydrophilic groups |
US20070155851A1 (en) | 2005-12-30 | 2007-07-05 | Azaam Alli | Silicone containing polymers formed from non-reactive silicone containing prepolymers |
US20070161769A1 (en) | 2006-01-06 | 2007-07-12 | Schorzman Derek A | Polymerizable silicon-containing monomer bearing pendant cationic hydrophilic groups |
EP2004796B1 (en) | 2006-01-18 | 2015-04-08 | DexCom, Inc. | Membranes for an analyte sensor |
CA2577760A1 (en) | 2006-02-27 | 2007-08-27 | Tyco Healthcare Group Lp | Pressurized dip coating system |
JP5183495B2 (en) | 2006-02-27 | 2013-04-17 | エドワーズ ライフサイエンシーズ コーポレイション | Method and apparatus using flex circuit technology for reference electrode channel fabrication |
DE602007006433D1 (en) | 2006-02-27 | 2010-06-24 | Edwards Lifesciences Corp | METHOD FOR PRODUCING AN ACTIVE ELECTRODE USING FLEXIBLE CIRCUIT TECHNOLOGY AND FLEXIBLE CIRCUIT COMPRISING SUCH ELECTRODE |
US20070202562A1 (en) | 2006-02-27 | 2007-08-30 | Curry Kenneth M | Flux limiting membrane for intravenous amperometric biosensor |
US20070233013A1 (en) | 2006-03-31 | 2007-10-04 | Schoenberg Stephen J | Covers for tissue engaging members |
US7960447B2 (en) | 2006-04-13 | 2011-06-14 | Bausch & Lomb Incorporated | Cationic end-capped siloxane prepolymer for reduced cross-link density |
US7468397B2 (en) * | 2006-06-30 | 2008-12-23 | Bausch & Lomb Incorporated | Polymerizable siloxane-quaternary amine copolymers |
AU2007276777A1 (en) | 2006-07-25 | 2008-01-31 | Glumetrics, Inc. | Flourescent dyes for use in glucose sensing |
US8114023B2 (en) * | 2006-07-28 | 2012-02-14 | Legacy Emanuel Hospital & Health Center | Analyte sensing and response system |
US7871456B2 (en) * | 2006-08-10 | 2011-01-18 | The Regents Of The University Of California | Membranes with controlled permeability to polar and apolar molecules in solution and methods of making same |
ATE519423T1 (en) | 2006-09-27 | 2011-08-15 | Univ Connecticut | IMPLANTABLE BIOSENSOR AND METHOD OF USE |
US20080076897A1 (en) * | 2006-09-27 | 2008-03-27 | Kunzler Jay F | Pendant end-capped low modulus cationic siloxanyls |
JP2008086855A (en) | 2006-09-29 | 2008-04-17 | Fujifilm Corp | Biochemical instrument |
US7831287B2 (en) | 2006-10-04 | 2010-11-09 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US20080143014A1 (en) | 2006-12-18 | 2008-06-19 | Man-Wing Tang | Asymmetric Gas Separation Membranes with Superior Capabilities for Gas Separation |
US8088097B2 (en) | 2007-11-21 | 2012-01-03 | Glumetrics, Inc. | Use of an equilibrium intravascular sensor to achieve tight glycemic control |
US7751863B2 (en) | 2007-02-06 | 2010-07-06 | Glumetrics, Inc. | Optical determination of ph and glucose |
EP2120680A2 (en) | 2007-02-06 | 2009-11-25 | Glumetrics, Inc. | Optical systems and methods for rationmetric measurement of blood glucose concentration |
EP2122334B1 (en) | 2007-02-06 | 2018-01-24 | Medtronic Minimed, Inc. | Method for polymerizing a monomer solution within a cavity to generate a smooth polymer surface |
ATE506368T1 (en) | 2007-05-01 | 2011-05-15 | Glumetrics Inc | PYRIDINE BORONIC ACID QUENCHER FOR USE IN ANALYTICAL SENSORS |
EP2150814A2 (en) * | 2007-05-10 | 2010-02-10 | Glumetrics, Inc. | Device and methods for calibrating analyte sensors |
EP2162057A1 (en) | 2007-05-10 | 2010-03-17 | Glumetrics, Inc. | Equilibrium non-consuming fluorescence sensor for real time intravascular glucose measurement |
US7691917B2 (en) | 2007-06-14 | 2010-04-06 | Bausch & Lomb Incorporated | Silcone-containing prepolymers |
US20090004243A1 (en) * | 2007-06-29 | 2009-01-01 | Pacetti Stephen D | Biodegradable triblock copolymers for implantable devices |
WO2009009756A2 (en) * | 2007-07-11 | 2009-01-15 | Glumetrics, Inc. | Polyviologen boronic acid quenchers for use in analyte sensors |
EP2181160B1 (en) * | 2007-08-06 | 2016-05-11 | Medtronic Minimed, Inc. | Hpts-mono cys-ma polymerizable fluorescent dyes for use in analyte sensors |
US8417312B2 (en) | 2007-10-25 | 2013-04-09 | Dexcom, Inc. | Systems and methods for processing sensor data |
US8396528B2 (en) | 2008-03-25 | 2013-03-12 | Dexcom, Inc. | Analyte sensor |
US20090242399A1 (en) | 2008-03-25 | 2009-10-01 | Dexcom, Inc. | Analyte sensor |
US20090247856A1 (en) | 2008-03-28 | 2009-10-01 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
WO2009129186A2 (en) | 2008-04-17 | 2009-10-22 | Glumetrics, Inc. | Sensor for percutaneous intravascular deployment without an indwelling cannula |
CN101342465B (en) | 2008-09-01 | 2011-11-09 | 天津工业大学 | Hollow fiber porous film and process for producing same |
-
2001
- 2001-07-27 US US09/916,711 patent/US20030032874A1/en not_active Abandoned
-
2002
- 2002-07-26 AT AT02748255T patent/ATE332666T1/en not_active IP Right Cessation
- 2002-07-26 EP EP02748255A patent/EP1411823B1/en not_active Expired - Lifetime
- 2002-07-26 DE DE60213096T patent/DE60213096D1/en not_active Expired - Fee Related
- 2002-07-26 JP JP2003516370A patent/JP4295615B2/en not_active Expired - Lifetime
- 2002-07-26 WO PCT/US2002/023903 patent/WO2003011131A2/en active IP Right Grant
- 2002-07-26 AU AU2002317584A patent/AU2002317584A1/en not_active Abandoned
- 2002-07-26 EP EP06112130A patent/EP1669022A3/en not_active Withdrawn
-
2004
- 2004-12-22 US US11/021,162 patent/US7471972B2/en not_active Expired - Lifetime
-
2008
- 2008-10-28 US US12/260,017 patent/US8509871B2/en active Active
-
2013
- 2013-07-16 US US13/943,622 patent/US9328371B2/en not_active Expired - Fee Related
-
2016
- 2016-03-02 US US15/059,086 patent/US9804114B2/en not_active Expired - Lifetime
-
2017
- 2017-09-29 US US15/720,329 patent/US20180024086A1/en not_active Abandoned
Patent Citations (100)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3933593A (en) * | 1971-02-22 | 1976-01-20 | Beckman Instruments, Inc. | Rate sensing batch analysis method |
US4076656A (en) * | 1971-11-30 | 1978-02-28 | Debell & Richardson, Inc. | Method of producing porous plastic materials |
US4073713A (en) * | 1975-09-24 | 1978-02-14 | The Yellow Springs Instrument Company, Inc. | Membrane for enzyme electrodes |
US4197840A (en) * | 1975-11-06 | 1980-04-15 | Bbc Brown Boveri & Company, Limited | Permanent magnet device for implantation |
US4324257A (en) * | 1978-02-20 | 1982-04-13 | U.S. Philips Corporation | Device for the transcutaneous measurement of the partial oxygen pressure in blood |
US4259540A (en) * | 1978-05-30 | 1981-03-31 | Bell Telephone Laboratories, Incorporated | Filled cables |
US4255500A (en) * | 1979-03-29 | 1981-03-10 | General Electric Company | Vibration resistant electrochemical cell having deformed casing and method of making same |
US4374013A (en) * | 1980-03-05 | 1983-02-15 | Enfors Sven Olof | Oxygen stabilized enzyme electrode |
US4431507A (en) * | 1981-01-14 | 1984-02-14 | Matsushita Electric Industrial Co., Ltd. | Enzyme electrode |
US4436094A (en) * | 1981-03-09 | 1984-03-13 | Evreka, Inc. | Monitor for continuous in vivo measurement of glucose concentration |
US4431004A (en) * | 1981-10-27 | 1984-02-14 | Bessman Samuel P | Implantable glucose sensor |
US4508680A (en) * | 1982-06-08 | 1985-04-02 | National Aerospace Laboratory Of Science And Technology Agency | Method of manufacturing a rocket combustion chamber |
US4650547A (en) * | 1983-05-19 | 1987-03-17 | The Regents Of The University Of California | Method and membrane applicable to implantable sensor |
US4577642A (en) * | 1985-02-27 | 1986-03-25 | Medtronic, Inc. | Drug dispensing body implantable lead employing molecular sieves and methods of fabrication |
US4721677A (en) * | 1985-09-18 | 1988-01-26 | Children's Hospital Medical Center | Implantable gas-containing biosensor and method for measuring an analyte such as glucose |
US4890620A (en) * | 1985-09-20 | 1990-01-02 | The Regents Of The University Of California | Two-dimensional diffusion glucose substrate sensing electrode |
US4803243A (en) * | 1986-03-26 | 1989-02-07 | Shin-Etsu Chemical Co., Ltd. | Block-graft copolymer |
US4994167A (en) * | 1986-04-15 | 1991-02-19 | Markwell Medical Institute, Inc. | Biological fluid measuring device |
US5304468A (en) * | 1986-08-13 | 1994-04-19 | Lifescan, Inc. | Reagent test strip and apparatus for determination of blood glucose |
US5002572A (en) * | 1986-09-11 | 1991-03-26 | Picha George J | Biological implant with textured surface |
US5007929B1 (en) * | 1986-11-04 | 1994-08-30 | Medical Products Dev | Open-cell silicone-elastomer medical implant |
US5007929A (en) * | 1986-11-04 | 1991-04-16 | Medical Products Development, Inc. | Open-cell, silicone-elastomer medical implant |
US4902294A (en) * | 1986-12-03 | 1990-02-20 | Olivier Gosserez | Implantable mammary prosthesis adapted to combat the formation of a retractile shell |
US4984929A (en) * | 1987-01-08 | 1991-01-15 | Julius Blum Gesellschaft M.B.H. | Fitting for fastening the rail member of a drawer |
US4810470A (en) * | 1987-06-19 | 1989-03-07 | Miles Inc. | Volume independent diagnostic device |
US4823808A (en) * | 1987-07-06 | 1989-04-25 | Clegg Charles T | Method for control of obesity, overweight and eating disorders |
US4986671A (en) * | 1989-04-12 | 1991-01-22 | Luxtron Corporation | Three-parameter optical fiber sensor and system |
US5101814A (en) * | 1989-08-11 | 1992-04-07 | Palti Yoram Prof | System for monitoring and controlling blood glucose |
US5190041A (en) * | 1989-08-11 | 1993-03-02 | Palti Yoram Prof | System for monitoring and controlling blood glucose |
US5282848A (en) * | 1990-08-28 | 1994-02-01 | Meadox Medicals, Inc. | Self-supporting woven vascular graft |
US5380536A (en) * | 1990-10-15 | 1995-01-10 | The Board Of Regents, The University Of Texas System | Biocompatible microcapsules |
US5733336A (en) * | 1990-10-31 | 1998-03-31 | Baxter International, Inc. | Ported tissue implant systems and methods of using same |
US5593440A (en) * | 1990-10-31 | 1997-01-14 | Baxter International Inc. | Tissue implant systems and methods for sustaining viable high cell densities within a host |
US5713888A (en) * | 1990-10-31 | 1998-02-03 | Baxter International, Inc. | Tissue implant systems |
US5741330A (en) * | 1990-10-31 | 1998-04-21 | Baxter International, Inc. | Close vascularization implant material |
US6514718B2 (en) * | 1991-03-04 | 2003-02-04 | Therasense, Inc. | Subcutaneous glucose electrode |
US5397848A (en) * | 1991-04-25 | 1995-03-14 | Allergan, Inc. | Enhancing the hydrophilicity of silicone polymers |
US5706807A (en) * | 1991-05-13 | 1998-01-13 | Applied Medical Research | Sensor device covered with foam membrane |
US5496453A (en) * | 1991-05-17 | 1996-03-05 | Kyoto Daiichi Kagaku Co., Ltd. | Biosensor and method of quantitative analysis using the same |
US5491474A (en) * | 1991-05-22 | 1996-02-13 | Polar Electro Oy | Telemetric transmitter unit |
US5384028A (en) * | 1992-08-28 | 1995-01-24 | Nec Corporation | Biosensor with a data memory |
US5307263A (en) * | 1992-11-17 | 1994-04-26 | Raya Systems, Inc. | Modular microprocessor-based health monitoring system |
US5285513A (en) * | 1992-11-30 | 1994-02-08 | At&T Bell Laboratories | Optical fiber cable provided with stabilized waterblocking material |
US5299571A (en) * | 1993-01-22 | 1994-04-05 | Eli Lilly And Company | Apparatus and method for implantation of sensors |
US5497772A (en) * | 1993-11-19 | 1996-03-12 | Alfred E. Mann Foundation For Scientific Research | Glucose monitoring system |
US5593852A (en) * | 1993-12-02 | 1997-01-14 | Heller; Adam | Subcutaneous glucose electrode |
US5391250A (en) * | 1994-03-15 | 1995-02-21 | Minimed Inc. | Method of fabricating thin film sensors |
US5390671A (en) * | 1994-03-15 | 1995-02-21 | Minimed Inc. | Transcutaneous sensor insertion set |
US5484404A (en) * | 1994-05-06 | 1996-01-16 | Alfred E. Mann Foundation For Scientific Research | Replaceable catheter system for physiological sensors, tissue stimulating electrodes and/or implantable fluid delivery systems |
US5482473A (en) * | 1994-05-09 | 1996-01-09 | Minimed Inc. | Flex circuit connector |
US5624537A (en) * | 1994-09-20 | 1997-04-29 | The University Of British Columbia - University-Industry Liaison Office | Biosensor and interface membrane |
US5590651A (en) * | 1995-01-17 | 1997-01-07 | Temple University - Of The Commonwealth System Of Higher Education | Breathable liquid elimination analysis |
US5607565A (en) * | 1995-03-27 | 1997-03-04 | Coulter Corporation | Apparatus for measuring analytes in a fluid sample |
US5882494A (en) * | 1995-03-27 | 1999-03-16 | Minimed, Inc. | Polyurethane/polyurea compositions containing silicone for biosensor membranes |
US5611900A (en) * | 1995-07-20 | 1997-03-18 | Michigan State University | Microbiosensor used in-situ |
US5735273A (en) * | 1995-09-12 | 1998-04-07 | Cygnus, Inc. | Chemical signal-impermeable mask |
US5711861A (en) * | 1995-11-22 | 1998-01-27 | Ward; W. Kenneth | Device for monitoring changes in analyte concentration |
US6011984A (en) * | 1995-11-22 | 2000-01-04 | Minimed Inc. | Detection of biological molecules using chemical amplification and optical sensors |
US6212416B1 (en) * | 1995-11-22 | 2001-04-03 | Good Samaritan Hospital And Medical Center | Device for monitoring changes in analyte concentration |
US6187614B1 (en) * | 1996-03-07 | 2001-02-13 | Matsushita Electronics Corporation | Electronic component, method for making the same, and lead frame and mold assembly for use therein |
US6049727A (en) * | 1996-07-08 | 2000-04-11 | Animas Corporation | Implantable sensor and system for in vivo measurement and control of fluid constituent levels |
US5708354A (en) * | 1996-12-18 | 1998-01-13 | Mcdermott Technology, Inc. | Portable electromagnetic acoustic transducer pulser controller |
US6208894B1 (en) * | 1997-02-26 | 2001-03-27 | Alfred E. Mann Foundation For Scientific Research And Advanced Bionics | System of implantable devices for monitoring and/or affecting body parameters |
US20040045879A1 (en) * | 1997-03-04 | 2004-03-11 | Dexcom, Inc. | Device and method for determining analyte levels |
US20040011671A1 (en) * | 1997-03-04 | 2004-01-22 | Dexcom, Inc. | Device and method for determining analyte levels |
US6214185B1 (en) * | 1997-04-17 | 2001-04-10 | Avl Medical Instruments | Sensor with PVC cover membrane |
US5861019A (en) * | 1997-07-25 | 1999-01-19 | Medtronic Inc. | Implantable medical device microstrip telemetry antenna |
US5871514A (en) * | 1997-08-01 | 1999-02-16 | Medtronic, Inc. | Attachment apparatus for an implantable medical device employing ultrasonic energy |
US5897578A (en) * | 1997-08-01 | 1999-04-27 | Medtronic, Inc. | Attachment apparatus and method for an implantable medical device employing ultrasonic energy |
US6200772B1 (en) * | 1997-08-23 | 2001-03-13 | Sensalyse Holdings Limited | Modified polyurethane membrane sensors and analytical methods |
US6512939B1 (en) * | 1997-10-20 | 2003-01-28 | Medtronic Minimed, Inc. | Implantable enzyme-based monitoring systems adapted for long term use |
US6013113A (en) * | 1998-03-06 | 2000-01-11 | Wilson Greatbatch Ltd. | Slotted insulator for unsealed electrode edges in electrochemical cells |
US6537318B1 (en) * | 1998-04-06 | 2003-03-25 | Konjac Technologies, Llc | Use of glucomannan hydrocolloid as filler material in prostheses |
US6175752B1 (en) * | 1998-04-30 | 2001-01-16 | Therasense, Inc. | Analyte monitoring device and methods of use |
US20040039406A1 (en) * | 1998-06-01 | 2004-02-26 | Jessen Jonh W. | Method and apparatus for placing and maintaining a percutaneous tube into a body cavity |
US6187062B1 (en) * | 1998-06-16 | 2001-02-13 | Alcatel | Current collection through thermally sprayed tabs at the ends of a spirally wound electrochemical cell |
US6180416B1 (en) * | 1998-09-30 | 2001-01-30 | Cygnus, Inc. | Method and device for predicting physiological values |
US6201980B1 (en) * | 1998-10-05 | 2001-03-13 | The Regents Of The University Of California | Implantable medical sensor system |
US6016448A (en) * | 1998-10-27 | 2000-01-18 | Medtronic, Inc. | Multilevel ERI for implantable medical devices |
US6206856B1 (en) * | 1998-11-04 | 2001-03-27 | Sakharam D. Mahurkar | Safety syringe |
US20040015134A1 (en) * | 1998-11-13 | 2004-01-22 | Elan Pharma International, Ltd. | Drug delivery systems and methods |
US20040030285A1 (en) * | 1998-11-13 | 2004-02-12 | Gilad Lavi | Drug delivery systems and methods |
US6520326B2 (en) * | 1999-02-25 | 2003-02-18 | Medtronic Minimed, Inc. | Glucose sensor package system |
US6360888B1 (en) * | 1999-02-25 | 2002-03-26 | Minimed Inc. | Glucose sensor package system |
US6189536B1 (en) * | 1999-04-15 | 2001-02-20 | Medtronic Inc. | Method for protecting implantable devices |
US6527729B1 (en) * | 1999-11-10 | 2003-03-04 | Pacesetter, Inc. | Method for monitoring patient using acoustic sensor |
US6520997B1 (en) * | 1999-12-08 | 2003-02-18 | Baxter International Inc. | Porous three dimensional structure |
US6694191B2 (en) * | 2000-01-21 | 2004-02-17 | Medtronic Minimed, Inc. | Ambulatory medical apparatus and method having telemetry modifiable control software |
US20020022883A1 (en) * | 2000-06-13 | 2002-02-21 | Burg Karen J.L. | Tissue engineering composite |
US6683535B1 (en) * | 2000-08-09 | 2004-01-27 | Alderon Industries, Llc | Water detection system and method |
US6699218B2 (en) * | 2000-11-09 | 2004-03-02 | Insulet Corporation | Transcutaneous delivery means |
US6695860B1 (en) * | 2000-11-13 | 2004-02-24 | Isense Corp. | Transcutaneous sensor insertion device |
US20030006669A1 (en) * | 2001-05-22 | 2003-01-09 | Sri International | Rolled electroactive polymers |
US20030002874A1 (en) * | 2001-06-14 | 2003-01-02 | Takeshi Uesaka | Photographing device, recording medium, program, camera and camera production method |
US20030032874A1 (en) * | 2001-07-27 | 2003-02-13 | Dexcom, Inc. | Sensor head for use with implantable devices |
US20030023317A1 (en) * | 2001-07-27 | 2003-01-30 | Dexcom, Inc. | Membrane for use with implantable devices |
US6702857B2 (en) * | 2001-07-27 | 2004-03-09 | Dexcom, Inc. | Membrane for use with implantable devices |
US20030036803A1 (en) * | 2001-08-14 | 2003-02-20 | Mcghan Jim J. | Medical implant having bioabsorbable textured surface |
US20040030294A1 (en) * | 2001-11-28 | 2004-02-12 | Mahurkar Sakharam D. | Retractable needle single use safety syringe |
US20040010207A1 (en) * | 2002-07-15 | 2004-01-15 | Flaherty J. Christopher | Self-contained, automatic transcutaneous physiologic sensing system |
Cited By (294)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9439589B2 (en) | 1997-03-04 | 2016-09-13 | Dexcom, Inc. | Device and method for determining analyte levels |
US8527025B1 (en) | 1997-03-04 | 2013-09-03 | Dexcom, Inc. | Device and method for determining analyte levels |
US8676288B2 (en) | 1997-03-04 | 2014-03-18 | Dexcom, Inc. | Device and method for determining analyte levels |
US8527026B2 (en) | 1997-03-04 | 2013-09-03 | Dexcom, Inc. | Device and method for determining analyte levels |
US8155723B2 (en) | 1997-03-04 | 2012-04-10 | Dexcom, Inc. | Device and method for determining analyte levels |
US7974672B2 (en) | 1997-03-04 | 2011-07-05 | Dexcom, Inc. | Device and method for determining analyte levels |
US9931067B2 (en) | 1997-03-04 | 2018-04-03 | Dexcom, Inc. | Device and method for determining analyte levels |
US7970448B2 (en) | 1997-03-04 | 2011-06-28 | Dexcom, Inc. | Device and method for determining analyte levels |
US8923947B2 (en) | 1997-03-04 | 2014-12-30 | Dexcom, Inc. | Device and method for determining analyte levels |
US7835777B2 (en) | 1997-03-04 | 2010-11-16 | Dexcom, Inc. | Device and method for determining analyte levels |
US7792562B2 (en) | 1997-03-04 | 2010-09-07 | Dexcom, Inc. | Device and method for determining analyte levels |
US9339223B2 (en) | 1997-03-04 | 2016-05-17 | Dexcom, Inc. | Device and method for determining analyte levels |
US8175673B2 (en) | 1998-04-30 | 2012-05-08 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8346336B2 (en) | 1998-04-30 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8480580B2 (en) | 1998-04-30 | 2013-07-09 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US20070249919A1 (en) * | 1998-04-30 | 2007-10-25 | Abbott Diabetes Care, Inc. | Analyte monitoring device and methods of use |
US9326714B2 (en) | 1998-04-30 | 2016-05-03 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8473021B2 (en) | 1998-04-30 | 2013-06-25 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US20090187088A1 (en) * | 1998-04-30 | 2009-07-23 | Abbott Diabetes Care Inc. | Analyte Monitoring Device and Methods of Use |
US9072477B2 (en) | 1998-04-30 | 2015-07-07 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9066694B2 (en) | 1998-04-30 | 2015-06-30 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9066695B2 (en) | 1998-04-30 | 2015-06-30 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9066697B2 (en) | 1998-04-30 | 2015-06-30 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9042953B2 (en) | 1998-04-30 | 2015-05-26 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9014773B2 (en) | 1998-04-30 | 2015-04-21 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8465425B2 (en) | 1998-04-30 | 2013-06-18 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9011331B2 (en) | 1998-04-30 | 2015-04-21 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8597189B2 (en) | 1998-04-30 | 2013-12-03 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8974386B2 (en) | 1998-04-30 | 2015-03-10 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8612159B2 (en) | 1998-04-30 | 2013-12-17 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8617071B2 (en) | 1998-04-30 | 2013-12-31 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8409131B2 (en) | 1998-04-30 | 2013-04-02 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8622906B2 (en) | 1998-04-30 | 2014-01-07 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8880137B2 (en) | 1998-04-30 | 2014-11-04 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8391945B2 (en) | 1998-04-30 | 2013-03-05 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8641619B2 (en) | 1998-04-30 | 2014-02-04 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8380273B2 (en) | 1998-04-30 | 2013-02-19 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8372005B2 (en) | 1998-04-30 | 2013-02-12 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8366614B2 (en) | 1998-04-30 | 2013-02-05 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8357091B2 (en) | 1998-04-30 | 2013-01-22 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8353829B2 (en) | 1998-04-30 | 2013-01-15 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8840553B2 (en) | 1998-04-30 | 2014-09-23 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8346337B2 (en) | 1998-04-30 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8774887B2 (en) | 1998-04-30 | 2014-07-08 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8744545B2 (en) | 1998-04-30 | 2014-06-03 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8738109B2 (en) | 1998-04-30 | 2014-05-27 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8734346B2 (en) | 1998-04-30 | 2014-05-27 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8649841B2 (en) | 1998-04-30 | 2014-02-11 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8734348B2 (en) | 1998-04-30 | 2014-05-27 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8162829B2 (en) | 1998-04-30 | 2012-04-24 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8306598B2 (en) | 1998-04-30 | 2012-11-06 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8177716B2 (en) | 1998-04-30 | 2012-05-15 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8660627B2 (en) | 1998-04-30 | 2014-02-25 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8224413B2 (en) | 1998-04-30 | 2012-07-17 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8226555B2 (en) | 1998-04-30 | 2012-07-24 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8666469B2 (en) | 1998-04-30 | 2014-03-04 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8226558B2 (en) | 1998-04-30 | 2012-07-24 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8226557B2 (en) | 1998-04-30 | 2012-07-24 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8231532B2 (en) | 1998-04-30 | 2012-07-31 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8688188B2 (en) | 1998-04-30 | 2014-04-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8235896B2 (en) | 1998-04-30 | 2012-08-07 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8287454B2 (en) | 1998-04-30 | 2012-10-16 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US10478108B2 (en) | 1998-04-30 | 2019-11-19 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8672844B2 (en) | 1998-04-30 | 2014-03-18 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8255031B2 (en) | 1998-04-30 | 2012-08-28 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8260392B2 (en) | 1998-04-30 | 2012-09-04 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8265726B2 (en) | 1998-04-30 | 2012-09-11 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8670815B2 (en) | 1998-04-30 | 2014-03-11 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8275439B2 (en) | 1998-04-30 | 2012-09-25 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8273022B2 (en) | 1998-04-30 | 2012-09-25 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8652043B2 (en) | 2001-01-02 | 2014-02-18 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9011332B2 (en) | 2001-01-02 | 2015-04-21 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9610034B2 (en) | 2001-01-02 | 2017-04-04 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8668645B2 (en) | 2001-01-02 | 2014-03-11 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9498159B2 (en) | 2001-01-02 | 2016-11-22 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US10052051B2 (en) | 2002-05-22 | 2018-08-21 | Dexcom, Inc. | Silicone based membranes for use in implantable glucose sensors |
US9549693B2 (en) | 2002-05-22 | 2017-01-24 | Dexcom, Inc. | Silicone based membranes for use in implantable glucose sensors |
US11020026B2 (en) | 2002-05-22 | 2021-06-01 | Dexcom, Inc. | Silicone based membranes for use in implantable glucose sensors |
US9179869B2 (en) | 2002-05-22 | 2015-11-10 | Dexcom, Inc. | Techniques to improve polyurethane membranes for implantable glucose sensors |
US8064977B2 (en) | 2002-05-22 | 2011-11-22 | Dexcom, Inc. | Silicone based membranes for use in implantable glucose sensors |
US8543184B2 (en) | 2002-05-22 | 2013-09-24 | Dexcom, Inc. | Silicone based membranes for use in implantable glucose sensors |
US10154807B2 (en) | 2002-05-22 | 2018-12-18 | Dexcom, Inc. | Techniques to improve polyurethane membranes for implantable glucose sensors |
US8053018B2 (en) | 2002-05-22 | 2011-11-08 | Dexcom, Inc. | Techniques to improve polyurethane membranes for implantable glucose sensors |
US8050731B2 (en) | 2002-05-22 | 2011-11-01 | Dexcom, Inc. | Techniques to improve polyurethane membranes for implantable glucose sensors |
US8865249B2 (en) | 2002-05-22 | 2014-10-21 | Dexcom, Inc. | Techniques to improve polyurethane membranes for implantable glucose sensors |
US9801574B2 (en) | 2002-05-22 | 2017-10-31 | Dexcom, Inc. | Techniques to improve polyurethane membranes for implantable glucose sensors |
US9541519B2 (en) | 2002-10-18 | 2017-01-10 | Medtronic Minimed, Inc. | Amperometric sensor electrodes |
US20060211921A1 (en) * | 2003-04-04 | 2006-09-21 | Brauker James H | Optimized sensor geometry for an implantable glucose sensor |
US7881763B2 (en) | 2003-04-04 | 2011-02-01 | Dexcom, Inc. | Optimized sensor geometry for an implantable glucose sensor |
US8364229B2 (en) | 2003-07-25 | 2013-01-29 | Dexcom, Inc. | Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise |
US10376143B2 (en) | 2003-07-25 | 2019-08-13 | Dexcom, Inc. | Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise |
US9763609B2 (en) | 2003-07-25 | 2017-09-19 | Dexcom, Inc. | Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise |
USRE43399E1 (en) | 2003-07-25 | 2012-05-22 | Dexcom, Inc. | Electrode systems for electrochemical sensors |
US8442610B2 (en) | 2003-08-01 | 2013-05-14 | Dexcom, Inc. | System and methods for processing analyte sensor data |
US8700117B2 (en) | 2003-08-01 | 2014-04-15 | Dexcom, Inc. | System and methods for processing analyte sensor data |
US8052601B2 (en) | 2003-08-01 | 2011-11-08 | Dexcom, Inc. | System and methods for processing analyte sensor data |
US8676287B2 (en) | 2003-08-01 | 2014-03-18 | Dexcom, Inc. | System and methods for processing analyte sensor data |
US8788006B2 (en) | 2003-08-01 | 2014-07-22 | Dexcom, Inc. | System and methods for processing analyte sensor data |
US8622905B2 (en) | 2003-08-01 | 2014-01-07 | Dexcom, Inc. | System and methods for processing analyte sensor data |
US8394021B2 (en) | 2003-08-01 | 2013-03-12 | Dexcom, Inc. | System and methods for processing analyte sensor data |
US8911369B2 (en) | 2003-12-05 | 2014-12-16 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US8160671B2 (en) | 2003-12-05 | 2012-04-17 | Dexcom, Inc. | Calibration techniques for a continuous analyte sensor |
US10299712B2 (en) | 2003-12-05 | 2019-05-28 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US9579053B2 (en) | 2003-12-05 | 2017-02-28 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US8287453B2 (en) | 2003-12-05 | 2012-10-16 | Dexcom, Inc. | Analyte sensor |
US8249684B2 (en) | 2003-12-05 | 2012-08-21 | Dexcom, Inc. | Calibration techniques for a continuous analyte sensor |
US11020031B1 (en) | 2003-12-05 | 2021-06-01 | Dexcom, Inc. | Analyte sensor |
US11633133B2 (en) | 2003-12-05 | 2023-04-25 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US8428678B2 (en) | 2003-12-05 | 2013-04-23 | Dexcom, Inc. | Calibration techniques for a continuous analyte sensor |
US11000215B1 (en) | 2003-12-05 | 2021-05-11 | Dexcom, Inc. | Analyte sensor |
US10327638B2 (en) | 2004-05-03 | 2019-06-25 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8792955B2 (en) | 2004-05-03 | 2014-07-29 | Dexcom, Inc. | Transcutaneous analyte sensor |
US9833143B2 (en) | 2004-05-03 | 2017-12-05 | Dexcom, Inc. | Transcutaneous analyte sensor |
US20100041971A1 (en) * | 2004-05-03 | 2010-02-18 | Dexcom, Inc. | Implantable analyte sensor |
US20090062633A1 (en) * | 2004-05-03 | 2009-03-05 | Dexcorn, Inc. | Implantable analyte sensor |
US7857760B2 (en) | 2004-07-13 | 2010-12-28 | Dexcom, Inc. | Analyte sensor |
US9044199B2 (en) | 2004-07-13 | 2015-06-02 | Dexcom, Inc. | Transcutaneous analyte sensor |
US9814414B2 (en) | 2004-07-13 | 2017-11-14 | Dexcom, Inc. | Transcutaneous analyte sensor |
US9775543B2 (en) | 2004-07-13 | 2017-10-03 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8663109B2 (en) | 2004-07-13 | 2014-03-04 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8280475B2 (en) | 2004-07-13 | 2012-10-02 | Dexcom, Inc. | Transcutaneous analyte sensor |
US9986942B2 (en) | 2004-07-13 | 2018-06-05 | Dexcom, Inc. | Analyte sensor |
US10022078B2 (en) | 2004-07-13 | 2018-07-17 | Dexcom, Inc. | Analyte sensor |
US11064917B2 (en) | 2004-07-13 | 2021-07-20 | Dexcom, Inc. | Analyte sensor |
US9668677B2 (en) | 2004-07-13 | 2017-06-06 | Dexcom, Inc. | Analyte sensor |
US11045120B2 (en) | 2004-07-13 | 2021-06-29 | Dexcom, Inc. | Analyte sensor |
US8231531B2 (en) | 2004-07-13 | 2012-07-31 | Dexcom, Inc. | Analyte sensor |
US11026605B1 (en) | 2004-07-13 | 2021-06-08 | Dexcom, Inc. | Analyte sensor |
US9610031B2 (en) | 2004-07-13 | 2017-04-04 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8721545B2 (en) | 2004-07-13 | 2014-05-13 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8615282B2 (en) | 2004-07-13 | 2013-12-24 | Dexcom, Inc. | Analyte sensor |
US8483791B2 (en) | 2004-07-13 | 2013-07-09 | Dexcom, Inc. | Transcutaneous analyte sensor |
US11883164B2 (en) | 2004-07-13 | 2024-01-30 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US8452368B2 (en) | 2004-07-13 | 2013-05-28 | Dexcom, Inc. | Transcutaneous analyte sensor |
US10314525B2 (en) | 2004-07-13 | 2019-06-11 | Dexcom, Inc. | Analyte sensor |
US8750955B2 (en) | 2004-07-13 | 2014-06-10 | Dexcom, Inc. | Analyte sensor |
US8457708B2 (en) | 2004-07-13 | 2013-06-04 | Dexcom, Inc. | Transcutaneous analyte sensor |
US10993641B2 (en) | 2004-07-13 | 2021-05-04 | Dexcom, Inc. | Analyte sensor |
US8792953B2 (en) | 2004-07-13 | 2014-07-29 | Dexcom, Inc. | Transcutaneous analyte sensor |
US10524703B2 (en) | 2004-07-13 | 2020-01-07 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8801611B2 (en) | 2004-07-13 | 2014-08-12 | Dexcom, Inc. | Transcutaneous analyte sensor |
US10993642B2 (en) | 2004-07-13 | 2021-05-04 | Dexcom, Inc. | Analyte sensor |
US10980452B2 (en) | 2004-07-13 | 2021-04-20 | Dexcom, Inc. | Analyte sensor |
US8565848B2 (en) | 2004-07-13 | 2013-10-22 | Dexcom, Inc. | Transcutaneous analyte sensor |
US10932700B2 (en) | 2004-07-13 | 2021-03-02 | Dexcom, Inc. | Analyte sensor |
US7905833B2 (en) | 2004-07-13 | 2011-03-15 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8886272B2 (en) | 2004-07-13 | 2014-11-11 | Dexcom, Inc. | Analyte sensor |
US7885697B2 (en) | 2004-07-13 | 2011-02-08 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8515519B2 (en) | 2004-07-13 | 2013-08-20 | Dexcom, Inc. | Transcutaneous analyte sensor |
US9414777B2 (en) | 2004-07-13 | 2016-08-16 | Dexcom, Inc. | Transcutaneous analyte sensor |
US10709362B2 (en) | 2004-07-13 | 2020-07-14 | Dexcom, Inc. | Analyte sensor |
US10709363B2 (en) | 2004-07-13 | 2020-07-14 | Dexcom, Inc. | Analyte sensor |
US10722152B2 (en) | 2004-07-13 | 2020-07-28 | Dexcom, Inc. | Analyte sensor |
US10918313B2 (en) | 2004-07-13 | 2021-02-16 | Dexcom, Inc. | Analyte sensor |
US7783333B2 (en) | 2004-07-13 | 2010-08-24 | Dexcom, Inc. | Transcutaneous medical device with variable stiffness |
US10918315B2 (en) | 2004-07-13 | 2021-02-16 | Dexcom, Inc. | Analyte sensor |
US20090156919A1 (en) * | 2004-07-13 | 2009-06-18 | Dexcom, Inc. | Transcutaneous analyte sensor |
US10918314B2 (en) | 2004-07-13 | 2021-02-16 | Dexcom, Inc. | Analyte sensor |
US9247900B2 (en) | 2004-07-13 | 2016-02-02 | Dexcom, Inc. | Analyte sensor |
US8313434B2 (en) | 2004-07-13 | 2012-11-20 | Dexcom, Inc. | Analyte sensor inserter system |
US9055901B2 (en) | 2004-07-13 | 2015-06-16 | Dexcom, Inc. | Transcutaneous analyte sensor |
US20090163790A1 (en) * | 2004-07-13 | 2009-06-25 | Dexcom, Inc. | Transcutaneous analyte sensor |
US10799158B2 (en) | 2004-07-13 | 2020-10-13 | Dexcom, Inc. | Analyte sensor |
US10799159B2 (en) | 2004-07-13 | 2020-10-13 | Dexcom, Inc. | Analyte sensor |
US10827956B2 (en) | 2004-07-13 | 2020-11-10 | Dexcom, Inc. | Analyte sensor |
US10813576B2 (en) | 2004-07-13 | 2020-10-27 | Dexcom, Inc. | Analyte sensor |
US9078626B2 (en) | 2004-07-13 | 2015-07-14 | Dexcom, Inc. | Transcutaneous analyte sensor |
US10610136B2 (en) | 2005-03-10 | 2020-04-07 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10918317B2 (en) | 2005-03-10 | 2021-02-16 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10856787B2 (en) | 2005-03-10 | 2020-12-08 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
EP3305191A1 (en) | 2005-03-10 | 2018-04-11 | DexCom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
EP4252649A2 (en) | 2005-03-10 | 2023-10-04 | Dexcom, Inc. | Method for processing analyte sensor data for sensor calibration |
US10743801B2 (en) | 2005-03-10 | 2020-08-18 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10918318B2 (en) | 2005-03-10 | 2021-02-16 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10610137B2 (en) | 2005-03-10 | 2020-04-07 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10716498B2 (en) | 2005-03-10 | 2020-07-21 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10918316B2 (en) | 2005-03-10 | 2021-02-16 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10925524B2 (en) | 2005-03-10 | 2021-02-23 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
EP4248864A2 (en) | 2005-03-10 | 2023-09-27 | DexCom, Inc. | Method for processing analyte sensor data for sensor calibration |
EP3797682A1 (en) | 2005-03-10 | 2021-03-31 | Dexcom, Inc. | Method for processing analyte sensor data for sensor calibration |
EP2596747A1 (en) | 2005-03-10 | 2013-05-29 | DexCom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10617336B2 (en) | 2005-03-10 | 2020-04-14 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10610135B2 (en) | 2005-03-10 | 2020-04-07 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10898114B2 (en) | 2005-03-10 | 2021-01-26 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
EP2561807A1 (en) | 2005-03-10 | 2013-02-27 | DexCom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10709364B2 (en) | 2005-03-10 | 2020-07-14 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US11051726B2 (en) | 2005-03-10 | 2021-07-06 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US11000213B2 (en) | 2005-03-10 | 2021-05-11 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
EP3932297A1 (en) | 2005-03-10 | 2022-01-05 | Dexcom, Inc. | Method for processing analyte sensor data for sensor calibration |
EP3821803A1 (en) | 2005-03-10 | 2021-05-19 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US7651596B2 (en) | 2005-04-08 | 2010-01-26 | Dexcom, Inc. | Cellulosic-based interference domain for an analyte sensor |
US20070173709A1 (en) * | 2005-04-08 | 2007-07-26 | Petisce James R | Membranes for an analyte sensor |
US20060252027A1 (en) * | 2005-05-05 | 2006-11-09 | Petisce James R | Cellulosic-based resistance domain for an analyte sensor |
US8744546B2 (en) | 2005-05-05 | 2014-06-03 | Dexcom, Inc. | Cellulosic-based resistance domain for an analyte sensor |
US20060249381A1 (en) * | 2005-05-05 | 2006-11-09 | Petisce James R | Cellulosic-based resistance domain for an analyte sensor |
US10300507B2 (en) | 2005-05-05 | 2019-05-28 | Dexcom, Inc. | Cellulosic-based resistance domain for an analyte sensor |
EP2499969A1 (en) | 2005-06-21 | 2012-09-19 | DexCom, Inc. | Analyte sensor |
US10813577B2 (en) | 2005-06-21 | 2020-10-27 | Dexcom, Inc. | Analyte sensor |
EP2532302A1 (en) | 2005-06-21 | 2012-12-12 | DexCom, Inc. | Analyte sensor |
EP2517623A1 (en) | 2005-06-21 | 2012-10-31 | DexCom, Inc. | Analyte sensor |
US8915850B2 (en) | 2005-11-01 | 2014-12-23 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9078607B2 (en) | 2005-11-01 | 2015-07-14 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US11363975B2 (en) | 2005-11-01 | 2022-06-21 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9326716B2 (en) | 2005-11-01 | 2016-05-03 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US10952652B2 (en) | 2005-11-01 | 2021-03-23 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US11103165B2 (en) | 2005-11-01 | 2021-08-31 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8920319B2 (en) | 2005-11-01 | 2014-12-30 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US11911151B1 (en) | 2005-11-01 | 2024-02-27 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US11272867B2 (en) | 2005-11-01 | 2022-03-15 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US10201301B2 (en) | 2005-11-01 | 2019-02-12 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US10231654B2 (en) | 2005-11-01 | 2019-03-19 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US11399748B2 (en) | 2005-11-01 | 2022-08-02 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
EP1785085A1 (en) * | 2005-11-12 | 2007-05-16 | Roche Diagnostics GmbH | Implantable electrode system, method and device for measuring the concentration of an analyte in a human or animal body |
US20070151868A1 (en) * | 2005-11-12 | 2007-07-05 | Arnulf Staib | Implantable electrode system, method and apparatus for measuring an analyte concentration in a human or animal body |
EP1785086A3 (en) * | 2005-11-12 | 2009-01-28 | Roche Diagnostics GmbH | Implantable electrode system, method and device for measuring the concentration of an analyte in a human or animal body |
EP1785086A2 (en) | 2005-11-12 | 2007-05-16 | Roche Diagnostics GmbH | Implantable electrode system, method and device for measuring the concentration of an analyte in a human or animal body |
US20070179568A1 (en) * | 2006-01-31 | 2007-08-02 | Sdgi Holdings, Inc. | Methods for detecting osteolytic conditions in the body |
US8095198B2 (en) | 2006-01-31 | 2012-01-10 | Warsaw Orthopedic. Inc. | Methods for detecting osteolytic conditions in the body |
EP4282332A2 (en) | 2006-02-22 | 2023-11-29 | DexCom, Inc. | Analyte sensor |
EP3756537A1 (en) | 2006-02-22 | 2020-12-30 | DexCom, Inc. | Analyte sensor |
EP2829224A2 (en) | 2006-02-22 | 2015-01-28 | DexCom, Inc. | Analyte sensor |
US8133178B2 (en) | 2006-02-22 | 2012-03-13 | Dexcom, Inc. | Analyte sensor |
EP2407095A1 (en) | 2006-02-22 | 2012-01-18 | DexCom, Inc. | Analyte sensor |
EP2407094A1 (en) | 2006-02-22 | 2012-01-18 | DexCom, Inc. | Analyte sensor |
US9724028B2 (en) | 2006-02-22 | 2017-08-08 | Dexcom, Inc. | Analyte sensor |
EP3892186A1 (en) | 2006-02-22 | 2021-10-13 | DexCom, Inc. | Analyte sensor |
EP2407093A1 (en) | 2006-02-22 | 2012-01-18 | DexCom, Inc. | Analyte sensor |
EP3649925A1 (en) | 2006-02-22 | 2020-05-13 | DexCom, Inc. | Analyte sensor |
EP3513708A1 (en) | 2006-03-09 | 2019-07-24 | Dexcom, Inc. | Systems and methods for processing analyte sensor data |
EP4218548A1 (en) | 2006-03-09 | 2023-08-02 | Dexcom, Inc. | Systems and methods for processing analyte sensor data |
WO2007102842A2 (en) | 2006-03-09 | 2007-09-13 | Dexcom, Inc. | Systems and methods for processing analyte sensor data |
US20070227907A1 (en) * | 2006-04-04 | 2007-10-04 | Rajiv Shah | Methods and materials for controlling the electrochemistry of analyte sensors |
US20100096278A1 (en) * | 2006-04-04 | 2010-04-22 | Medtronic Minimed, Inc. | Methods and materials for controlling the electrochemistry of analyte sensors |
US8137277B2 (en) | 2006-04-11 | 2012-03-20 | Warsaw Orthopedic, Inc. | Volumetric measurement and visual feedback of tissues |
US7918796B2 (en) | 2006-04-11 | 2011-04-05 | Warsaw Orthopedic, Inc. | Volumetric measurement and visual feedback of tissues |
US20070238998A1 (en) * | 2006-04-11 | 2007-10-11 | Sdgi Holdings, Inc. | Volumetric measurement and visual feedback of tissues |
US20090099433A1 (en) * | 2006-06-19 | 2009-04-16 | Arnulf Staib | Amperometric sensor and method for its manufacturing |
US8527024B2 (en) | 2006-06-19 | 2013-09-03 | Roche Diagnostics Operations, Inc. | Amperometric sensor and method for its manufacturing |
US9700252B2 (en) | 2006-06-19 | 2017-07-11 | Roche Diabetes Care, Inc. | Amperometric sensor and method for its manufacturing |
US11382539B2 (en) | 2006-10-04 | 2022-07-12 | Dexcom, Inc. | Analyte sensor |
US11399745B2 (en) | 2006-10-04 | 2022-08-02 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US10349873B2 (en) | 2006-10-04 | 2019-07-16 | Dexcom, Inc. | Analyte sensor |
US9451908B2 (en) | 2006-10-04 | 2016-09-27 | Dexcom, Inc. | Analyte sensor |
US8423114B2 (en) | 2006-10-04 | 2013-04-16 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US10136844B2 (en) | 2006-10-04 | 2018-11-27 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
EP2796090A1 (en) | 2006-10-04 | 2014-10-29 | DexCom, Inc. | Analyte sensor |
US7831287B2 (en) | 2006-10-04 | 2010-11-09 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US9504413B2 (en) | 2006-10-04 | 2016-11-29 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US20080214910A1 (en) * | 2007-03-01 | 2008-09-04 | Buck Harvey B | System and method for operating an electrochemical analyte sensor |
US7751864B2 (en) | 2007-03-01 | 2010-07-06 | Roche Diagnostics Operations, Inc. | System and method for operating an electrochemical analyte sensor |
EP2796093A1 (en) | 2007-03-26 | 2014-10-29 | DexCom, Inc. | Analyte sensor |
US10791928B2 (en) | 2007-05-18 | 2020-10-06 | Dexcom, Inc. | Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise |
EP4159114A1 (en) | 2007-10-09 | 2023-04-05 | DexCom, Inc. | Integrated insulin delivery system with continuous glucose sensor |
EP4098177A1 (en) | 2007-10-09 | 2022-12-07 | DexCom, Inc. | Integrated insulin delivery system with continuous glucose sensor |
EP4250312A2 (en) | 2007-10-25 | 2023-09-27 | DexCom, Inc. | Systems and methods for processing sensor data |
US11102306B2 (en) | 2008-02-21 | 2021-08-24 | Dexcom, Inc. | Systems and methods for processing, transmitting and displaying sensor data |
US8229535B2 (en) | 2008-02-21 | 2012-07-24 | Dexcom, Inc. | Systems and methods for blood glucose monitoring and alert delivery |
US9020572B2 (en) | 2008-02-21 | 2015-04-28 | Dexcom, Inc. | Systems and methods for processing, transmitting and displaying sensor data |
US8591455B2 (en) | 2008-02-21 | 2013-11-26 | Dexcom, Inc. | Systems and methods for customizing delivery of sensor data |
US9143569B2 (en) | 2008-02-21 | 2015-09-22 | Dexcom, Inc. | Systems and methods for processing, transmitting and displaying sensor data |
US11896374B2 (en) | 2008-03-25 | 2024-02-13 | Dexcom, Inc. | Analyte sensor |
US10602968B2 (en) | 2008-03-25 | 2020-03-31 | Dexcom, Inc. | Analyte sensor |
US8396528B2 (en) | 2008-03-25 | 2013-03-12 | Dexcom, Inc. | Analyte sensor |
US9566026B2 (en) | 2008-03-28 | 2017-02-14 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
US20090247855A1 (en) * | 2008-03-28 | 2009-10-01 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
US9173606B2 (en) | 2008-03-28 | 2015-11-03 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
US8682408B2 (en) | 2008-03-28 | 2014-03-25 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
US11730407B2 (en) | 2008-03-28 | 2023-08-22 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
US8954128B2 (en) | 2008-03-28 | 2015-02-10 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
US9173607B2 (en) | 2008-03-28 | 2015-11-03 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
US8583204B2 (en) | 2008-03-28 | 2013-11-12 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
US10143410B2 (en) | 2008-03-28 | 2018-12-04 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
US9693721B2 (en) | 2008-03-28 | 2017-07-04 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
US11147483B2 (en) | 2008-03-28 | 2021-10-19 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
US9572523B2 (en) | 2008-03-28 | 2017-02-21 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
US9549699B2 (en) | 2008-03-28 | 2017-01-24 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
US20100025238A1 (en) * | 2008-07-31 | 2010-02-04 | Medtronic Minimed, Inc. | Analyte sensor apparatuses having improved electrode configurations and methods for making and using them |
US10327678B2 (en) | 2008-07-31 | 2019-06-25 | Medtronic Minimed, Inc. | Analyte sensor apparatuses comprising multiple implantable sensor elements and methods for making and using them |
US8700114B2 (en) | 2008-07-31 | 2014-04-15 | Medtronic Minmed, Inc. | Analyte sensor apparatuses comprising multiple implantable sensor elements and methods for making and using them |
US20100030045A1 (en) * | 2008-07-31 | 2010-02-04 | Medtronic Minimed, Inc. | Analyte sensor apparatuses comprising multiple implantable sensor elements and methods for making and using them |
US10980461B2 (en) | 2008-11-07 | 2021-04-20 | Dexcom, Inc. | Advanced analyte sensor calibration and error detection |
US20160161439A1 (en) * | 2011-02-03 | 2016-06-09 | Arkray, Inc. | Analyzing Device, Sensor Testing Device, Testing Method and Computer-Readable Storage Medium |
US10295495B2 (en) * | 2011-02-03 | 2019-05-21 | Arkray, Inc. | Analyzing device, sensor testing device, testing method and computer-readable storage medium |
US20160161440A1 (en) * | 2011-02-03 | 2016-06-09 | Arkray, Inc. | Analyzing Device, Sensor Testing Device, Testing Method and Computer-Readable Storage Medium |
US9297777B2 (en) * | 2011-02-03 | 2016-03-29 | Arkray, Inc. | Analyzing device, sensor testing device, testing method and computer-readable storage medium |
US20120199496A1 (en) * | 2011-02-03 | 2012-08-09 | Arkray, Inc. | Analyzing Device, Sensor Testing Device, Testing Method and Computer-Readable Storage Medium |
CN102628832A (en) * | 2011-02-03 | 2012-08-08 | 爱科来株式会社 | Analyzing device, sensor testing device and testing method |
EP4233718A2 (en) | 2011-04-08 | 2023-08-30 | DexCom, Inc. | Systems and methods for processing and transmitting sensor data |
EP3536241A1 (en) | 2011-04-08 | 2019-09-11 | Dexcom, Inc. | Systems and methods for processing and transmitting sensor data |
US11997483B2 (en) | 2011-04-08 | 2024-05-28 | Dexcom, Inc. | Systems and methods for processing and transmitting sensor data |
EP3505064A1 (en) | 2011-09-23 | 2019-07-03 | Dexcom, Inc. | Systems and methods for processing and transmitting sensor data |
EP3505065A1 (en) | 2011-09-23 | 2019-07-03 | Dexcom, Inc. | Systems and methods for processing and transmitting sensor data |
EP3092949A1 (en) | 2011-09-23 | 2016-11-16 | Dexcom, Inc. | Systems and methods for processing and transmitting sensor data |
EP3888551A1 (en) | 2011-09-23 | 2021-10-06 | Dexcom, Inc. | Systems and methods for processing and transmitting sensor data |
Also Published As
Publication number | Publication date |
---|---|
JP2005525834A (en) | 2005-09-02 |
JP4295615B2 (en) | 2009-07-15 |
US7471972B2 (en) | 2008-12-30 |
US20030032874A1 (en) | 2003-02-13 |
EP1411823B1 (en) | 2006-07-12 |
AU2002317584A1 (en) | 2003-02-17 |
US9804114B2 (en) | 2017-10-31 |
DE60213096D1 (en) | 2006-08-24 |
US20130299350A1 (en) | 2013-11-14 |
US20160178558A1 (en) | 2016-06-23 |
EP1411823A2 (en) | 2004-04-28 |
US8509871B2 (en) | 2013-08-13 |
EP1669022A3 (en) | 2006-06-21 |
US20090045055A1 (en) | 2009-02-19 |
WO2003011131A2 (en) | 2003-02-13 |
EP1669022A2 (en) | 2006-06-14 |
US9328371B2 (en) | 2016-05-03 |
WO2003011131A3 (en) | 2003-08-21 |
ATE332666T1 (en) | 2006-08-15 |
US20180024086A1 (en) | 2018-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9804114B2 (en) | Sensor head for use with implantable devices | |
US9931067B2 (en) | Device and method for determining analyte levels | |
US7136689B2 (en) | Device and method for determining analyte levels | |
US6405066B1 (en) | Implantable analyte sensor | |
ES2324804T3 (en) | A GLUCOSE SENSOR. | |
US8527025B1 (en) | Device and method for determining analyte levels | |
US5914026A (en) | Implantable sensor employing an auxiliary electrode | |
US20040045879A1 (en) | Device and method for determining analyte levels | |
CA2406814A1 (en) | Implantable analyte sensor | |
US20170290538A1 (en) | Amperometric sensor and method for its manufacturing | |
WO2004060297A2 (en) | Hydrophilic cross-linking agents for use in enzymatic sensors | |
GB2197486A (en) | Enzyme electrode sensor | |
US20240158827A1 (en) | Enzyme mediator functionalized polymers for use with analyte sensors | |
CN117942073A (en) | Enzyme mediator functionalized polymers for use with analyte sensors | |
JP2020156911A (en) | Biosensor probe and method for producing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: DEXCOM, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:RHODES, RATHBUN K.;TAPSAK, MARK A.;BRAUKER, JAMES H.;AND OTHERS;REEL/FRAME:021595/0445;SIGNING DATES FROM 20010917 TO 20011001 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
CC | Certificate of correction | ||
FPAY | Fee payment |
Year of fee payment: 4 |
|
FEPP | Fee payment procedure |
Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
FPAY | Fee payment |
Year of fee payment: 8 |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 12TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1553); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 12 |